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Abstract 
The work described in this thesis pertains to three separate collaborative projects, 
each involving the synthesis of putative precursors and intermediates to polyketides - 
the pseudomonic acids (mupirocin), strobilurin A and alternapyrone. 
Following a general introduction, chapter 2 describes isotopic labelling studies 
conducted on the antibacterial pseudomonic acids. A growth production study of 
Pseudomonas fluorescens determined the optimal conditions for feeding studies. 
Thiol esters 1 and 2 were prepared and fed to the bacteria. No incorporation of 
isotopic label into pseudomonic acid was observed for either of these substrates. 
Chapter 3 discusses the synthesis of mupirocin metabolites isolated from mutant 
strains of P. fluorescens. Mupiric acid 3 and its C-2 epimer 4 were prepared using a 
cross metathesis approach to unequivocally assign the C-2 centre as the R 
configuration. A flexible route for the synthesis of lactone 5, the proposed DH4 
mutant metabolite, has also been developed. The core was prepared via a 
stereoselective Prins cyclisation. Some unexpected side products resulting from this 
key step, give further insight into the mechanism of the Prins reaction. 
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Chapter 4 summarises the synthesis of putative strobilurin precursors, thiol esters 
6 and 7. These were then fed to Strobilurus tenacellus by Zeeck and Thormann. 
Incorporation patterns have shown that the C-2-C-3 bond is cleaved during strobilurin 
biosynthesis. An attempted precursor-directed biosynthesis, employing thiol ester 8 as 
the unnatural substrate, is also discussed. 
The preparation of putative alternapyrone precursors, thiol esters 9 and 10 is 
discussed in chapter 5. Thiol ester 9 has been fed to partially purified cell-free extracts 
of the genetically engineered PKSN by Fujii and Kasahara and showed positive 
incorporation. 
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Introduction 
Chapter 1 Introduction 
1.1 Polyketide Biosynthesis 
The polyketides are a diverse group of naturally occurring secondary metabolites 
related by their common biogenesis. Predominantly derived from acetate, they 
encompass a wide spectrum of compounds of varied structure, functionality and 
biological activity (Figure 1). 1.2.3 
O 
O 
O OH 
Patulin 
(toxin) 
OMe 
Rapamycin 
(immunosuppressant) 
Soraphen A 
(antifungal) 
OH OH IOI/ OH 
OH O 
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Figure 1: Examples of polyketide secondary metabolites. 
Polyketides are assembled by multifunctional enzyme complexes called 
polyketide synthases (PKSs) in a manner analogous to fatty acid biosynthesis. The 
PKS contains all the catalytic domains required to complete the synthesis, in tandem 
with an acyl carrier protein (ACP) which functions as a transport system to deliver the 
chain to the various enzymes as required. 
Firstly, a starter unit is loaded onto the acyl transferase domain of the PKS and is 
transferred onto the ketosynthase (Scheme 1). A malonyl extender unit is then loaded 
onto the malonyl transferase domain via malonyl-CoA (itself derived from acetyl- 
CoA). These two units undergo a condensation reaction catalysed by the ketosynthase 
to form acetoacetate. This is then passed on to the ketoreductase (which reduces the 
keto group), dehydratase (which removes water) and enoyl reductase (which reduces 
the double bond) as required. The nascent chain is then either transferred back onto 
the ketosynthase domain, where it accepts another extender unit and starts off another 
-1- 
Chapter I Introduction 
cycle, or it is passed onto the thiol esterase which cleaves the chain from the PKS and 
releases it, usually as the free acid or as an acyl ester. 
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Scheme 1: Biosynthesis of fatty acid and polyketide metabolites. 
Whereas the fatty acid synthases (FASs) usually have set starter and extender 
units (acetyl-CoA and malonyl-CoA respectively) and each successive chain 
elongation step is followed by a fixed sequence of ketoreduction, dehydration and 
enoyl reduction, the PKSs have been shown to accept a variety of starter and extender 
units (Figure 2) and to undergo some, all or none of the functional group 
modifications at each cycle, resulting in more structurally varied products. 
Starter Units Extender Units 
00000 0 
SCoA O SCOR HO SCoA 
ý 
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SCoA 
a 
Malonyl-CoA Butyryl-CoA 
CrI, 
Isobutyryl-CoA Benzoyl-CoA Acetyl-CoA Cinnamoyl-CoA 0 0 
OO 
yIIý xII 
O0 SCoA SCoA 
HO 
jI-Iý jIýI 
SCoA 
HOSCoA 
7 
SCoA OO 
Acetoacetyl-CoA Hexanoyl-CoA 
Octanoyl-CoA Methylmalonyl-CoA Ethylmalonyl-CoA 
Figure 2: Examples of starter and extender units accepted by the polyketide 
synthases. 
Further structural alterations can also be applied to the basic polyketide structure 
after assembly by tailoring enzymes. Examples of such modifications include 
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methylation (catalysed by S-adenosyl methionine (SAM)) and cyclisation (aided by 
the cyclases). 
To date, polyketide synthases have been found to adopt three different structural 
forms. The type I systems, found in fungal PKSs, consist of one very large multi- 
functional polypeptide which contains all the necessary enzyme activities as discrete 
catalytic domains covalently bonded together. In the bacterial type II systems, 
however, the same catalytic functions are found as fully dissociable enzymes 
associated into a multi-enzyme complex. The type III systems responsible for the 
synthesis of chalcones and stilbenes in plants and polyhydroxyphenols in bacteria, are 
distinct from the other two types of PKS in that they do not involve an acyl carrier 
protein. Unlike their type I and type II counterparts which use ACP to activate the 
acyl-CoA substrates and tether the nascent polyketide chains, type III PKSs act 
directly on the CoA substrates. 
Analysis of the genes responsible for PKS synthesis has led to further 
characterisation. It was established that systems could be either modular or iterative. 
Modular PKSs contain a separate set of enzymes for each catalytic cycle. An example 
of this type of PKS is that responsible for the synthesis of 6-deoxyerythronolide B (a 
precursor to erythromycin) in the bacterium Saccharopolyspora erythraea. 5 It was 
found that the genes responsible for 6-deoxyerythronolide B, were organised into 
three large open reading frames (ORFs) designated eryAI, eryAll and eryAIII 
respectively, which encode for three large multifunctional proteins (-350 kDa each), 
entitled DEBS 1, DEBS 2 and DEBS 3 (Scheme 2). 
Each of these proteins contains the catalytic domains for two condensation 
cycles, i. e. two modules. The chain is passed from module to module, domain to 
domain until it reaches the thiol esterase domain at the end of the sequence. Here it is 
cleaved from the PKS and lactonised to form the 14-membered ring macrolide. 
Analysis of the domains present in each module makes it possible to predict the level 
of reduction in each intermediate and hence the overall product. For instance in 
module 1, we expect a condensation reaction followed by reduction of the ketone to 
an alcohol, whereas in module 4a condensation reaction followed by a complete 
round of reduction is expected. 
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Scheme 2: Domain organisation of the 6-deoxyerythronolide B polyketide synthase. 5 
Iterative PKSs on the other hand, use the same constituent enzymes repeatedly as 
necessary. Each cycle does not necessarily use each catalytic domain, so again, there 
are many possible structural variants. An example of this type of PKS is that 
responsible for 6-methylsalicylic acid. 6 Comprising of only 5 domains (ketosynthase, 
acyl transferase, dehydratase, ketoreductase and acyl carrier protein respectively), it 
catalyses three rounds of chain extension, carrying out different levels of reductive 
processing at each stage (Scheme 3). For example, after the first condensation no 
reduction whatsoever occurs whereas after the second the ketoreductase and 
dehydratase enzymes act to reduce the newly formed ketone to an olefin. During the 
third cycle, the chain undergoes cyclisation, dehydration and enolisation to afford the 
acid product. There is much speculation as to how this specificity arises. 
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1.2 Elucidation of Polyketide Biosynthetic Pathways 
Many approaches are used to study biosynthetic pathways and to substantiate true 
biosynthetic intermediates and precursors. These include: 
(i) employing isotopically-labelled compounds; 
(ii) studying extracted and purified enzyme systems in vitro; 
(iii) investigating the effects of organisms with blocked biosynthetic pathways. 
1.2.1 Isotopic Labels 
Isotopic labels have been used for decades in the elucidation of biosynthetic 
pathways. They can reveal a great deal about possible precursors, intermediates, 
mechanisms, reaction sites, tautomerism, migrations, enzyme specificity, the order of 
7'g reaction etc., and so are widely utilised . '9 
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The proposed precursor is prepared incorporating one or more isotopic labels at 
suitable sites and then fed to the living organism, usually at the point in its lifecycle 
immediately prior to secondary metabolite production. When enough time has passed 
to allow incorporation of the putative substrate, growth is halted and the product is 
extracted. The product can then be analysed for label incorporation and the label 
located if present. For example, when [2-13C]-glycerol 11 was fed to Streptomyces 
kitasatoensis by the Japanese group of Omura et al. and the glucoside metabolite 
leucomycin A3 isolated, a 13C label was found to incorporate at C-4, indicating that 
the organism had assimilated the precursor (Scheme 4). 10 
OH 
HOOH 
OH 
11 
Scheme 4: Incorporation of [2-13C]-glycerol into leucomycin A3.10 
Radioactive labels such as 3H and 14C are ß-emitters and so can easily be detected 
using a scintillation counter to test for activity. However, locating the exact position 
of the label in the target molecule can usually only be achieved by degradation studies 
(the exception being tritium, which is NMR active). This involves progressively 
breaking the molecule down into smaller known components and measuring the 
radioactivity at each stage, as for instance in the work of Birch et al. on griseofulvintl 
(Scheme 5). This can be tedious and very time consuming and so radioactive labels 
are no longer used to a great extent in microbial systems, although they can be useful 
tracers. 
Stable isotopic labels on the other hand, can be detected by NMR spectroscopy 
and mass spectrometry. This makes locating the incorporated label much easier than 
for radiolabels. Although direct NMR analysis is restricted to nuclei which possess a 
nuclear magnetic moment (e. g. 'H, 13C and 15N), various techniques have been 
employed to indirectly ascertain the position of isotopes, such as 180, which are not 
NMR active. The first step is always to completely assign the natural abundance 
spectra. These act as reference spectra to which the spectra obtained post-feeding can 
be compared. 
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Deuterium is a commonly used isotopic label. It has a low natural abundance of 
0.16% and can be detected directly by 2H NMR spectroscopy as it has a nuclear spin, 
I=1. However, as deuterium has a small gyromagnetic ratio 2H NMR spectroscopy is 
not very sensitive and due to quadrupolar relaxation of the nucleus, signals are broad 
leading to poorly resolved spectra. 9 Thus, a complementary method of detection is to 
look for the disappearance (or a reduction in the integral), of a signal in the 111 NMR 
spectrum. By comparison with the natural abundance spectrum the site of 
incorporation can be determined. 
OMe 0 OMe 0 
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Me0 0" 14C 
/CI 
Me e 
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(7.0 14C) 
Bam, e 
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Ba(OH)2 Conc. HNO3 0 
11 
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(1.02 "C) MeO OH 
Cl 
(2.9514C) 
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11(ii) HCl 
OH 
HO OH 
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1 KNO2, AcOH, KOH OH 
! ýAI i AIl1_ 
HO NO2 
O2N OH 
Me NO2 
(3.02 14C) 
1 Ba(OH)2, Br2 " 
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(0.97 14C) )Up3, ClrO3" I H2SO4, H3PO4 
HO OH 
Ba(OH)2, Br2 
NO2 
BaCO3 
(0.01 14C) 
(1.04 "4C) 
1 Pyrolysis 
Me'Me + 
110 
CHI3 
(i) Ba(OH)2, Br2 
(ii) KIO3, CrO3, 
H2SO4, H3PO4 
BaCO3 
(0.00 '4C) 
" UZCO3 
1 
Ba1O3 
(1.0514C) 
0 KIO3. CrO3. 
BaCO3 + Br3CNO2 HZSO4, H3P0a BaCO3 
(1.03 14C) M. (0.00'4C) 
Scheme 5: Degradation studies carried out by Birch et al. to locate the positions of 
incorporation of 14C in griseofulvin. 1l 
-7- 
Chapter 1 Introduction 
Carbon-13 is another commonly used isotopic label. It has a natural abundance of 
approximately 1.1%. 7 The site of incorporation is easily determined by an enhanced 
signal in the 13C NMR spectrum. 8 'H-13C coupling may also be observed in the 'H 
NMR spectrum. 8 
Multiple labels allow coupling patterns to be exploited. For instance, spin-spin 
coupling between two vicinal 13C labels produces a doublet (J between 30-90 Hz)8 in 
the 13C spectrum. This means that even very low levels of incorporation (<1%) can be 
detected as satellite signals either side of the natural abundance peak, making this a 
very sensitive technique. 
Although not itself NMR active, 180 can be detected indirectly from the 13C 
NMR spectrum by a-isotope effects .9 The 
13C-180 signal appears 0.01-0.035 ppm 
upfield of the corresponding 13C-160 signal and the 13C='80 signal appears 0.03-0.5 
ppm upfield of the corresponding 1 3C=160 signal. 
Incorporation of more than one isotopic label can also be useful in determining 
whether a precursor is incorporated intact into a product. For example, in the case of a 
precursor incorporating vicinal13C labels, a loss of 13C-'3C coupling indicates that the 
mechanism by which the final compound is formed involves cleavage of that bond. 8 It 
is also possible that the precursor may have been metabolised previously and broken 
down by the organism prior to incorporation, usually indicated by multiple 13C 
incorporation. Hutchinson and co-workers encountered degradation problems of this 
nature whilst attempting to ascertain the biosynthetic pathway of tylactone. 12 Having 
fed ethyl ester 12 to Streptomyces fradiae, the group were surprised to discover that 
C-18 of tylactone was not selectively 13C enriched (Scheme 6). Instead, it was equally 
enriched at C-17, C-18, C-19, C-20 and C-23 (all known to derive from C-3 of 
propionate), indicating that the precursor had degraded to propionate prior to 
incorporation. 
OH 0 
"v _OEt 
S. fradiae 
"O 
12 
Ö J 
Tylactone 
Scheme 6: Multiple sites of 13C incorporation in t'lactone indicating prior 
degradation of precursor. ' 
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Incorporation of one or more deuterium atoms either one (a) or two ((3) bonds 
away from a 13C nucleus also causes diagnostic chemical shifts and coupling 
patterns .9 In molecules with one deuterium vicinal to the 
13C, the 13C signal is a- 
shifted 0.3 ppm upfield in the 13C NMR spectrum and appears as a 1: 1: 1 triplet due to 
2H-13C coupling. For each additional deuterium there is a further upfield shift and a 
further increase in multiplicity (Figure 3). (3-isotope shifts, on the other hand, are 
typically in the region of 0.01 to 0.1 ppm and appear as singlets due to the minute 2H- 
13C coupling values. 
No D One D Two D Three D 
nS (n + 0.3)8 (n + 0.6)6 (n + 0.9)8 
Figure 3: Hypothetical a-isotope effects observed in the '3C NMR spectrum due to 
2H-13C coupling. 
The relative efficiency of incorporation of labelled precursors is another source 
of information. In theory, the greater the level of incorporation, the less metabolism 
that precursor has undergone. Mayer and Thiericke used this hypothesis to good effect 
in their study of the decarestrictines. 13 Having fed sodium [1-13C2]-acetate to the 
fungus Penicillium simplicissimum and isolated decarestrictines B, D and F, the 
relative enrichment levels for C-1, C-3, C-5, C-7 and C-9 were found to be 
consistently much higher for decarestricine F (Scheme 7). They therefore concluded 
that decarestrictine F is produced earlier in the biosynthetic pathway than B and D. 
They could also deduce the order in which the acetate units were combined in this 
family of metabolites, starting with the C-9-C-10 unit and working anti-clockwise 
around the molecule. 
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Scheme 7: Proposed biosynthetic relationship of decarestrictine B, D and F. 13 
However, while the relative rates of incorporation are indicative of where a 
particular intermediate lies in the biosynthetic pathway, there are many other factors 
to consider as to why a particular incorporation is high or low (such as ease of 
penetration of the precursor, competing mechanisms, culture conditions etc. ) and so 
they do not conclusively prove the order in which biosynthetic intermediates are 
formed. 
1.2.2 Cell-Free Enzyme Systems 
Cell-free enzyme, systems allow investigation of enzyme function, substrate 
specificity, intermediates, stereoselectivity, possible inhibitors, pH/temperature 
dependence etc. in a controlled in vitro environment. They are obtained by lysis of the 
cell membranes and extraction of the enzymes within. A variety of methods have been 
employed, including digestion with enzymes such as lysozyme or lysostaphin, 
chemical degradation using alkali or detergent and physical destruction of the cell 
wall by sonication, osmotic shock, shearing or grinding with abrasives (such as glass 
beads, sand). '4"5 Unfortunately, due to the harsh conditions employed and the 
sensitivity of many enzyme complexes, these techniques are not amenable to all 
systems. Often enzymes become denatured when removed from their natural 
environment and lose bioactivity. 
Cell-free extracts are of particular benefit in complex systems - such as plant and 
mammalian systems - where incorporation of labelled compounds is so diluted by the 
metabolic processes that it is difficult to detect the labels after isolation, in systems 
where only minute quantities of the compound under investigation can be detected in 
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the crude extract or in situations where the putative precursor is unable to penetrate to 
the site of synthesis due to permeability or transport problems. 
Bryostatin 1, present in trace quantities in the marine bryozoan Bugula neritina, 
exhibits selective activity against B-cell lymphomas and leukaemia. 16 Kerr et al. used 
cell-free extracts of B. neritina to investigate the biosynthetic precursors of this 
valuable metabolite. '7 They were particularly interested in the origins of the gem 
dimethyl groups at C-8 and C-18 (which they proposed could be derived from SAM 
or isobutyrate), the ethylidene substituents at C-13 and C-21 (which they suggested 
were either the result of direct acetate addition to the polyketide chain or an intact 
four carbon unit) and the C-25-C-27 starter unit (possible sources included 
propionate, glycerol and n-butyrate). The group administered radiolabelled precursors 
to the extracts and measured the activity of the resulting bryostatin. [3H]-Acetate, 
[3H]-SAM and [3H]-glycerol all showed incorporation (though the sites of 
incorporation were not determined) whereas [14C]-propionate, [14C]-n-butyrate, ['4C]- 
isobutyrate and [14C]-succinate failed to incorporate. The PKS proposed to be 
responsible for bryostatin biosynthesis was later found by Haygood and co-workers in 
the genome of the symbiotic bacterium "Candidatus Endobugula sertula". 18 This was 
found to contain methyl transerase domains (known to use SAM as a methyl source) 
verifying at least one of these results. Haygood and co-workers are also of the opinion 
that acetyl-CoA condensation onto the (3-keto groups at C-13 and C-21 by BryR 
during biosynthesis is the most likely origin of the ethylidene moieties. 
Bryostatin 1 
Unlabelled substrates can also be used for feeding studies with cell-free extracts. 
Because there is little or no background production, any biosynthesis of the desired 
metabolite can be taken as a positive incorporation. For example, Watanabe and 
Townsend'9 extracted and partially purified the PKS responsible for norsolorinic acid 
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(the first known intermediate in the biosynthetic pathway to the carcinogen aflatoxin 
B1) from Aspergillus parasiticus. In the presence of acetyl-CoA, malonyl-CoA and 
NADPH, norsolorinic acid is produced by the extracts via hexanoate 13 (Scheme 8). 
In the absence of NADPH, however, the hexanoate intermediate 13 cannot be formed 
and thus no norsolorinic acid is observed. Production of the acid is restored when 
exogenous hexanoyl thiol ester 14 is fed to the system, thus confirming its 
intermediacy in the biosynthetic pathway. 
O 
-'ýS-CoA 0 
+ A. parosintus 
00 NADPH S-CoA 13 
HO S-CoA 
0 OH 0 OH 0 )LS-CoA 
0 
+ A. parasiticus 
00X S-CoA ý HO OH 
13 
HO S-COA O Norsolorinic Acid 
ooO H A. parasificus 
HO 
AS-COA 
+ _, 
14 0 
Scheme 8: Biosynthesis of norsolinic acid by cell-free extracts of A. parasiticus. 19 
Watanabe and co-workers used cell-free extracts to probe the cofactor 
requirements for the biosynthesis of the antitumor agent azinomycin B in 
Streptomyces sahachiroi. 20 NADPH was found to be essential for azinomycin B 
production, as was SAM. Flavin adenine dinucleotide (FAD) and tetrahydrofolate on 
the other hand were not required and rather surprisingly for a proposed polyketide, 
adenosine triphosphate (ATP) did not appear to have much of an effect on azinomycin 
B production. 
0 
AS-CoA 
OO 
HOS-CoA 
S. sahachiroi CFE 
NADPH, SAM 
Scheme 9: Cofactor requirements for azinomycin B production in cell-free extracts of 
S. sahachiroi. 20 
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The immunosuppresent cyclosporin A, produced by the fungus Tolypocladium 
niveum, is comprised of eleven constituent amino acids. 21 The biosynthesis of one of 
these, designated Bmt, is believed to take place in two phases; a polyketide back bone 
assembly followed by introduction of the amino group. In order to investigate the first 
phase of Bmt biosythesis, Schneider-Scherzer and co-workers prepared and partially 
purified cell-free extracts from T. niveum. 22 By assaying fractions for NADPH 
consumption dependent on acetyl-CoA, malonyl-CoA and SAM they were able to 
isolate the polyketide synthase responsible for the Bmt backbone. The PKS could now 
be investigated in isolation and its polyketide product, designated Bmt backbone, and 
substrate specificity determined. 
O OH 0 OH 0 AS-CoA 
T. niveum CFE amination 
+ S-ACP --------+ --- OH 
0 
NADPH, SAM _= 
NH2 
/Jv" ' 
Bmt Backbone Bmt 
HO S-CoA 
Scheme 10: Investigation of Bmt biosynthesis in cell-free extracts of T. niveum 22 
Staunton and co-workers used cell-free extracts to good effect in determining the 
mode of action and substrate specificity of the thiol esterase domain of the 6- 
deoxyerythronolide B PKS. 23 The enzyme was found to form acyl-enzyme 
intermediates which then underwent nucleophilic displacement (by either an external 
nucleophile such as water or alcohol or an internal hydroxyl group) to release the 
chain from the enzyme (Scheme 11). The enzyme was found to have broad substrate 
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specificity, accepting a variety p-nitrophenyl esters and thiol esters with varying acyl 
chain lengths and substitution patterns. 
MW = 38323 Da 
NO2 ^e 
MW . 38153 Da 
_ITý 
ý l! fý 
O 
OH OEt 
_ 
IT H. O. FLOH 
OO 
OH 
O 
OH 
OH Acyl-Enzyme Intermediate OH 1: 2 
OH I 
acyl carrier protein 
T thiol esterase 
Scheme 11: Mode of action of thiol esterase domain of 6-deoxyerythronolide B. 23 
However, although cell-free extracts allow very specific experiments to be 
designed (especially in conjunction with modern genetic techniques) within a highly 
controlled environment and are generally good models, care must be taken in drawing 
parallels to more complex in vivo systems. 
1.2.3 Organisms with Blocked Biosynthetic Pathways 
Introducing a block into an organism's biosynthetic pathway and analysing the 
results, is a valuable method of studying biosynthesis. The block may be endogenous, 
caused by a genetic mutation or it may be exogenous, induced by a chemical inhibitor. 
In many cases a genetic mutation is used to determine the function of a particular 
gene or the cluster to which it belongs. For example, Schmidt and co-workers in 
searching for the genes responsible for equisetin synthesis, identified three polyketide 
synthase sequences within the Fusarium heterosporum genome, each a potential 
target. 24 In order to determine which of the three produced the polyketide, they 
performed a knockout mutagenesis on their preferred candidate, designated pks2, 
which resulted in a loss of equisetin production (Scheme 12). They concluded that 
pks2 was indeed responsible for equisetin biosynthesis. 
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Scheme 12: Loss of equisetin biosynthesis in P. heterosporum due to pks2 
knockout. 24 
Disruption of the ambM gene (thought to encode for a C-methyl transferase 
enzyme), in the gene cluster of the ambruticins produced by Sorangium cellulosum 
leads to derivatives of the natural products lacking a methyl group at the C-15 
position. 25 
xs 
28 
HO O\O 
22 
24 
O '''OH x° 27 
R 
wJaý Ambruticin SR= OH 
Ambrucitin VS5 R= NH2 
S. cetiulosum Ambrucitin VS3 R= NH(CH3)2 
webe 
28 
HO +O°+ +x 24 '0 
): 
O xx 
Os ""OH 27 
R 
15"Desmethylambruticin SR= OH 
15"Desmethylambruticin VS5 R= NH2 
15"Desmethylambruticin VS3 R= NH(CH3)2 
Scheme 13: Role of ambM in ambruticin biosynthesis ascertained by a knockout 
experiment. 25 
Leadlay, Staunton and co-workers also used an endogenous block to investigate 
the role of the DEBS 1 protein in 6-deoxyerythronolide B biosynthesis. By 
repositioning the thiol esterase domain from the end of DEBS 3 to the end of DEBS 1, 
they successfully interrupted the chain extension process and isolated triketide lactone 
15, the product of premature PKS release (Scheme 14) 26 Extending this methodology, 
two additional intermediates were obtained by relocating the thiol esterase to the end 
of modules 3 and 5 27'28 
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Scheme 14: Repositioning of the thiol esterase domain of 6-deoxyerythronolide B to 
the end of DEBS 1 to block further biosynthesis. 26 
Exogenous blocks can also yield valuable biosynthetic information. For instance, 
Martin and McDaniel specifically inhibited production of the antibiotic candicidin in 
Streptomyces griseus using cerulenin, an inhibitor known to block the condensation of 
malonyl-CoA subunits in the formation of fatty acids (Scheme 15). 29 As the synthesis 
of other proteins and RNA were not affected they concluded that candicidin must be 
prepared via the polyketide biosynthetic pathway (known to be highly analogous to 
the fatty acid biosynthetic pathway). Omura et al. also used this inhibitor to show that 
;0 the macrolides antibiotic tylosin was polyketide derived. 
0 
H2N 
Cerulenin 
S. riseus 
Scheme 15: Inhibition of candicidin production in S. griseus by cerulenin. 29 
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Corcoran and Vygantas successfully employed the NADPH inhibitor 3-ß-[2- 
(dimethylamino)ethoxy]androst-5-en-17-one (GEB) in their study of erythromycin 
intermediates in Streptomyces erythreus 31 They found that in the presence of this 
inhibitor, 6-deoxyerythronolide B accumulated rather than erythronolide B and so 
concluded that 6-deoxyerythronolide B was a precursor to erythronolide B. 
Erythronolide B 
S. ernthrrus 
HH 
GEB 
6-Deoxyerythronolide B 
Scheme 16: Inhibition of NADPH in S. erythreus by GEB resulting in a switch to 
6-deoxyerythronolide B production. 31 
1.3 Directing Polyketide Biosynthesis 
In the literature there are many examples of research groups using their knowledge of 
a biosynthetic pathway in order to alter it to their advantage. ' Some groups have even 
combined PKS genes from more than one source. 32,33 In this way, novel compounds 
can be produced in vivo/in vitro without the need for a lengthy total synthesis. There 
are five main approaches; precursor directed biosynthesis and mutasynthesis, domain 
mutagenesis, linking of modules, combining multimodular protein subunits and 
modifying post-PKS processing. 
In general, enzymes are known to have narrow substrate specificity (though there 
are exceptions). Fortunately however, enzymes involved in the production of 
secondary metabolites are often less substrate specific than those responsible for 
primary metabolism. Precursor-directed biosynthesis involves feeding analogues of 
natural biosynthetic precursors to the producing organism in the hope that they will be 
assimilated into the final product giving an analogue of the natural product. For 
example, Chen et al. used this method to produce novel analogues of the avermectin 
family - known for their potent antiparasitic activity. 
34 The group fed 2- 
methylpentanoate 16 and 2-methylhexanoate 17 starter units to Streptomyces 
avermitilis and found that they incorporated in place of the natural isobutyryl 
(avermectin Ala) and isopropyl (avermectin Alb) precursors in the metabolites formed 
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(Scheme 17). Unsurprisingly, the new derivatives, designated avermectin Aic and 
avermectin Aid respectively, displayed potent anthelmintic and insecticidal activity. 
eä 
pNS. avermitilis Averme 
0 
16 
p9Ne 
S. avermitilis 
Avermt 
17 0 
Scheme 17: Precursor-directed biosynthesis to produce novel avermectin analogues. 34 
Mutasynthesis is a similar approach in which the PKS is genetically altered so as 
to disable the first chain extension cycle (typically by knocking out the ketosynthase 
domain in the first module). The mutant PKS is then supplied with a synthetic non- 
natural diketide or triketide intermediate in the hope that it will be processed in place 
of the natural starter unit. Staunton and co-workers used this approach, also working 
with the avermectins, to prepare a cyclohexyl derivative. 5A mutant strain of S. 
avermitilis was prepared which lacked a branched chain ketoacid decarboxylase and 
was thus unable to produce the L-valine and L-isoleucine derived starter units required 
for polyketide production. Then a cyclohexyl derivative of a proposed biosynthetic 
intermediate 18 was fed to the organism and was assimilated to produce a novel 
avermectin, doramectin. Again, this avermectin derivative displayed high levels of 
antiparasitic activity and has been developed by Pfizer in their animal health product 
Dectomax®. 
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Scheme 18: Mutasynthesis to produce the novel avermectin analogue doramectin. 35 
Domain mutagenesis (i. e. swopping, inactivating or deleting individual domains) 
is a very versatile technique. New starter and extender units can be introduced by 
exchanging loading domains, the level and stereochemical outcome of ketoreduction 
can be altered by swopping KR domains and various reduction processes can be 
introduced or eliminated from the biosynthetic pathway by addition or deletion of the 
domains responsible. For example, McDaniel et al. replaced the KR of module 2 of 
the erythromycin PKS with the DH and KR domains of module 4 of the rapamycin 
PKS. 36 Instead of obtaining the tetraketide lactone 19 and hemiketal 20 previously 
observed for expression of the first three DEBS domains, 28 as expected, dehydrated 
derivatives designated KOS009-7a and KOS009-7b respectively were observed 
(Scheme 19). 
As well as swopping individual domains, it is also possible to combine entire 
modules either from different locations within the same PKS or from more than one 
source. Khosla and co-workers successfully used this strategy to fuse module 1 of the 
erythromycin (DEBS) PKS to both module 3 of the same PKS and module 5 of the 
rifamycin PKS resulting in two lactones 21 and 22 which differed only at the C-4 
position (Scheme 20). 37 Staunton and co-workers developed this methodology further, 
to assemble a trimodular system comprising of erythromycin and rapamycin modules, 
which was capable of producing simple statin analogues 23 and 24.38 
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Scheme 19: Domain mutagenesis to include an additional reduction process. 36'28 
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Scheme 20: Linking of modules from the erythromycin, rifamycin and rapamycin 
PKSs. 37'38 
It is also possible to combine entire multimodular proteins either in their native 
form or genetically modified in some way. Tang et al. produced a variety of novel 
macrocycles using this approach. 39 By combining protein fragments from the PKSs of 
deoxyerythronolide B (DEBS) and narbonolide (PikPKS) a novel hybrid macrolide 
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was produced (Figure 4). Extending this methodology to further PKS fragments (both 
natural and genetically engineered) an entire library of hybrid polyketides was 
created. 
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Figure 4: Hybride polyketide produced by combining protein fragments from the 
6-deoxyerythronolide B and narbonolide PKSs. 39 
Finally, mixing and matching post-tailoring genes is another method of 
introducing polyketide biodiversity. As discussed above, knockout experiments are 
regularly conducted to determine the biosynthetic function of a gene. However, 
should the ensuing structural modification prove constructive, the alteration can be 
expoited to produce novel metabolites. For example, disrupting the eryK gene of the 
erythromycin PKS in S. erythraea prevents C-12 hydroxylation from taking place. 40 
This results in an accumulation of erythromycins B and D, rather than the natural 
product, erythromycin A (Scheme 21). Erythromycin B is known to be more acid 
stable than erythromycin A (a major drawback of this commercial antibiotic, as it 
degrades rapidly in the stomach), 41 whilst also retaining antibacterial activity and thus 
may offer an alternative remedy. 
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Scheme 21: Disruption of eryK prevents C-12 hydroxylation in erythromycin A 
biosynthesis. 0 
1.4 The Use of N-Acetylcysteamine Thiol Esters in Biosynthesis 
Lynen and co-workers were the first to document the use of N-acetylcysteamine 
(NAC) thiol esters for biosynthetic studies 42.43 They used them to model coenzyme A 
(CoA) in the in vitro studies of fatty acid synthesis and found that they were 
incorporated extremely well by the fatty acid synthases in place of the natural 
derivatives of CoA. They had two reasons for choosing NAC thiol esters. Firstly, the 
NAC thiol ester bond is stable in aqueous solution at neutral pH and room 
temperature, enabling it to function in cellular metabolism. Secondly, having 
determined that the reactive site of CoA is a thiol group, 42 they soon realised through 
experimentation, that acyl groups bound to sulfur behave differently to the 
corresponding esters and free acids. This is due to the difference in electronic 
behaviour of oxygen and sulfur. The lone pairs on the oxygen atom delocalise into the 
acyl group whereas the sulfur atom does not readily permit resonance stabilisation 
around the thiol ester linkage and so the carbonyl carbon retains its electrophilic 
characteristics to a greater degree, making it more prone to nucleophilic attack. 
NAC thiol esters have also been shown to be recognised and processed both in 
vitro and in vivo by the analogous polyketide synthases. Cane et al. 44 and Hutchinson 
and co-workers12 found they could be incorporated intact into macrolides such as 
erythromycin and tylactone in place of the free acids and ethyl esters, which degraded 
prior to incorporation (Scheme 22). They have been successfully used to probe the 
catalytic function of polyketide synthases from plant and bacterial origin45 and to 
analyse enzyme kinetics46 and substrate specificity. 23 
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Scheme 22: Incorporation of thiol esters into the polyketide macrolides erythromycin 
and tylactone. '2'44 
Furthermore, NAC thiol esters have been used in place of complex thiol esters 
such as acyl carrier proteins (ACPs). 23 23,47 Comparing the structure of N- 
acetylcysteamine to that of CoA and ACP it is easy to see the structural similarities 
(Figure 5). 
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Figure 5: Comparison of structures of N-acetylcysteamine, CoA and ACP. 
NAC thiol esters are easily prepared by condensation of the putative carboxylic 
acid precursor with N-acetylcysteamine in the presence of DCC and DMAP (Scheme 
23). 48 This ease of preparation adds to their popularity as precursors for feeding 
studies. 
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Scheme 23: General reaction for the synthesis of NAC thiol esters. 8 
1.5 Aims 
The overall aim of this project was to further investigate polyketide biosynthesis, 
focusing on three different metabolites - the pseudomonic acids (mupirocin), 
strobilurin A and alternapyrone. 
The Pseudomonic Acids: Using isotopically labelled thiol esters we hoped to 
perform feeding studies with Pseudomonas fluorescens NCIMB 10586 to establish 
the origins of the 9-hydroxynonanoic acid side chain of pseudomonic acid A. We also 
wanted to prepare mutant metabolites of the mupirocin gene cluster in order to 
unequivocally assign their stereochemistry, whilst developing flexible synthetic 
methodology for future targets. 
Strobilurin A: Strobilurin A is proposed to be assembled from a benzoyl-CoA starter 
unit which is itself derived from phenylalanine via cinnamic acid. We aimed to 
synthesise isotopically labelled cinnamic acids to show that the C-2-C-3 bond is 
cleaved during biosynthesis, adding credence to this hypothesis. In addition, we 
sought to explore a precursor-directed biosynthesis of p-fluorostrobilurin A using a 
fluorinated derivative of cinnamic acid. 
Alternapyrone: Our objective was to prepare putative alternapyrone precursors for 
feeding studies with cell-free extracts of PKSN (a PKS isolated from Alternaria 
solani). In particular, our goal was to investigate the C-methylation process which 
occurs in all but the third catalytic cycle. 
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Chapter 2 The Pseudomonic Acids: Isotopic Labelling Studies 
2.1 The Pseudomonic Acids 
The pseudomonic acids are polyketide derived secondary metabolites, produced by 
Pseudomonas f luorescens, (a diverse species of bacteria that is commonly found in a 
wide range of terrestrial and aquatic habitats), which show varying degrees of 
antibiotic activity. 49,50 
The basic structure of all the pseudomonic acids is a C17 monic acid entity with a 
C9 fatty acid side chain (Figure 6). 51 The four most abundant pseudomonic acids are 
pseudomonic acid A, 5' pseudomonic acid B, which has an additional hydroxyl group 
at C-8,52 pseudomonic acid C, which has a double bond in place of the epoxide group 
at C-10-C-1153 and pseudomonic acid D, which has an alkene group at C-4'-C-5' in 
the side chain. 54 The extract of wild-type P. fluorescens NCIMB 10586 comprises of 
a mixture of pseudomonic acids (90% pseudomonic acid A, 8% pseudomonic acid B 
and <2% of pseudomonic acids C and D) and is given the generic name 
"mupirocin", 54 although mupirocin is also frequently used to refer solely to the major 
metabolite, pseudomonic acid A. 
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Figure 6: The pseudomonic acids. 
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Mupirocin is the active pharmaceutical ingredient of Bactroban® and Bactroban 
Nasal® (originally developed by Beecham and now marketed by GlaxoSmithKline). 
These topical and intranasal ointments are used clinically to treat a variety of bacterial 
skin infections and as a means of controlling Staphylococcus aureus (in particular 
methicillin-resistant Staphylococcus aureus), succeeding where other antibiotics have 
failed. 55'56 
Mupirocin is a potent inhibitor of Gram positive bacteria. It is believed to act by 
blocking the activity of bacterial isoleucyl-tRNA synthase 57 This enzyme is 
necessary for protein synthesis. Without it, the bacterial cell is unable to manufacture 
vital cell proteins or form protective cell walls. Most antibiotics act on either bacterial 
DNA or the cellular walls of bacteria. Mupirocin is only the second naturally 
occurring inhibitor of bacterial isoleucyl-tRNA synthase to be discovered, the first 
being furanomycin 58'59 Its unusual mode of action means it shows no cross resistance 
with antibiotics such as penicillin, streptomycin, methicillin, erythromycin and many 
other common antibiotics. The pseudomonic acids and their derivatives are therefore 
important pharmaceutical targets and have been the subject of many total 
syntheses 60'61'62 
00 
HO 
NH2 
Furanomycin 
2.2 Isotopic Labelling Studies on the Pseudomonic Acids 
Several labelling studies have been successfully carried out on the pseudomonic 
acids 63'M [1-14C]-, [1-13C]-, [2-13C]- and [1,2-13C2]-acetates all showed good 
incorporation into pseudomonic acid A, accounting for the origins of the carbon 
backbone (Scheme 24). The incorporation pattern has also revealed some aspects of 
the biosynthetic pathway. For instance, the labelling of both C-1 and C-9' by [1-13C]- 
acetate discounts the possibility of the ester linkage forming via a Baeyer-Villiger- 
type oxidation of a preformed acetate-derived aliphatic chain. Instead it suggests the 
condensation of two distinct biosynthetic units. The incorporation of [2-13C]-acetate at 
C-15, shows that unlike C-17, it is derived from a cleaved acetate unit and not S- 
adenosyl methionine (SAM), suggesting that this moiety was also enzymatically 
constructed from two distinct segments 63 
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Scheme 24: Labelling pattern of pseudomonic acid from acetate, propionate and 
63.64 
methionine precursors. 
[1-13C]-Propionate incorporated solely at the C-7' position (though this position 
was also labelled from C-1 of acetate). This, coupled with the fact that the C-8'-C-9' 
acetate unit is not incorporated in the usual head to tail fashion observed for 
polyketides, again suggests the union of two separate biosynthetic units (most likely 
the starter unit which primes the 9-hydroxynonanoic acid side chain). However, 
although [2-14C]- and [3-'3C]-propionate were also incorporated, they did so at 
positions which indicated that degradation to [1-14C]- and [2-'3C]-acetate respectively 
had occurred prior to assimilation. This seems to suggest that propionate is not the 
actual starter unit for the 9-hydroxynonanoic acid side chain, merely a precursor to it. 
D, L-[Me-14C]-Methionine and L-[Me-'3C]-methionine were both incorporated 
into pseudomonic acid A verifying the source of the one-carbon branches at C- 16 and 
C-17. The failure of [14C]-formate (another "Cl pool" donor) to incorporate reinforced 
this assignment. 
[ 1-'3C, 2H3]-Acetate was fed to P. fluorescens by Martin and Simpson64 in order 
to determine the biosynthetic origins of the hydrogen atoms. By measuring the (3- 
shifts in the 13C NMR spectrum they were able to ascertain the number of deuterium 
atoms bonded to the adjacent carbon atom (Scheme 24). No deuterium was found on 
C-8, (though this is in agreement with the proposed biosynthesis of the polyketide 
backbone in which C-8 is fully unsaturated - see Scheme 38, Chapter 3), but no 
explanation was proposed for the lack of deuterium at C-2 or C-2'. 
Incorporation of [ 1-'3C, 1802]-acetate revealed the origins of the oxygen atoms of 
pseudomonic acid A (Scheme 24). From the results of these labelling studies it has 
been postulated that ring closure is effected by attack of the 5-hydroxyl group either 
onto an enone, I, or onto C-16 with a good leaving group, II (Scheme 25). It is also 
entirely possible that 6-hydroxylation, which presumably arises as a result of an 
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oxidation using atmospheric oxygen, occurs prior to the formation of the 
tetrahydropyran ring. The results of this feeding study also reinforce the earlier 
assumption that the ester linkage in pseudomonic acid is formed by the condensation 
of two distinct moieties, as the linking oxygen atom is derived from acetate and not 
the atmosphere. 
18 0) 
180H 
180 
18OH 
H180 O 
eOH 
yOx 
Scheme 25: Proposed mecha 
OH 
180 180 HtaO H O, 
t aQ 180 1 aQ 
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X= activating group 
nisms for the formation of the tetrahydropyran ring. 
Many possible precursors to pseudomonic acid have been ruled out by 
incorporation studies. Substrates such as [3- 14C] -3-hydroxy-3-methylglutarate 25,64.65 
[3,6-13C2]-3-hydroxy-3-methylglutarate 26,64 [1,5- 14C"] -3-hydroxy-3-methylglutarate 
27,65 (RS)-[2-14C]-mevalonic acid 2863 and diethyl [1,2-13G]-malonate 2966 (Figure 7) 
either failed to incorporate or showed multiple label incorporation indicating that they 
had degraded completely to acetate prior to incorporation. 
HO OH Hp OOO 
p 
(J[`OH 
p HOý '" 
ýOH 
EtO ""OEt 
25 "= 14C 0= 12C 0= 12C 
28 "= 10C 29 "= 13C 
26 "= 13C "= 13C "= 12C 
27 " =12`. " =12C " =14C 
Figure 7: Isotopically labelled compounds which failed to incorporate into 
63.64 pseudomonic acid. . 65.66 
2.3 Investigation of 9-Hydroxynonanoic Acid as an Intermediate in 
Mupirocin Biosynthesis 
As discussed above, many different feeding studies have been performed on the 
pseudomonic acids over the years and much has been ascertained about their 
biosynthetic origins and their metabolic mode of assembly. However, there are still 
many puzzling and unexplained results to be investigated and theories to be confirmed 
experimentally. 
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One such hypothesis is that the pseudomonic acids are derived from two distinct 
units -a monic acid moiety and a 9-hydroxynonanoic acid entity. However, 
incorporation of labelled 9-hydroxynonanoic acid and monic acid into pseudomonic 
acid has never been formally demonstrated. 
As well as its relevance to the biosynthesis of pseudomonic acid, 9- 
hydroxynonanoic acid is also important in its own right, as it is a rare example of an 
odd-numbered carbon chain fatty acid and so may help to shed some light on the 
origins of this unusual class of compounds. 
Sugden66 has previously prepared [1-13C]-9-hydroxynonanoic acid 32 as shown 
in Scheme 26. Treatment of 8-bromooctanol 30 with 13C labelled potassium cyanide 
gave nitrile 31 in 81% yield. This then underwent hydrolysis to afford the desired acid 
32 in 87% yield. Upon feeding free acid 32 to P. fluorescens he discovered 13C 
incorporation at C-1', C-3', C-5', C-7', C-9', C-1, C-3, C-5, C-7, C-9, C-11 and C-13 
indicating that the substrate had degraded to [1-13C]-acetate prior to incorporation. 
" (i) NaOH 
0 
" 
HO,, 
_, 
(-),,. Br KN HO` 
/ 
k 
, CN 
(")HCi HO\\/ý 
/v OH v\ v 
306 
81% 316 87% 32 
Scheme 26: Sugden's route to [1-13C]-9-hydroxynonanoic acid 32.66 
As described in section 1.4, there are several examples in the literature of thiol 
esters acting as substrates for feeding studies in situations where the free acid has 
failed to incorporate. It was therefore decided to prepare the corresponding NAC thiol 
ester with two vicinal 13C atoms to increase the sensitivity of label detection in the 
product post feeding. 
Unlabelled 9-hydroxynonanoic NAC acid thiol ester 43 has previously been 
prepared on a very small scale by Donlevy67 (Scheme 27). Treatment of 6-bromo-l- 
hexanol 33 with sodium cyanide gave 34, followed by protection of the hydroxyl 
group and reduction of the nitrile functionality in 35 furnished aldehyde 36 in 73% 
yield. This then underwent a Horner-Wadsworth-Emmons chain elongation with 
triethyl phosphonoacetate 37 to yield the unsaturated ester 38. Hydrogenation of the 
olefin followed by hydrolysis of the resulting ester, furnished acid 40 which was then 
deprotected and coupled to N-acetylcysteamine 42 to furnish thiol ester 43 in 79% 
yield. 
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Scheme 27: Donlevy's final synthetic route to the thiol ester 43.7 
Our initial route was based upon that of Donlevy but a slightly different synthesis 
of aldehyde 36, which avoided the use of cyanide, was employed. Using the same 
starting material, 6-bromo-l-hexanol 33 and following the general procedure of 
Bäckvall et a1., 68 chain extension by addition of nitromethane was investigated. The 
reaction did not proceed at room temperature but when heated to reflux furnished 
nitroheptanol 44. The latter was then converted to aldehyde 36 by protection of the 
hydroxyl group and Nef reaction of the resulting nitroalkane 46 (Scheme 28). 
Unfortunately, this route was low yielding due to the formation of several by-products 
during the addition of nitromethane (possibly due to the elevated temperatures 
required), although enough of the protected aldehyde 36 was prepared to continue the 
synthesis for another two steps, yielding the unsaturated ester 39. Performing the 
addition and protection steps in the opposite order only served to decrease the yields 
further. Nef reaction of 45 produced an array of inseparable products and so it became 
clear that a new route was required. 
-30- 
Chapter 2 The Pseudomonic Acids: Isotopic Labelling Studies 
HO1 y NO2 
DBU40%%3NO 
`4ý4Jý 
DH, pTSA O 
HO Br THPO N02 KOH, KMnO4 
` '6 7 MeOH THPO H 33 THPO`ý' Br 46 78% 5 
DHP pTSA /g DBU, CH3NO2 
36 
97% 45 
Scheme 28: Synthesis of aldehyde 36 via Nef reaction of nitroalkane 46. 
It was interesting to speculate if a hydroxyl protecting group was really required 
at all throughout the synthesis. Concerned that such a flexible chain might be prone to 
cyclisation/polymerisation reactions, Donlevy's original plan had been to remove the 
protecting group at the end of the synthesis. However, having completed his synthesis 
of the protected 9-hydroxynonanoic acid NAC thiol ester, he found the thiol group 
was unstable to the acidic conditions required to remove the tetrahydropyran group. 
He attempted the final step without a protecting group and did not encounter any 
problems. We therefore decided to try the entire synthesis without a protecting group. 
A one step synthesis of 7-hydroxyheptanal 48 from aleuritic acid 47 was reported 
by Pawar et al. during their synthesis of the insect pheromone ferrulactone 11.69 A 
natural product isolated from shellac, aleuritic acid 47 underwent oxidative cleavage 
with sodium periodate to yield 7-hydroxyheptanal 48 in 76% yield. Reaction of 
aldehyde 48 with triethyl phosphonoacetate 37 furnished unsaturated ester 52 in 82% 
yield which was subsequently reduced quantitatively to the saturated ester 54. 
Hydrolysis of ester 54 in refluxing sodium hydroxide furnished 9-hydroxynonanoic 
acid 41. Finally, a DCC/DMAP mediated coupling of acid 41 with N- 
acetylcysteamine 42 furnished thiol ester 43 in 59% yield (Scheme 29). The optimised 
route was then used to prepare [1,2- 13 C21-9-hydroxynonanoic acid NAC thiol ester 1, 
as shown, by using commercially available ethyl [1,2-13C2]-bromoacetate 50 (and 
later [1,2-13C2]-triethyl phosphonoacetate 51 when this became available) to introduce 
the labels. A disappointingly low overall yield of 39% was achieved, due to the 
formation of a N, S-diacetylcysteamine contaminant in the final coupling step. 
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Scheme 29: Optimised route for the preparation of thiol esters 43 and 1. 
2.4 Biosynthesis of Pseudomonic Acid A by Pseudomonas 
fluorescens NCIMB 10586 
As described in section 2.1, mupirocin is produced by Pseudomonas fluorescens 
NCIMB 10586. This strain was used throughout this work for feeding studies of 
putative precursors. Before attempting any feeding studies, however, it was necessary 
to establish the production pattern of mupirocin, and so a growth study was 
conducted. This involved growing the bacteria under the conditions described in the 
experimental section (chapter 7) and monitoring the levels of mupirocin production at 
regular intervals by HPLC. 
In order to quantify the pseudomonic acid A content in the extracts, volumetric 
standards of mupirocin were prepared and run in duplicate on the HPLC. A peak 
corresponding to pseudomonic acid A was observed at 21.5 minutes (Figure 8). By 
running solutions of varying concentration, we were able to correlate the data into a 
linear graph, from which samples of unknown concentration could be determined 
(Figure 9). The graph was found to be linear in the range investigated (0.0078 - 0.250 
mg/mL) and so provided the concentration of the samples fell between these two 
limits, their concentration could be determined accurately. 
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Figure 8: HPLC trace of mupirocin standard (1 mg/mL volumetric solution). 
Samples of the fermentation broth were taken every two hours, starting ten hours 
after inoculation of the secondary stage medium. 1 mL aliquots were taken from two 
flasks at each interval, combined, microcentrifuged and then the supernatant was 
analysed immediately by HPLC. The pH of each of the samples was also measured. 
This enabled the growth production and pH variance curves of pseudomonic acid A to 
be constructed (Figure 10 and Figure 11). 
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Figure 9: Mupirocin quantification graph. 
-33- 
0 50 100 150 200 
Average Peak Area (mAu*min) 
0.1600 1 
0.1400 - 
0.1200 
C) 
0.1000 
C 
0.0800 
Co L 
0.0600 
ý. i 
0.0400 
0.0200 
0.0000 -1- 
10 
. 
20 30 40 50 60 
Time (hours) 
Figure 10: Growth production curve of pseudomonic acid A. 
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As shown in Figure 10, pseudomonic acid production commenced approximately 
10 hours after inoculation of the secondary stage medium and so this is the point at 
which we would begin to pulse feed our precursor to the bacteria. A maximum of 
0.162 mg/mL was reached at approximately 50-52 hours and so isolation of the 
secondary metabolite was conducted at this time point. The culture was extracted with 
ethyl acetate, methylated with diazomethane and purified by Sephadex® and silica 
column chromatography to afford 40 mg (0.04 mg/mL) of methyl pseudomonate. 
The quantity of pseudomonic acid A produced by the bacteria during this study 
was much lower than previous reports. Martin70 achieved unisolated yields (as 
determined by HPLC) of approximately 0.40 mg/mL, as did Donlevy. 67 However, it 
should be noted that they only succeeded in isolating approximately 0.13 and 0.06 
mg/mL respectively. Laosripaiboon71 attained HPLC yields of 0.07-0.10 mg/mL and 
an isolated yield of 0.01 mg/mL. Thomas and co-workers currently achieve isolated 
yields of approximately 0.02 mg/mL. 72 P. fluorescens is known to be temperamental 
and yields can vary dramatically from medium to medium and over time. 0.71 
Yields decrease further when a substrate is added to the culture. In order to 
investigate the effect of feeding on mupirocin yields, sodium acetate solutions of 
various concentration were pulse fed to P. fluorescens at five one hour intervals, 
starting at 10 hours. Samples were taken at three different time points (four in the case 
of the control) and analysed by HPLC. As the concentration of substrate was 
increased, the yield of mupirocin decreased. When a concentration of 250 mg/L was 
employed, the yield of mupirocin was approximately half the control value. Even at a 
concentration of 50 mg/L the yield of mupirocin had decreased by about a third. 
The 'H and 13C NMR spectra of methyl pseudomonate (more stable than 
pseudomonic acid) have been assigned by Mellows and co-workers63 and Everett and 
Tyler73 (Figure 12 and Figure 13) and thus isotopic label incorporation can be 
detected by comparison with the reference spectra. 
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Mupirocin Yields Following Sodium Acetate Feeds 
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Figure 14: The effect of feed substrate concentration on the yield of mupirocin. 
Thiol ester 1 was then fed to P. fluorescens and 18 mg of pseudomonic acid were 
isolated. Unfortunately, no 1 3C incorporation was observed in the '3C NMR spectrum 
(Figure 16). In particular, no satellite signals were observed adjacent to the C-I' or C- 
2' signals (even after 40,000 scans) to indicate '3C-13C coupling. Thus, we cannot 
conclude anything from this experiment other than that thiol ester 1 has not 
incorporated on this occasion. 
However, metabolites recently isolated by Wu from various mupW mutants (J. 
Wu, unpublished results) seem to suggest that this result might in fact he legitimate. 
Acids 57 and 58, which have C5 and C7 sidechains respectively, seem to suggest that 
the C9 sidechain might be elongated post esterification rather than beforehand. These 
results, in conjunction with the failed free acid feeds of Sugden66 provide mounting 
evidence that 9-hydroxynonanoic acid may in fact not be a precursor to pseudomonic 
acid. 
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Figure 15: MupW mutants with truncated side-chains. 
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2.5 Investigation of 3-Hydroxypropanoic Acid as a Polyketide 
Starter Unit 
Odd-chained fatty acids are unusual in natural products. As discussed in section 1. I, 
fatty acids are usually primed from an acetyl-CoA starter unit and malonyl-CoA 
extender units (both two carbon units) leading to an even number of carbons in their 
chain. Thus, in order for the 9-hydroxynonanoic acid side chain of pseudomonic acid 
to have an odd number of carbons, it must either have started out as an even-chained 
acid and undergone cleavage of some description (this can be ruled out by labelling 
studies) or have been primed from an odd-chained starter unit such as 3- 
hydroxypropionate. 
In 2002, Fuchs and co-workers discovered the genes responsible for an enzyme 
which catalyses the reduction of malonyl-CoA to 3-hydroxypropionate. 74 The 
enzyme, malonyl-CoA reductase, consists of two active sites, an aldehyde 
dehydrogenase and an alcohol dehydrogenase, to effect the transformation in two 
steps (Scheme 30). The discovery of this pathway lent credence to the possible 
involvement of this moiety as a starter unit for polyketide biosynthesis. 
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Scheme 30: Proposed 3-hydroxypropionate cycle. 74 
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This mode of biosynthesis would also explain the unusual labelling pattern of the 
9-hydroxynonanoic acid sidechain in which the C-8'-C-9' unit deviates from the usual 
head-to-tail acetate incorporation generally observed for polyketide metabolites 
(Scheme 31) and would also explain why incorporation was only observed for C- I of 
the propionate precursor, as the recyling of this entity to acetyl-CoA would result in 
the loss of any isotopic labels at the C-2 or C-3 positions. 
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Scheme 31: Unusual labelling pattern of 9-hydroxynonanoic acid side chain. 63 
Furthermore, homology testing shows that three of the mupirocin genes (which 
will be discussed in more detail in section 3.1), mupQ, mupS and macpD, which 
encode for an acyl-CoA synthase, a 3-oxoacyl-ACP reductase and an acyl carrier 
protein respectively and have yet to be assigned a definitive role in mupirocin 
synthesis, show considerable similarity to difC, difD and difE from the difficidin 
cluster. 75 Difficidin is also proposed to be derived from a C3 starter unit with the 
likely involvement of these three genes. 
C3, ý 
Difficidin 
Figure 17: Difficidin is proposed to derive from a C3 starter unit. 75 
In order to investigate the possible role of 3-hydroxypropanoic acid in mupirocin 
biosynthesis we aimed to prepare suitable isotopically labelled substrates and to 
conduct a feeding study with Pseudomonas fluorescens. Sugden66 has previously 
-39- 
Chapter 2 The Pseudomonic Acids: Isotopic Labelling Studies 
prepared sodium [1-13C]-3-hydroxypropanoate 61 and sodium [1-13C, 2 2H2]-3- 
hydroxypropanoate 62 (Scheme 32). Starting from 3-chloropropanol 59, addition of 
[13C]-potassium cyanide gave nitrile 60 which was then hydrolysed using either 
deuterated or protio sodium hydroxide to give the free acids 61 and 62 in quantitative 
yield. The two substrates were then fed in duplicate to P. fluorescens. Although 
initially the mono-labelled precursor 61 appeared to incorporate, the second feed did 
not substantiate this result. The tri-labelled propionate 62 failed to incorporate on 
either attempt. 
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Scheme 32: Sugden's synthesis of labelled 3-hydroxypropionoates 61 and 62.66 
Owing to the success of NAC thiol esters in feeding studies, we turned our 
attention towards the synthesis of [1,2-13C2]-3-hydroxypropanoic acid N- 
acetylcysteamine thiol ester 75. It was hoped that not only would the thiol ester 
incorporate better than the free acid but also that the two vicinal 13C labels would 
increase the sensitivity of the experiment. Watts has previously investigated the 
synthesis of 75 as shown in Scheme 33.6 He optimised his route using unlabelled 
material, successfully preparing thiol ester 73 in 23% overall yield. Starting from 
Evans' oxazolidinone (S)-63, acylation with acyl chloride gave (S)-64 in 95% yield. 
Hydroxymethylation using titanium tetrachloride and trioxane afforded the alcohol 
(S)-66 which unfortunately was found to decompose under standard chromatography 
conditions. However, the corresponding silyl ether (S)-68 could be isolated furnishing 
52% yield of the desired compound over the two steps. Cleavage of the auxiliary gave 
acid 70 in quantitative yield, which was then coupled to N-acetylcysteamine 42 to 
give thiol ester 72. Finally, deprotection of the silyl group afforded the desired thiol 
ester 74 in 70% yield. Adjusting the synthesis to incorporate vicinal 13C labels via 
[1,2- 13 C21-sodium acetate and pivaloyl chloride, Watts successfully prepared thiol 
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ester 73 in 16% overall yield but did not have enough material to effect the 
deprotection. 
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Scheme 33: Watts' preparation of thiol ester 74.76 
As this was a promising route, it was decided to try and further optimise the 
conditions. In particular, it was hoped to improve the yield of the hydroxymethylation 
step and also to attempt the synthesis without a protecting group. As the auxiliary was 
employed merely to avoid volatility and water solubility problems we investigated the 
use of a different auxiliary. Oppolzer's sultam 76 was chosen on the basis that it tends 
to produce crystalline solids which may be amenable to recrystallisation, thus offering 
an alternative purification to column chromatography. Acylation of auxiliary 76 gave 
acetylsultam 77 in 97% yield (Scheme 34). Hydroxymethylation afforded 29% of the 
desired alcohol 78 (this was the isolated yield though IH NMR analysis of mixed 
fractions showed that the real yield was probably closer to 46%) but interestingly 
dimer 79 (approximately 22% as determined by 'H NMR analysis) was also observed. 
These two products were difficult to separate by column chromatography leading to 
very low yields for this step. Premixing the trioxane and titanium tetrachloride prior to 
addition did not aid matters, nor did adding 3% methanol (to aid formaldehyde 
monomer formation and prevent polymerisation). 7 Lowering the number of 
equivalents of trioxane decreased the yield further and attempts to protect the crude 
mixture as the TBDPS silyl ether also proved futile. Cleavage of the auxiliary with 
lithium hydroxide and hydrogen peroxide gave 3-hydroxypropanoic acid 80 in 
quantitative yield. However, attempts to couple acid 80 to N-acetylcysteamine 42 
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were unsuccessful. None of the characteristic signals for thiol ester 74 were present in 
the NMR spectra of the crude product. In particular, a multiplet signal at 4.33-4.41 
ppm in the 'H NMR spectrum was too far upfield to be attributed to the 3-H2 protons 
(or any of the reagent/by-product protons). It does however, compare well with the 3- 
H2 signal of ß-lactone 81 which comes at 4.28 ppm78 and so this seems the most 
plausible explanation. 
NaH, AcCI O (i) TiC14, iPr2EtN 
f7o 
OO 
97% (i) TiC 4, trioxane + 
ý, 
NH N 
ööO ýSý ýý OO 79 O> OOO 78(29%) 
76 77 
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100% 
O0O 
^ 
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42 0 42 0 
Scheme 34: Towards the synthesis of thiol ester 74. 
Reverting to Watts' choice of auxiliary, Evans' oxazolidinone 63, did nothing to 
improve matters and so it was decided to develop a new route which would avoid 
installing a one-carbon unit (Scheme 35). Mono-protection of diol 82 gave silyl ether 
83 in 85% yield. Swern oxidation afforded aldehyde 84 in 95% yield which then 
underwent a Pinnick type oxidation with sodium chlorite to furnish acid 70 in 
quantitative yield. This was then coupled to N-acetylcysteamine 42 to give thiol ester 
72 and deprotected using hydrogen fluoride pyridine complex to give the desired thiol 
ester 74 in 38% yield. 
(i) (COCI)2, DMSO 0 
nBuU, TBDPSCI (ii) NEt3 
HOýý\OH 85 
TBDPSO 
% 95% TBDPSO H 82 83 84 
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Scheme 35: Revised route to thiol ester 74. 
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As all three carbons in the final thiol ester come from the starting diol 82, this 
must be the source for any isotopic labels. Due to the symmetrical nature of the 
starting material and the desire for two vicinal 13C labels, the only commercially 
available option is [13C3]-1,3-propanediol 86. As this is extremely expensive we opted 
to investigate its synthesis. Reduction of diethyl malonate 85 with lithium aluminium 
hydride gave diol 82 in 51% yield (Scheme 36). However, although comparable to 
literature yields for this reaction (the highest yield in the literature is 63%79), overall 
this route was deemed too inefficient for expensive13C substrates. 
ýw 
oO 
UAIH4 Ao, 
EtOýýOEtP 
HOýýOH HO `ý' ýOH 
85 51% 82 86 
Scheme 36: Preparation of diol 82 from diethyl malonate 85. 
The new route was however ideal for deuterium incorporation. Lithium 
aluminium deuteride is a relatively cheap source of isotopic label and thus the 
deuterated thiol ester 2 was selected as a precursor for feeding studies. Reduction of 
diethyl malonate 85 with lithium aluminium hydride gave diol 87 in 64% yield. 
Mono-protection was affected in 92% yield to give silyl ether 88, which underwent a 
Swern oxidation in 81% yield to afford aldehyde 89. Pinnick oxidation gave acid 90 
in quantitative yield which was then coupled to N-acetylcysteamine 42 to give thiol 
ester 91 in 79% yield. Finally, deprotection of thiol ester 91 furnished thiol ester 2 in 
38% yield. 
O0 DDDD 
L1AID4 nBuli, TBDPSCI 
DDDD 
ýý/ ý/ 
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Scheme 37: Preparation of thiol ester 2. 
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Thiol ester 2 was fed to P. fluorescens in duplicate (as described in section 2.2). 
Unfortunately, no pseudomonic acid was isolated on either attempt nor from the 
control flasks and so the only conclusion that can be drawn from these experiments is 
that the bacteria had stopped producing. Due to time constraints this experiment could 
not be repeated with a fresh batch of P. fluorescens. 
2.6 Conclusions and Further Work 
[1,2- 13 C21-9-Hydroxynonanoic acid NAC thiol ester 1 was prepared in 5 steps and 
39% overall yield. Once a growth production study had been conducted, thiol ester 1 
was fed to P. fluorescens but did not show any incorporation of 13C into the isolated 
pseudomonic acid. Taken in conjunction with the results of Sugden, 66 and the recent 
truncated metabolites 57 and 58 isolated by Wu (J. Wu, unpublished results), this may 
imply that the 9-hydroxynonanoic acid chain is not preformed before esterification to 
the monic acid fragment but is constructed in situ once this union has occured. 
However, care must be taken in interpreting these results as there are many reasons 
why feeding experiments might be unsuccessful. 
[3,3_2 H2]-3-Hydroxy propanoic acid NAC thiol ester 2 was also prepared and fed 
to P. fluorescens. Unfortunately, both feeding studies with thiol ester 2, including the 
control flasks, failed to produce any pseudomonic acid. The only conclusion that can 
be drawn from these experiments is that P. fluorescens had stopped producing. 
Martin70 and Sugden66 have both previously reported problems with inconsistent 
production of pseudomonic acid. This experiment will need to be repeated with the 
remaining material when a fresh batch of P. fluorescens is available. 
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3.1 Investigation of the Mupirocin Gene Cluster 
In 2003 Thomas and co-workers sequenced the mupirocin gene cluster and 
assigned putative enzymatic functions to many of the genes/domains identified, based 
on their similarity to other polyketide and fatty acid synthases (Figure 18 and Table 
s0 1). 
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Al KS10 -? A1 ---_® 
Acyl Transferase 
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KS Kelosynthase 
® Keloreductase 
® Dehydratase 
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LIM Acyl Carrier Protein 
HY Putative hydoxylase 
7 Unknown function 
Figure 18: The mupirocin gene cluster. 80 
Gene Putative Function Gene Putative Function 
mupA FMNH-, -dependent oxygenase mupN regulatory DNA binding protein 
mupB 3-oxoacyl-ACP synthase mupO cytochrome P450 
mupC NADH/NADPH oxidoreductase mupP function unknown 
mupD 3-oxoacyl-ACP reductase mupQ acyl-CoA synthase 
mupE enoyl reductase mupS 3-oxoacyl-ACP reductase 
mupF ketoreductase mupT ferredoxin dioxygenase 
mupG 3-oxoacyl-ACP synthase I mupU acyl-CoA synthase 
mupH HMG-CoA-synthase mupV oxidoreductase 
mupJ enoyl-CoA-hydratase mup dioxygenase 
mupK enoyl-CoA-hydratase mupR 
N-AHL-responsive 
transcriptional activator 
mupL hydrolase mupX amidase/hydrolase 
mupM isoleucyl-tRNA synthase mupl N-AHL synthase 
Table 1: Putative functions assigned to mupirocin type II genes by Thomas and co- 
workers based on homology testing. 80 
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The mupirocin PKS is unusual in that it contains elements of both type I and type 
II PKS structure and is both iterative and modular in places. 80 The large 
multifunctional mupirocin (mmp) genes encode for the modular type I proteins - 
MMP 1, MMP3 and MMP4 proposed to be responsible for the synthesis of the monic 
acid precursor, MMP2, an iterative type I protein thought to be responsible (in 
conjunction with mupE) for the production of the 9-hydroxynonanoic acid entity and 
MMP5 and MMP6, which have yet to be assigned a role. The genes mupA - mupX 
and macpA-E encode for type II mono-functional proteins, most of which have yet to 
be assigned an explicit role in mupirocin biosynthesis but are probably involved in the 
tailoring steps that modify the basic polyketide backbone to furnish the overall 
product. 
Unlike other modular PKS systems, the modules in the mup PKS are not 
arranged in the order expected for mupirocin synthesis. Synthesis is predicted to 
commence at MMP3 in the centre of the gene cluster continuing on to MMP4 before 
returning to MMP1 and MMP2 at the beginning of the cluster (Scheme 38). 
Positioning of the thiol esterase domain in the centre of the gene cluster rather than at 
the end is highly unusual, leading to suggestions that perhaps this domain catalyses 
release of the 9-hydroxynonanoic acid entity rather than the fully synthesised 
mupirocin or performs the condensation step which unites the two moieties. A further 
unusual characteristic is the lack of acyl transferase domains within each of the 
condensation modules. How exactly the extender units are delivered to the growing 
chain is still a mystery. A deeper understanding of the unique features of the 
mupirocin polyketide synthase may therefore help to explain not only the mechanism 
by which mupirocin is synthesised but also the mechanism by which many other 
complex polyketide metabolites are furnished. 
To date, several gene deletions have been carried out on the mupirocin gene 
cluster. Knock out experiments on the ACPs, KS1, KR1, TE, AT!, AT2, McTI 
domains, the multifunctional genes mmpE and mmpF, and the mupC, mupD, mupE, 
mupF, mupG, mupH, mupl, mupJ, mupK, mupL, mupM, mupN, mupO, mupQ, mupR, 
mupS, mupT, mupU, mupV, mupW, mupX, macpA, macpB, macpC, macpD and 
macpE monofunctional genes all resulted in a loss/reduction of pseudomonic acid 
production and in some cases the appearance of new products. 
81 
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Scheme 38: Proposed domain organisation of the mupirocin polyketide synthase and 
putative biosynthetic intermediates. 80 
For example, mutation of the mupW gene led to a mutant metabolite, mupirocin 
W, which lacked the tetrahydropyran ring of the pseudomonic acids and had instead a 
tetrahydrofuran ring (Scheme 39). ` This indicates that in mupirocin synthesis, mupW 
is involved in formation of the tetrahydropyran ring, i. e. it facilitates C-16 oxidation. 
In the absence of the tetrahydropyran ring, the structure of the product 92 is less rigid 
permitting attack of the C- I O-C-11 epoxide by the C-7 hydroxyl group to form a 
tetrahydrofuran ring. Whether this transformation occurs in situ or as a consequence 
of the acidic work-up has yet to be determined. 
OH O 
HO 
OH 
ý/ºý O 
TI/O 
OH O 
,, "InW OH Pseudomonic acid A 
' Yý Tf 8 OH OH 0 
\\ý 
OH dnuq WO 
8 OH I IOI 
OH 92 OH 
OH OH Mupirocin W 
Scheme 39: Mutation of mupW results in mupirocin W. 82 
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Similarly, mutation of mupC and mupF result in production of mupirocin C and 
mupirocin F respectively. Based on these structures it has been proposed that mupC, a 
proposed dienyl-CoA reductase, is responsible for reduction of the C-8-C-9 double 
bond of the polyketide backbone (the unreduced product subsequently rearranges) and 
that mupF, a putative ketoreductase, is responsible for reduction of the C-7 carbonyl 
group. 8' 
O OH O 
O 'I Ol OH =O Mg OH 
O 
8' '1 _0 OO 
eY ýý 
OH OH Mupirocin 
C OH Mupirocin F 
Mupl and mupR (which are named out of sequence) showed significant identity 
with quorum sensing regulatory proteins such as those encoded by Las! and LasR 
from Pseudomonas aeruginosa and Lud and LuxR from Vibrio fischeri. 83 Mupl was 
found to produce a diffusible inducer molecule which activates the mup promoter 
region located upstream of mupA, effectively switching on mupirocin biosynthesis. 
MupR is likely to act as a regulator, boosting and suppressing mupl expression as 
required. 
Unsurpisingly, mupM, which encodes for an isoleucyl tRNA synthase, was found 
to confer mupirocin resistance. 80 This was demonstrated by expressing the mupM 
gene in a strain of E. coli, which subsequently raised the minimum inhibitory 
concentration of mupirocin required for that strain from 30 tg m1: 1 to 250 µg mL''. 
Mutation of mupO, mupU, mupV or macpE resulted in a switch from 
pseudomonic acid A to pseudomonic acid B production. 
84 Pseudomonic acid B might 
be expected to be derived from pseudomonic acid A by a simple hydroxylation at the 
C-8 position. However, the accumulation of pseudomonic acid B at the expense of 
pseudomonic acid A, seems to suggest that it is either a precursor to pseudomonic 
acid A or a shunt product of the pathway. The latter is in agreement with the findings 
of Mantle et a1., 85 who found that the relative patterns of radioactivity resulting from 
feeding studies with [1-14C]-acetate and L-[methyl- 14C] -methionine at early, mid and 
late stages of fermentation, were inconsistent with the assumption that pseudomonic 
acid B results from oxidation of pseudomonic acid A or that pseudomonic acid A 
results from reduction of pseudomonic acid B. 
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Mupirocin H, initially isolated by mutation of the muJ)H gene but also a product 
of mucpC, mupG, mupJ and mupK mutation is thought to be responsible for the 
acylation step in module 6 which in conjunction with macpC, mupG, muppJ and mupK 
introduces the 15-CH; moiety (Scheme 40). 86 MupH is proposed to catalyse the 
condensation of thiol ester 94 with acetate 93. The latter is produced by MupG 
catalysed decarboxylation and is delivered to the PKS by MacpC. Finally, MupJ 
catalysed dehydration of glutarate analogue 95 to give acid 96 and MupK catalysed 
decarboxylation furnishes (3-methyl-a, (3-unsaturated thiol ester 97. 
O0 
HO2C 
JL 
_ 
mupG 
93 
mupN TIOIf 
0 
94 
H -ryo s--0 
97 
nmpK 
-CO, 
RýSý 
nnr/rJ 
R Sý 
HO2Cý OH 
IOI 
-H, 0 
r-olr 
95 HO2C 96 
Scheme 40: Proposed mechanism for introduction of the 15-methyl group. 86 
Mutagenesis of mupH, which encodes a HMG-CoA-synthase, blocks this step 
(Scheme 41). 87 Thus, hydroxylation of 98 at C-6 to give 99, allows an intramolecular 
attack of the 6-hydroxyl onto the (3-carbonyl of the thiol ester and a subsequent retro- 
aldol reaction affording mupirocin H instead of the proposed product of module 6, 
thiol ester 100. That all five mutations result in the same product may be due to a 
knock on effect. 86 It is proposed that mutation of any of the individual functionalities 
impairs the overall progess of the enzyme bound metabolites along the biosynthetic 
assembly line, allowing time for 6-hydroxylation and cyclisation to occur. 
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Scheme 41: Disruption of mupH blocks acylation, leading to mupirocin H. 87 
However, although much has been ascertained about the mupirocin biosynthetic 
pathway to date, there are still many unanswered questions. In particular, the genes 
responsible for C-10-C-11 epoxidation and 6-hydroxylation have yet to be 
determined as well as the timing of these transformations in relation to the rest of the 
pathway. The mechanism by which the tetrahydropyran ring is formed is another 
anomaly, though evidence in the form of isolated mutant metabolites (J. Wu, 
unpublished results) is beginning to shed some light in these areas. 
3.2 Synthesis of Mupiric Acid 3 and the C-2 Epimer 4 
Mutation of the KR6 domain of the mupirocin gene cluster (and more recently 
mutation of the macpC, mupB, mupG, mupJ, mupK, mupL, mupQ, mupS, mmpF and 
ACP5 (J. Wu, unpublished results)) also led to the production of a novel metabolite, 
mupiric acid 3 (Scheme 42). Like mupirocin H, mupiric acid 3 is thought to form as a 
result of congestion in the metabolic pathway, diverging either by hydrolysis of the 
module 3 product or by nucleophilic attack of the (3-carbonyl (resulting from 
deactivation of the KR6 domain) of the module 4 thiol ester and a subsequent retro- 
aldol reaction (analogous to the mechanism proposed for mupirocin H formation). 
The resulting diene 101 then undergoes olefin reduction at the C-2-C-3 position to 
give mupiric acid 3. The structure of mupiric acid 3 was tentatively assigned by 
comparison with pseudomonic acid. 
86 However, in order to clarify that all 
stereochemical assignments were correct, a synthetic standard of acid 3 and its C-2 
epimer 4 were required. 
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Scheme 42: Proposed biosynthesis of the truncated metabolite mupiric acid 3. 
Initial retrosynthetic analysis led us to iodide 102, which had previously been 
prepared within our group by McKay61'58 and the known oxazolidinone 10389 
(Scheme 43). Furthermore, by varying the enantiomer of Evans' auxiliary used, it 
would be possible to gain access to both C-2 epimers. 
O OH O0 
/k/+v 
AO 
H R) O 
N4= 
(2S) 
OTBDMS 
102 
1 03 
Scheme 43: Retrosynthetic analysis of acids 3 and 4. 
Iodide 102 was prepared following the synthesis of McKay" (Scheme 44). 
Starting from Oppolzer's auxiliary 76, acylation using propionyl chloride furnished 
propionylsultam 104 in quantitative yield. This was subsequently treated with tert- 
butyldimethylsilyl triflate and triethylamine, followed by titanium tetrachloride and 
acetaldehyde to yield alcohol 105 in 82% yield. 
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Scheme 44: Synthesis of iodide 102. 
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This aldol step was particularly troublesome, requiring impeccably dry 
conditions for successful formation of the silyl enol ether moiety. Whilst trying to 
optimise the reaction conditions, a substantial quantity of a by-product was observed 
whenever an excess of acetaldehyde (relative to titanium (IV) chloride) was used. 
Spectral analysis confirmed the structure as acetate 110 and X-ray crystallography 
confirmed the stereochemistry. We were unable to determine exactly how this product 
formed. 'H and 1 3C NMR spectra of the acetaldehyde used, showed that although 
there was some hydrate present, no acetic acid could be detected. 
O OAc 
0, 
N 
OSO 
110 
Figure 19: X-ray structure of acetate by-product 110. 
Subsequent protection of the 3'-hydroxyl group with tort-butyldimethylsilyl gave 
silyl ether 106 in quantitative yield. Removal of the auxiliary with DIBAL-H afforded 
aldehyde 107, which was then chain extended by Horner-Wadsworth-Emmons 
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reaction to give the ester 108 in 83% yield. Subsequent reduction furnished alcohol 
109 in 92% yield which was then converted to iodide 102 with DIPHOS and iodine. 
Preparation of (S)-103 and (R)-103 proceeded via acylation of Evans' 
oxazolidinones (S)-63 and (R)-63 which were in turn prepared from L- (S)-111 and D- 
valine (R). 111, respectively (Scheme 45). 
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COOH 
(i) AcCI, MeOH 
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Scheme 45: Preparation of alkylation substrates. 
With both reactants in hand, we turned our attention towards the alkylation of 
(S)-103 with iodide 102 (Scheme 46). Unfortunately however, all attempts to effect 
this union proved futile, as none of the desired product 114 was observed. Table 2 
summarises the various conditions investigated. In each case, no reaction was 
observed by T. L. C. at -78 °C and gradual warming to room temperature simply 
resulted in decomposition of (S)-103. 
O 
OTBDMS 
102 OTBDMS (S)-103 114 
Scheme 46: Attempted alkylation of oxazolidinone (S)-103 with iodide 102. 
Reagents Temperature 
1. NaHMDS -78 °C --> R. T. 
2. LiHMDS -78 °C --> R. T. 
. LDA, HMPA -78 °C -º R. T. 
4. TiC14, iPr2NEt 0 °C 
Table 2: Conditions for the alkylation of oxazolidinone (S)-103 with iodide 102. 
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These results were disappointing as iodide 102 was successfully employed as an 
alkylating reagent by McKay61'88 and alkylation of (S)-103 with allyl iodide 115 has 
been shown both in the literature90 and within our own group91 to proceed in 
reasonably high yield. Indeed, treatment of (S)-103 with allyl iodide 115 and 
NaHMDS furnished the desired alkene (S)-116 in 70% yield (Scheme 47). Similarly, 
allylation of (R)-103 proceeded in 72% yield. 
o000 
v _NAO + NaHMDS 
115 70% 
(S)-103 (4S)-116 
o000 
v NýO + NaHMDSNý 
115 72% 
(R)-103 (4R)-116 
Scheme 47: Alkylation of oxazolidinones (S)-103 and (R)-103 with allyl iodide 115. 
With these compounds in hand, we revised our synthetic approach to the targets 3 
and 4. A recent publication by Marko and co-workers, 
62 described installation of the 
side chain of methyl pseudomonate C by cross metathesis of alkenes 117 and 118, 
giving the desired alkene 119 in 56% yield (Scheme 48). Only the trans isomer was 
observed. Applying this to the synthesis of acids 3 and 4, disconnection at the olefin 
leads us to alkene 116 and silyl ether 117, the same alkene used by Marko and co- 
workers (Scheme 49). 
OTBS OTBS 
0 O", Grubbs 2nd O 
Generation Catalyst 
+ /\. /O 
I 101 
56% O 
IOI 
OTES 
117 118 OTES 119 
Scheme 48: Marko and co-workers' cross metathesis approach to methyl 
pseudomonate C. 62 
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Scheme 49: Revised retrosynthesis of acids 3 and 4. 
Preparation of alkene 117 was achieved by silyl protection of aldol adduct 105 
using chlorotriethylsilane and imidazole to give 120, followed by cleavage of the 
auxiliary and a salt free Wittig reaction (Scheme 50). However, some of the labile 
triethylsilyl group was cleaved during the DIBAL-H reduction leading to a lower 
yield for this step than might be expected. 
O OH O OTES 
TESCI, Imidazole (i) DIBAIrH 
Y\ý 
Sý 
N= 
87°6 ýS1 
N 
(ii) NaH, PPh3MeBr OTES 
O/ \O 105 
00 120 55% 
117 
Scheme 50: Preparation of alkene 117. 
Cross metathesis of 117 and (4S)-116 proceeded in 50% yield giving a 1: 4 
mixture of the cis 121 and trans 123 isomers (Scheme 51). These were found to be 
inseparable by silica gel column chromatography (even when silver nitrate 
impregnated silica was employed92) or by preparative HPLC, although the latter did 
lead to partial deprotection of the silyl protecting group. Attempts to isomerise the 
double bond using iodine93 or bis-acetonitrile palladium (H) chloride94 led to a 
complex mixture of products. It was decided to continue the synthesis with the 
mixture of isomers in the hope that the final acid would be crystalline and thus 
purification could be achieved by recrystallisation. Thus, the mixture of 121 and 123 
was treated with lithium hydroxide and hydrogen peroxide in order to cleave the 
auxiliary, followed by acetic acid in THE and water to remove the protecting group 
furnishing a 4: 1 mixture of the desired acid 3 and its cis isomer 125 in 40% yield. 
Again, the isomers were inseparable by column chromatography. Acid 4 was prepared 
in an analogous manner from alkenes 117 and (4R)-116, also as a 1: 4 mixture of cis 
and trans isomers. 
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Figure 20: Comparison of the 'H NMR spectra of acids 3 and 4 (run in benzene-D6) 
with mupiric acid 3. 
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Scheme 51: Cross metathesis of alkenes reaction. 'Yields quoted are for 4: 1 mixtures. 
Comparison of the iH NMR spectra of acids 3 and 4 (run in CDC13) with that of 
the isolated metabolite, mupiric acid 3, was inconclusive. The three spectra were 
almost identical. Although slightly better correlation of the 2-CH3 was observed for 
the 2R diastereomer 3, the difference (approximately 0.002 ppm) was so small that no 
firm conclusion could be drawn. When the spectra of acids 3 and 4 were run in 
benzene-D6 however, they were significantly different (Figure 20). The signals 
corresponding to 3-HH (2.11 ppm) and 3-HH (2.22 ppm) in the 1H NMR spectrum of 
mupiric acid 3, were more resolved in the spectrum of the C-2 epimer 4, the former 
moving upfield towards the 6-H signal and the latter moving downfield towards the 2- 
H signal. This meant that we could confidently and unequivocally assign the C-2 
stereocentre of mupiric acid 3 as the R configuration. 
Although the 4: 1 mixtures had proved adequate for the structural elucidation of 
mupiric acid 3, we were still keen to obtain a pure sample and to develop the 
methodology for the synthesis of future mutant metabolites. Taylor and co-workers 
found that increased trans selectivity in cross metathesis could be achieved for 
substrates with a free hydroxyl group anti to an alkyl group at the allylic position 
9s 
Once the substrate 127 has reacted with the catalyst, a lone pair on the oxygen is 
proposed to chelate to the ruthenium to form a five-membered transition state 128 
(Scheme 52). The bulky allyltrimethylsilane 129 approaches from the least hindered 
a-face leading to two possible intermediates 130 and 131. The first of these, which 
leads to the cis product 132, is less favoured due to the steric interaction between the 
methyl and the trimethylsilyl substituents and thus the trans product 133 is favoured. 
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Scheme 52: Proposed five-membered ring chelate intermediate leading to increased 
trans selectivity. 95 
We briefly investigated deprotecting alkene 117 but encountered significant 
volatility problems and so instead we turned our attention towards the synthesis of the 
benzyl protected derivative 135. During some concurrent work (which will be 
discussed further in section 2.7) we found that benzyl ethers retain a degree of 
nucleophilicity about the oxygen lone pair. We hoped that the lone pair of the benzyl 
protected alkene 135 might chelate in a similar manner to the free alcohols reported 
by Taylor and co-workers. 
The benzyl protected alkene 135 was prepared analogously to its silyl 
counterpart (Scheme 53). Following Widmer's method, 96 alcohol 105 was treated 
with benzyl 2,2,2-trichloroacetimidate and triflic acid to give benzyl ether 134. 
Treatment with DIBAL-H to cleave the auxiliary followed by a salt free Wittig 
reaction furnished alkene 135 in 46% yield. This then underwent cross metathesis 
with (4S)-116 to afford a 6: 1 trans/cis mixture of the benzyl protected oxazolidinones 
136 and 137 and with (4R)-116 to afford a 6: 1 trans/cis mixture of the benzyl 
protected oxazolidinones 138 and 139. Both pairs of isomers were inseparable by 
column chromatography. 
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Scheme 53: Cross metathesis of alkene 135 with alkenes (4S)-116 and (4R)-116. 
Although the improvement to the trans/cis ratio was not quite as marked as had 
been hoped, these substrates do have the advantage of a more robust protecting group 
and so may find applications as intermediates to more complex mupirocin targets. 
However, in order for them to be useful, it must be possible to deprotect the benzyl 
ether in the presence of the olefin. In 1999, Crimmins and Emitte reported the use of 
DDQ (more commonly used for the deprotection of p-methoxy- and other substituted 
benzyl ethers97) to deprotect a benzyl ether in the presence of an alkene giving 141 in 
83% yield (Scheme 54) 98 Not only was this method mild and high yielding but the 
substrate employed 140 also contained an oxazolidinone and so was very similar to 
benzyl ethers 136-139. 
Bn Bn 
NO DDQ, Buffer NO 
BnOK OH 83% HOB` :OH 
H 
140 
O0 %ý H 141 ý` 
Scheme 54: DDQ deprotection of a benzyl ether in the presence of an alkene 98 
The mixture of alkenes 136 and 137 was treated with DDQ in the presence of 
buffer solution for 3 days. The reaction mixture was shaken rather than stirred as this 
proved a more efficient means of mixing the biphasic heterogeneous solution. 
Alcohols 142 and 143 were obtained in 71% yield and yet again proved inseparable. 
Finally, cleavage of the auxiliary with lithium hydroxide and hydrogen peroxide 
afforded mupiric acid 3 and its cis isomer 125 as a 6: 1 mixture. 
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Scheme 55: Preparation of mupiric acid 3 from benzyl ether 136. 
3.3 Studies Towards the Synthesis of the Proposed DH4 Lactone 5 
As described in section 1.1, the polyketides follow a logical progression of 
biosynthesis, allowing putative products, intermediates and mutant metabolites to be 
predicted. However, the stereochemistry of these compounds is not so easy to predict 
and often there may be more than one possible stereoisomer. The best way to 
conclusively prove the structure is to isolate the compound and compare it to 
authentic material. 
The mupirocin polyketide synthase, discussed in section 3.1 is thought to have 
many enzyme bound intermediates which are extended with each subsequent 
condensation cycle and reduced according to the domains present. In module 3 for 
instance, intermediate 144 is condensed with a malonate extender unit and then the 
ketone is reduced, dehydrated and methylated to give intermediate 145 (Scheme 56). 
Intermediate 145 is subsequently extended and the ketone moiety is reduced to give 
the proposed overall product of MMP4, diene 146. Genetic mutation of the DH 
domain in module 3 of the mupirocin PKS, however, is predicted to result in 
formation of one of four lactones 5,148,149 and 150 (Scheme 57). By deleting this 
domain, reduction of the hydroxyl group in module 3 is unable to take place, thus 
leaving the carbonyl of the mutant module 4 product 147 open to nucleophilic attack 
to form a lactone. 
In order to assist in the detection and structure elucidation of lactones 5,148,149 
and 150, authentic material is required. The stereochemistry of the methyl group at C- 
5 and the hydroxyl group at C-6 are not known as these are new stereogenic centres 
and so a flexible synthesis which gives access to all four diastereomers is required. 
Another reason for our interest in these substrates is that they do not possess a 
hydroxyl group at the position corresponding to C-6 of the pseudomonic acids (C-3). 
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As the timing of this oxidation is as yet unknown, we hoped to preempt the discovery 
of intermediates and mutant metabolites without this hydroxyl group and develop our 
methodology towards their synthesis. For convenience, we chose to focus initially on 
lactone 5. 
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Scheme 56: Predicted formation of intermediate 146 by the mupirocin PKS. 
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Scheme 57: Predicted lactone formation by the mupirocin PKS following mutation of 
the DH domain in module 3. 
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A recent publication by Yadav et al., 99 describes the synthesis of trisubstituted 
lactones from the corresponding tetrasubstituted tetrahydropyrans 152 (Scheme 58). 
The latter were accessed via a Prins cyclisation of homoallylic alcohol (R)-151 and 
aldehyde precursors, following procedures developed within our group. 1°° Subsequent 
protection of the secondary alcohol with MOMCI, DMAP and Hünig's base to give 
153 and deprotection of the primary alcohol with lithium and liquid ammonia 
afforded pre-lactone 154. PCC oxidation then afforded the corresponding lactone 155 
which could be deprotected with acid to give the desired 4-hydroxy-lactone 156. We 
decided to explore this approach to prepare lactone 5. 
(i) TFA BnOO .R BnOý0,,,, 
O .R 
OH 
(ii) K2C03, MeOH 
r1 
Bn0 iPr2NEt, MOMCI, DMAP t_ 1 
RCHO = 
v= 
OH MOM 
(R)-151 152 153 
Li, liq. NH3 
ODOR OOR 
HO/,,,,. 
O oR 
HCI, THF 
; \l 
1 PC C' benzene l1 
OH OMOM ÖMMO`M 
156 155 154 
Scheme 58: Lactone synthesis of Yadav et al. 99 
The crucial step in this synthesis was the Prins cyclisation, which determines the 
stereochemistry of the substituents at C-4, C-5 and C-6 as outlined in Scheme 59. 
Treatment of homoallylic alcohol 157 with an aldehyde in the presence of 
trifluoroacetic acid generates the oxocarbenium ion 158. Nucleophilic attack and ring 
closure via a chair transition state then furnishes the tetrahydropyran 159, with all four 
substituents in the equatorial position. Finally, hydrolysis of the trifluoroacetate group 
with potassium carbonate in methanol produces the tetrahydropyranol 160. 
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Scheme 59: Prins cyclisation to prepare tetrahydropyrans. 
It is possible to invert the centre at C-4 by a Mitsunobu reaction, thus access to 
both C-4 epimers should be possible. Thompson and co-workers showed that the 
stereochemistry of the substituent at the C-3 position of the tetrahydropyran ring is 
determined by the geometry of the homoallylic alcohol employed. 101 Upon generation 
of the intermediate oxocarbenium ion, the reaction is proposed to proceed via a chair- 
like transition state. It was shown that a trans homoallylic alcohol led to an equatorial 
substituent at C-3, whereas a cis homoallylic alcohol led to an axial substituent at C-3 
(Scheme 60). We should therefore have access to both of the C-3 epimers simply by 
varying the geometry of the alkene in the homoallylic alcohol. Thus, access to all four 
lactones should be possible following the proposed route. 
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Scheme 60: Stereoselective Prins cyclisation. 101 
Initial retrosynthetic analysis of lactone 5 identified the homoallylic alcohol (S). 
151 and aldehyde 161 as suitable precursors (Scheme 61). Both of these segments are 
known compounds. 
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Scheme 61: Initial retrosynthesis of lactone 5. 
Homoallylic alcohol 151 was the substrate employed by Yadav et al. 99 in their 
lactone syntheses. They reported a 64% overall yield and so we investigated the same 
approach (Scheme 62) working initially with the (R)-enantiomer as this was cheaper. 
Thus, treatment of (2R)-benzyl glycidyl ether 162 with propynyllithium in the 
presence of boron trifluoride diethyl etherate furnished alkyne 163 in 67% yield. 
Birch reduction of 163 at -78 °C yielded diol 164 in 61% yield. Interestingly, this 
reaction proceeded with very high stereoselectivity furnishing exclusively the trans 
stereoisomer, as determined by NMR spectroscopy. Crosby, 1°° working on an 
analogous system, obtained an (E): (Z) ratio of approximately 9: 1. Finally, selective 
protection of the primary hydroxyl group of 164 furnished homoallylic alcohol (R)- 
151 in 10% yield along with a mixture of di-O-benzyl protected material and some 
starting material ('7'76%). The doubly protected material could be converted back to 
diol 164 and reprotected to increase the overall yield of homoallylic alcohol (R)-151. 
However, this method proved tedious and so after several attempts this route was 
abandoned. 
," 
OBn 
CH3CCH, nBuLi 
_ 
OBn Na, Eq. NH3 
HO 
OH NaH, HO OBn 
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BF3. OEt2 OH 61% TBAI, DMPU,,, 
67% 163 1" 10% (R)-151 
Scheme 62: Synthesis of homoallylic alcohol (R)-151. 
In 2001, Nokami et al. reported the asymmetric synthesis of a series of 
homoallylic alcohols in up to 71% yield and >99% enantiomeric excess, using a chiral 
crotyl-donor 166 prepared from (-)-menthol 165 (Scheme 63). 
102 
OH 0 OH 
ý, Mgcl R RCHO 
AcOH %R 
pTSA. H20 OH 
165 
166 
Scheme 63: Crotyl transfer reaction of Nokami et a1.102 
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As well as being a more efficient route to the desired compound, this route 
proved a much cheaper alternative, as the chiral component, (-)-menthol 165, is 
readily available (as is (+)-menthol). Thus, ethane-1,2-diol 167 was mono-protected 
using sodium hydride and benzyl bromide to give 2-benzyloxyethanol 168 in 83% 
yield (Scheme 64). Swem oxidation afforded the aldehyde 169 in 44% yield which 
underwent crotylation to furnish the desired homoallylic alcohol (S)-151 in 59% 
yield. Despite numerous attempts, the yields for these last two steps were consistently 
lower than expected, possibly due to the steric hinderence of the bulky benzyl group. 
HO"-ý NaH, BnBr, DMPU, TBAI BOO 
DMSO, (COCI)2, NEy 
BnO` 
ýO 
OH ýýOH _H 
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168 
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OH, ý 
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HO166 ýOBn 
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Scheme 64: Synthesis of homoallylic alcohol (S)-151. 
Aldehyde 161 was prepared by a Dess-Martin oxidation of alcohol 109 (Scheme 
65). With both precursors in hand, we were ready to investigate Prins cyclisation. A 
mixture of homoallylic alcohol 151 and aldehyde 161 was treated with TFA and 
stirred for 4 hours. Although the results of this experiment were difficult to interpret 
due to the array of products which formed, it was apparent that the silyl protecting 
group did not stand up to the highly acidic conditions of the reaction. This presented a 
second homoallylic alcohol which presumably reacted further as no alkene signals 
were present in the NMR spectra of the products. Some unprotected aldehyde was 
recovered and (E)/(Z) isomerisation of the double bond of the starting alcohol (S)-151 
was also observed. Whether the desired tetrahydropyran 170 formed at all is 
speculative as it was not possible to purify the products sufficiently for detailed 
analysis. 
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Scheme 65: Treatment of homoallylic alcohol (S)-151 and aldehyde 161 with TFA. 
Because of the problem of the TBDMS ether stability in the Prins cyclisation, we 
next turned our attention to the use of a benzyl deprotecting group even though, if 
successful, this would require the selective deprotection of a primary benzyl ether 
over a secondary. 
DIBAL-H reduction and Horner-Wadsworth-Emmons reaction of 134 afforded 
ester 171 in 83% yield over two steps. A second DIBAL-H reduction furnished 
alcohol 172 in quantitative yield and this was subsequently converted to the desired 
aldehyde 173 immediately prior to further reaction. 
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Scheme 66: Preparation of aldehyde 173. 
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Prins cyclisation of homoallylic alcohol (S)-151 and aldehyde 173 proved very 
interesting (Scheme 67). Although the desired tetrahydropyran 175 was formed (albeit 
in a low 6% yield), a more abundant product was isolated in 31% yield. This product 
did not have an OH stretch in the IR spectrum and had a mass of 316 (rather than the 
expected mass of 334). The coupling patterns and constants for 3-H, 4-H, 5-Ha and 5- 
H, q in the 
'H NMR spectrum, indicated that the 4-H was being held at an angle that 
did not permit coupling except to 5-Heq. Furthermore, the aromatic signals in the 'H 
NMR spectrum integrated to 5 rather than 10 and long range coupling was observed 
between 4-H and 7-H2 in the HMBC spectrum. After careful consideration of all the 
analytical data the major product was assigned as bicycle 174. 
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Scheme 67: Prins cyclisation using aldehyde 173 and homoallylic alcohol (S)-151. 
In order to investigate the reaction further, alcohol (S). 151 was treated with a 
more readily available aldehyde. Propenal was chosen on the grounds that if we could 
construct the tetrahydropyran core using Prins chemistry, perhaps we could then 
couple it to the required sidechain by either cross metathesis or a Wittig reaction. 
Homoallylic alcohol (S)-151 and propenal 176 in the presence of TFA gave the 
desired tetrahydropyran 178 in only 5% yield, the C-4 epimer 179 in 2% yield and the 
bicyclic ether 177 in 14% yield. 
O OBn OBn ,,.. /ý/H +H 
OBn i 
i ii) K2CO3, MeOH ++ 
0"v= 
176 (S)-151 177(14%) OH OH 
178 (5%) 179 (2%) 
Scheme 68: Prins cyclisation of propenal 176 and homoallylic alcohol (S)-151. 
Both these results seemed to be at odds with the results published by Yadav et 
al., 99 who claim to have prepared tetrahydropyran 182 by Prins cyclisation of 
homoallylic alcohol 151 and (E)-but-2-enal 180 in 60-68% yield. Also, both 
Crosby1°° and Barry103 successfully employed a variety of unsaturated aldehydes in 
the Prins cyclisation achieving yields of 47-97% and 88% respectively. At this point 
we decided to repeat Yadav's reaction and although tetrahydropyran 182 did form in 
7% yield, the major product was bicycle 181, which formed in 59% yield (Scheme 
69). 
(i) TFA 
'0 
0 
+ 
1OBn 
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0 (S)-151 181 (59%) OH 
180 
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Scheme 69: Preparation of tetrahydropyran 182. 
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Changing the Prins conditions to boron trifluoride diethyl etherate, acetic acid 
and trimethylsilyl acetate (as a fluoride trap) increased the yield of the desired 
tetrahydropyran 183 to 14% (Scheme 70). However, although no bicycle formation 
was observed using these conditions, the yield was nevertheless inadequate. 
H OBn 
/ II + 
O 
176 (S)-151 
BF3 OEt2, TMSOAc, AcOH 
14% 
OBn 
Iv' 
OAc 
183 
Scheme 70: Prins cyclisation of propenal 176 and homoallylic alcohol (S)-151 using 
BF3. OEt2 conditions. 
Hart et al. 104 reported the synthesis of bicyclic ethers during the synthesis of 
trisubstituted tetrahydropyrans by Prins cyclisation from enol ethers. They proposed 
nucleophilic attack of the benzyl oxygen onto the oxycarbenium ion in place of 
trifluoroacetate as the likely mechanism for the formation of 184 (Scheme 71). 
®oBn ®, 
'l 
O 
EtO2C Et0 C 
EtO2C OBn 184 0 
Scheme 71: Formation of bicyclic ether 184 as proposed by Hart et a1.104 
Hart et al. found that using a bulkier protecting group in place of the benzyl ether 
prevented this intramolecular attack from occurring. Their chosen protecting group 
was tert-butyldiphenylsilyl ether and so we decided to follow suit. 
Homoallylic alcohol 187 was prepared as shown in Scheme 72. Ethane-1,2-diol 
167 was mono-protected as the silyl ether 185. Swern oxidation of 185 afforded 
aldehyde 186 which underwent alkylation to furnish the desired homoallylic alcohol 
187 in 76% yield. Initial yields for this crotylation step were in the region of 16%. 
However increasing the reaction time to 3 days dramatically increased the yield. 
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Scheme 72: Preparation of homoallylic alcohol 187. 
Treatment of homoallylic alcohol 187 with propenal 176 and TFA gave, after 
hydrolysis, an array of unidentifiable products, from which the desired 
tetrahydropyran 188 was isolated in 11% yield. On a positive note, no bicycle was 
produced using the new protecting group. Increasing the quantity of aldehyde from 4 
to 10 equivalents, resulted in a 52% yield of the desired compound (slightly 
contaminated with its C-3 epimer) and no side-products were observed. However, the 
reaction did not go to completion and (E)/(Z)-isomerisation of the starting material 
was again observed. 
, `\OTBDPS 
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H HO., ýý; oz 
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Scheme 73: Prins cyclisation using propenal 176 and homoallylic alcohol 187. 
The results from all these experiments seem to suggest that the Prins cyclisation 
towards the desired compound is not occurring fast enough, leading to isomerisation, 
side reactions and rearrangements. Rychnovsky et al. noted the formation of C-3 
epimers during Prins cyclisation and proposed a 2-oxonia-Cope rearrangement 
through a boat transition state, as the likely cause (Scheme 74). 105 They investigated 
ways of increasing the rate of the reaction (as this denies the competing 2-oxonia- 
Cope rearrangement time to occur) and successfully overcame the problem using a- 
acetoxy ethers and their segment-coupling approach. 1°6 
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Scheme 74: 2-Oxonia-Cope rearrangement through chair and boat transition states. 105 
Segment-coupling, 107 as the name suggests, involves coupling the two Prins 
reactants together prior to cyclisation. It was proposed, that esterification of acid 189 
and homoallylic alcohol 187 to give ester 190 followed by reductive acetylation 
would give access to the a-acetoxy ether 191 (Scheme 75). It was hoped that Prins 
cyclisation of this substrate would proceed without the difficulties experienced with 
the uncoupled substrates to give tetrahydropyran 192. 
/ OH HOB'' OTBDPS DCCn: )MAP 
OBn 
189 
O 
187 
/O 
OTBDPS 
OBn O 
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(i) DIBAI H 
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$ 
O 
OTBDPS 
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.......... 
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192 
OTBDPS 
OBn OAc 
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Scheme 75: Proposed segment-coupling approach to Prins cyclisation. 
Acid 189 proved a more challenging synthetic target than might be expected. For 
example, hydrolysis of ester 171 with sodium hydroxide resulted in elimination to 
give dienoic acid 193 (Scheme 76). Using milder conditions such as lithium 
hydroxide and hydrogen peroxide however resulted in a sluggish reaction which only 
gave the target acid 189 in 15% yield, even after a week. 
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Scheme 76: Hydrolysis of ester 171. 
(i) NaOH 
/ OH (ii) HCI 
Laganis and Chenard reported the use of sodium trimethylsilanoate to convert 
esters and other derivatives to the sodium salts of the corresponding carboxylic 
acids. 108 Methyl esters, acyl fluorides and trimethylsilyl acetates were all converted to 
their corresponding sodium salts in excellent yields. In the case of the methyl ester, 
the reaction is proposed to proceed via nucleophilic attack of the methoxy moiety by 
the silanoate (Scheme 77). 
OH0 
JII`ti 
iH 
/'l 9+ McOSiMe3f R0H Na O-SiMe3 RÖ Na 
Scheme 77: Proposed mechanism of sodium trimethylsilanoate. 108 
Methyl ester 194 was prepared from benzyl ether 134 by cleavage of the 
auxiliary with DIBAL-H followed by Horner-Wadsworth-Emmons reaction using 
trimethylphosphonoacetate. Unfortunately, the latter reaction was not as high 
yielding, nor as selective for the trans ester as the analogous reaction to prepare ethyl 
ester 171, affording 16% of the cis isomer and only 24% of the desired trans methyl 
ester 194. Treatment of methyl ester 194 with sodium trimethylsilanoate however, 
proceeded in 85% yield affording the desired acid 189. 
O OBn (i) DIBAL-H, (i) TMSO Na 
(ii) nBuLi, (MeO)2PCH2CO2Me Oma (ii) AcOH OH 
24% 85% OBn 
194 
0 OBn 
189 
0 
0 134 
Scheme 78: Hydrolysis of methyl ester 194 using sodium trimethylsilanoate. 
Due to the low yield obtained for methyl ester 194 in the previous route it was 
decided to access acid 189 from alcohol 172 via sequential Dess-Martin and Pinnick 
oxidations (Scheme 79). Although not as elegant an approach, as it effectively 
requires three steps to effect the desired ester to acid transformation, all three steps 
were fast, reliable and high yielding, furnishing acid 189 in 88% overall yield. 
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Scheme 79: Finalised route to acid 189. 
DCC/DMAP mediated esterification of homoallylic alcohol 187 and acid 189 
proceeded in 66% yield to afford ester 190. Unfortunately however, reductive 
acetylation did not give any of the desired a-acetoxy ether 191, but resulted instead in 
high yields of acetates 195 and 196. 
/ 
OBn 189 O 
OH + 
HO ., OTBDPS DCC/DMAP 
66% 
187 
1fO `ý'%'ý"OTBDPS 
OBn O 
190 
(i) DIBAL .H 
(ii) pyridine, DMAP, Ac2O 
= AcO OTBDPS 
OAc + 
OBn 
195 (64%) 196(83%) 
Scheme 80: Formation of acetates 195 and 196. 
A more thorough literature search of Rychnovsky's papers revealed an extensive 
study of the conditions required for this reaction. 
109 Each of the important reaction 
parameters were investigated including the number of equivalents of reagents, 
reaction times and temperature, quenching the reaction after the first step, solvent, 
substrates etc. Using their optimised conditions, most of the extensive range of 
substrates employed were converted to the corresponding a-acetoxy ethers in good to 
excellent yields. However, ester 197 failed to produce ether 198 under any of the 
conditions employed during the study (Scheme 81). Just as in the case of ester 190 
exclusive overreduction was always observed. This was proposed to be due to the 
instability of the corresponding aluminium hemiacetal intermediate. Thus, we were 
forced to admit defeat with the segment-coupling approach. Due to time constraints 
we decided not to pursue this target further. 
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Scheme 81: Unsuccessful reductive acetylation of Kopecky and Rychnovsky. 109 
3.4 Conclusions 
Mupiric acid 3 and its C-2 epimer 4 have been prepared using a cross metathesis 
approach. A 4: 1 translcis mixture of each compound was obtained. The C-2 centre of 
3 could thus be assigned as the R configuration by comparison of the 1H NMR spectra 
of the synthetic acids 3 and 4 with that of the isolated metabolite. 
A flexible route for the synthesis of mutant mupirocin metabolites lacking a 6- 
hydroxyl group has also been developed. This route centred on the proposed DH4 
lactone 5. Prins cyclisation to prepare the tetrahydropyran core was achieved (albeit in 
low yield) and problems such as labile protecting groups and bicycle formation were 
successfully overcome. Unfortunately, the problem of isomerisation due to side- 
reactions during this key step could not be resolved due to time constraints. If a means 
of speeding up the Prins cyclisation can be found in the future, this route should prove 
very useful for the preparation of novel mupirocin metabolites. 
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4.1 The Strobilurins 
Strobilurin A (or mucidin as it is also known), produced by Strohiluru. s' 
tenacellus and Oudemansiella mucida (Figure 21) as well as several other 
basidiomycete and ascomycete fungi, is a potent fungicide. '") It acts by inhibiting 
mitochondrial respiration, reversibly binding to the ubihydroquinone oxidation site 
(Qo) of the cytochrome be 1 complex. 
111 
producing fungi responsible for strobilurin A biosynthesis. 
The potential of strobilurin A as a candidate for agrochemical development was 
recognised soon after its discovery in 1976. ' 14 Its high antifungal activity in 
laboratory tests coupled with its "novel" mode of action and low toxicity towards 
mammalian cells were favourable features. Another advantage of using a natural 
product as the basis of an agrochemical lies in its ability to biodegrade, posing no 
lasting threat to the environment. 
During greenhouse testing, however, strobilurin A was found to be unstable. This 
lack of stability was attributed to the triene system of the molecule which was thought 
to be subject to photolytic and/or oxidative breakdown. 14 This led to widespread 
interest in the structural modification of strobilurin A as several companies competed 
to develop the perfect synthetic analogue. Many synthetic analogues of strobilurin A 
have since been developed, ' 15 all of which exploit the novel mode of action of the 
parent compound (Figure 22). These were originally marketed commercially by 
Zeneca, BASF, Shionogi and Novartis under a variety of trade names. 
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Figure 21: Strobilurus tenucellus112 and Oudemunsiellu nwc"idu113 - the mushroom 
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Figure 22: Agrochemicals based on the structure of strobilurin A. 
Many feeding studies have been performed on the fungi Oudemansiella 
mucida116 and Strobilurus tenacellus1 
7 in an effort to elucidate the biosynthetic 
pathway to strobilurin A. These are summarised in Figure 23. 
" [3-''C]-Phenylalanine 
I ý 
ýý ýMe 
" [DK]-Phenylalanine 
[U-14C]-Phenylalanine II I 
, 
OMe " [l 2-13C }-Acetate 
" [I-'3C. 'x0, ]-Acetate 
O" l, 
Strobilurin A 
"[ I-13C]-Benzoic Acid 
0 [D. L-C-HI]-Methionine 
Figure 23: Labelling pattern of strobilurin A from acetate, benzoic acid, 
phenylalanine and methionine precursors. ' 16,117 
These studies have demonstrated that strobilurin A is of mixed biosynthetic 
origin. The aliphatic portion is acetate derived and is likely to follow a polyketide 
biosynthetic pathway followed by a pinacol-like rearrangement (Scheme 82), ' 18 
whereas the benzyl fragment appears to be synthesized from phenylalanine 199, the 
latter being converted to benzoyl-CoA 201 prior to assembly. A possible route for this 
conversion via cinnamic acid 200 has been proposed by Zeeck and Thormann 
(Scheme 83). '17 
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Scheme 82: Proposed biosynthesis of strobilurin A. ' 18 
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Scheme 83: Proposed biosynthesis of benzoyl-CoA starter unit 201.1 17 
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4.2 Investigation of Cinnamic Acid as a Precursor to Strobilurin A 
In order to confirm this proposed pathway, further feeding studies with 
isotopically labelled precursors was required. Firstly, to confirm that cinnamic acid 
200 is an intermediate in strobilurin biosynthesis, it was decided to prepare and feed 
[3-13C]-cinnamic acid NAC thiol ester 6. However, cinnamic acid is also proposed to 
be an enzyme-bound intermediate in the biosynthesis of the main chain of strobilurin 
A (Scheme 82) and so to prove conclusively that incorporation of 200 occurs during 
formation of the benzoyl starter unit 201 and not during chain extension, it was also 
necessary to prepare and feed [2,3-13C2}-cinnamic acid NAC thiol ester 7. Cleavage of 
the '3C-13C bond would imply the thiol ester had been degraded to benzoyl-CoA 201 
prior to incorporation, whereas intact incorporation would verify direct assimilation 
by the PKS. 
Initially, a route comparable to that used for the synthesis of NAC 9- 
hydroxynonanoic acid thiol ester 43 was employed (Scheme 84). Reaction of 
benzaldehyde 202 with triethyl phosphonoacetate 37 furnished ethyl ester 203 in 67% 
yield. Subsequent hydrolysis and coupling reactions gave the required NAC cinnamic 
acid thiol ester 204. This route would give access to both [3-13C]-cinnamic acid NAC 
thiol ester 6 and [2,3-13C2]-cinnamic acid NAC thiol ester 7 using the appropriate 
isotopically labelled phosphonoacetates. 
O ANaH 
O1H 
O 
202 
EtO,. 
DO 
OEt 
37 
67% 
OO 
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ý OH 
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42 0 68% 
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Scheme 84: Initial route to cinnamic acid NAC thiol ester 204. 
On reflection, however, it was decided that a simple two step procedure 
incorporating features of two documented methods for the synthesis of cinnamic acid 
and cinnamic acid NAC thiol ester 
119,120 may be more efficient. The approach was 
first optimised using unlabelled material (Scheme 85). Following the method of 
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Augustyniak et al., ' 19 benzaldehyde 202 and malonic acid 206 in the presence of base 
underwent a Knoevenagel reaction, affording cinnamic acid 200 in 77% yield. This 
was then converted to the NAC thiol ester 204 in 68% yield using N-acetylcysteamine 
42, DCC and DMAP. 
O00H 
DCC. DMAP 
Vyiidin_ OH 
H+ HOOCCOOH H I nJinc 
H0 
HS'-"-" 
202 "= 12C 206 "= 12C 200 "= 
12C "= 12C (77%) 204 " _'2C "_ 12C (68%) 
205 9= 13C 207 "= 13C 
208 "= 12C "= 13C (100%) 42 
06"= 
12C " ='3C (60%) 
209 "= 13C "= 13C (57%) 7"= 13C "= 13C (67%) 
Scheme 85: Synthetic route to cinnamic acid NAC thiol esters 6,7 and 204. 
[3-13C]-cinnamic acid NAC thiol ester 6 was similarly prepared from [carbonyl- 
13C] 
-benzaldehyde 205 in 60% overall yield. Interestingly, a by-product was observed 
during the synthesis of thiol ester 6 which did not arise previously with the unlabelled 
material. Although this compound was not isolated, crude 1H NMR data suggested it 
was the addition product observed by Bjorklund and Leete'2° (Figure 24). 
H 
N 
S0H 
O 
SN -Ir 0-" 
0 
Figure 24: Addition by-product observed by Bjorklund and Leete. 120 
[2,3-'3C2]-cinnamic acid NAC thiol ester 7 was then prepared from [carbonyl- 
13C] 
-benzaldehyde 205 and [2- 
13C] 
-malonic acid 207 in 57% overall yield. Again the 
addition by-product was observed but to a lesser extent than in the previous 
experiment. A small quantity of N, S-diacetylcysteamine was also observed which 
could not initially be separated from the product by column chromatography or 
recrystallisation (an analytical sample was later purified by column chromatography 
using a methanol/ethyl acetate solvent system). However, as it was not expected to 
cause a problem during feeding studies, the mixture was fed without further 
purification. 
Thiol esters 6 and 7 were then sent to Universität Göttingen where feeding 
studies were performed by Zeeck and Thormann. Having fed approximately 150 mg 
of the labelled precursor 6 to Strobilurus tenacellus, strobilurin A was isolated, 
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analysed by '3C NMR and compared to unlabelled material (Figure 25). A 17 fold 
enhancement (compared with the natural abundance spectrum) was observed for the 
'3C signal at 131.9 ppm, assigned to C-7, confirming that cinnamic acid is a likely 
precursor to strobilurin A (Figure 26). 
279 14 
\1 \10 
4I /6O OMe 
13 12 
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OMe 
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Strobilurin A 
2. .ý 
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........ Ti TTT 
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Figure 25: '3C NMR spectrum of strobilurin A in CD; OD, courtesy of Zeeck and 
Thormann. 
xvo Aso xso xýa ýxa . xe xio xoo sa so ýo sa w ýo n 
Figure 26: '3C NMR spectrum of strobilurin A in CD3OD, showing incorporation of 
the [3-13C]-cinnamic acid precursor, courtesy of Zeeck and Thormann. 
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[2,3-'3C2]-cinnamic acid NAC thiol ester 7 (100 mg) was subsequently fed to the 
fungus and again the isolated product was analysed by '3C NMR. Assuming the 
proposed biosynthesis of the benzoyl-CoA starter unit is correct, ' 3C incorporation at 
the C-7 position but not at the C-8 position would be expected. We would also predict 
a loss of '3C-' 3C coupling, indicating cleavage of the C-2-C-3 bond. This is precisely 
what was observed (Figure 27). The signal assigned to C-7 at 131.9 ppm appeared as 
a singlet and was enhanced 13 fold (compared to the natural abundance spectrum) 
whereas no incorporation was observed for C-8, the signal at 127.9 ppm. The lack of 
incorporation at C-8 and loss of '3C-'3C coupling for the C-7 signal proves 
conclusively that cinnamic acid is a precursor to benzoyl-CoA and is not merely 
incorporating in place of the nascent diketide chain during polyketide biosynthesis. 
160 140 120 100 so 60 40 
Figure 27: '3C NMR spectrum of strobilurin A in CD3OD, showing incorporation of 
the [2,3-13C]-cinnamic acid precursor, courtesy of Zeeck and Thormann. 
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4.3 Investigation of the Role of p-Fluorocinnamic Acid in the 
Precursor-Directed Biosynthesis ofp-Fluorostrobilurin A 
Organofluorine compounds are of great medicinal value12' and a significant number 
of important man-made drugs, including prozac® (fluoxetine), mefloquin® 
(fluconazole) and cypro® (cyprofloxacin) contain fluorinated active pharmaceutical 
ingrediants. The replacement of hydrogen with fluorine results in a strongly polarised 
C-F bond, which can alter the acidity of neighbouring functional groups122 and 
fluorine can also function as a hydrogen bond acceptor. ' 23 This affects the substrate- 
enzyme binding of the molecule and ultimately its bioactivity. For several reasons 
fluorine is also a useful biomarker. Firstly, it is similar in size to a hydrogen atom 
(1.35 versus 1.20 
A)122 and can therefore replace hydrogen without notable steric 
interference. The high C-F bond strength (485 kJ mol'1)124 generally protects fluorine 
from metabolic transformations and finally 19F is NMR active with comparable 
sensitivity to 'H NMR and so 
19F NMR spectroscopy is an effective method for 
studying the metabolism of fluorinated compounds. 
Only a handful of natural products containing fluorine have been identified to 
date. 122 Preparing fluorinated derivatives of natural products synthetically can be time 
consuming and with no guarantee that the new compound will be any more active 
than the original compound, not a very sagacious approach. One way of incorporating 
fluorine into a natural product without the need for a total synthesis is to use 
precursor-directed biosynthesis. 
As described in section 1.3, precursor-directed biosynthesis involves feeding a 
derivative of a natural precursor to the producing organism in the hope that it will be 
processed in its place. Many fluorinated analogues have been prepared in this way. 
For example, Hill and Thompson successfully prepared novel derivatives of the 
fungicide soraphen A 214 by feeding fluorinated cinnamates to Sorangium cellulosum 
(Scheme 86). 125 Interestingly, the bacteria could not process any of the substrates 
which had the fluorine at the ortho- position but produced 3'-fluoro-, 4'-fluoro-, 3', 4'- 
difluoro- and 4', 5'-difluoro- soraphen A (215-218) when fed the corresponding 
cinnamates (210-213). 
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Scheme 86: Precursor-directed biosynthesis of fluorinated soraphen A derivatives 
215-218 in S. cellulosum. 125 
O'Hagan and co-workers126 studied the incorporation of sodium 8- 
fluorooctanoate 219 into piliformic acid by Poronia piliformis (Scheme 87) and found 
it incorporated to almost the same extent as the natural octanoate precursor, furnishing 
the novel 9-fluoropiliformate 220. 
0 
0 
Na P. piliformis HO 
F -ý HO 
219 OF 
0 220 
Scheme 87: Precursor-directed biosynthesis of fluorinated piliformic acid 220 in P. 
piliformis. 126 
Soares-Sello conducted several precursor-directed biosynthetic studies on the 
strobilurins during the course of her PhD. 
' 18 Working with Bolinea lutea, she fed a 
variety of fluorinated precursor analogues, including free acids, benzoic acid NAC 
thiol esters, cinnamic acid NAC thiol esters and phenylalanines, and determined that 
the cinnamic acid NAC thiol esters (221-226) afforded the best yields and levels of 
incorporation (Scheme 88). However, although she could detect the possible presence 
of 2-fluoro-, 3-fluoro-, 4-fluoro-, 3,4-difluoro-, 3,5-difluoro- and 3-fluoro-4-methyl- 
strobilurin A analogues (227-232) in the fungal extracts, she was unable to separate 
them from the natural compound by preparative T. L. C. 
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Scheme 88: Precursor-directed biosynthesis of fluorinated strobilurins in B. lutea. 118 
Thormann also prepared a variety of fluorinated strobilurins. 117 By feeding 
fluorinated benzoic acid NAC thiol esters and cinnamic acid NAC thiol esters 
(prepared in Bristol) to Strobilurus tenacellus, he was able to isolate and purify the 
fluorinated strobilurin analogues by HPLC. However, in contrast to the work of 
Soares-Sello, Thormann found that the benzoic acid NAC thiol esters gave higher 
incorporation than the cinnamic acid NAC thiol esters. 
As discussed in section 1.1.1 the level of incorporation of one isotopically 
labelled precursor compared to another may possibly be an indication as to their 
relative positions in a biosynthetic pathway. Although other factors play a role, the 
higher incorporation of benzoic acid NAC thiol esters in Thormann's experiments 
might indicate that benzoic acid occurs later in the biosynthetic pathway than 
cinnamic acid. This is in agreement with cinnamic acid degrading to benzoyl-CoA 
prior to assembly. Equally the work of Soares-Sello might indicate that cinnamic acid 
occurs later in the biosynthetic pathway than benzoic acid, incorporating during chain 
assembly. To settle the debate (at least in the case of Strobilurus tenacellus) it was 
decided to prepare [2-13C] p-fluorocinnamic acid NAC thiol ester 8 for a feeding 
study. As before, intact incorporation of both biomarkers would imply incorporation 
of the precursor during polyketide synthesis and not during starter unit production. 
p-fluorocinnamic acid NAC thiol ester 223 was prepared as shown in Scheme 89. 
Knoevenagel condensation of p-fluorobenzaldehyde 233 with malonic acid 206 
furnished p-fluorocinnamic acid 234 in 100% yield. DCC/DMAP mediated coupling 
with N-acetylcysteamine 42 afforded the corresponding thiol ester 223 in 68% yield. 
Purification of the thiol ester proved challenging due to the formation of NS- 
diacetylcysteamine in situ which virtually co-ran with thiol ester 223. Increasing the 
polarity of the eluent by the addition of methanol however, led to improved separation 
and easier purification of the desired compound. 
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Scheme 89: Preparation of thiol esters 223 and 8. 
The same route was followed to prepare thiol ester 8 from [2-13C]-malonic acid 
207 in 21% overall yield. This low yield was due to the formation of two products 
which had not been observed previously. The first was the N-acyl urea 236. 
Precedence for this type of compound is seen in the work of Holmberg127 and 
Keck. 128 It is proposed that this stable compound is formed by rearrangement of the 
O-acyl urea 238 which is the first reaction intermediate in the coupling process. Keck 
implies that dilute solutions are more prone to this rearrangement and both groups 
found the addition of strong acid catalysts to be beneficial in counteracting the 
problem. The second by-product is the addition product 237 analogous to that 
observed by Bjorklund and Leete. 120 
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Thiol ester 8 was sent to Germany where Zeeck and Thormann conducted a 
feeding study with Strobilurus tenacellus. Unfortunately, no 13C or 19F incorporation 
was observed in the isolated product and so no conclusions could be drawn from this 
experiment. 
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4.4 Conclusions 
[3-13C]-Cinnamic acid thiol ester 6 and [2,3-13C2]-cinnamic acid thiol ester 7 were 
prepared in two steps from isotopically labelled benzaldehyde and malonic acid and 
fed to S. tenacellus by Zeeck and Thormann. Thiol ester 6 showed specific 
incorporation at C-7 of strobilurin A, indicating that cinnamic acid is a likely 
precursor to strobilurin A. Thiol ester 7 also incorporated solely at the C-7 position 
with a loss of 13C-13C coupling, indicating cleavage of the C-2-C-3 of the precursor 
prior to incorporation. 
[2-13C] p-Fluorocinnamic acid thiol ester 8 was analogously prepared and fed to 
S. tenacellus. No 13C or 19F incorporation was observed indicating that the attempted 
precursor-directed biosynthesis had failed. 
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5.1 Phytotoxins Produced by Alternaria solani 
Alternaria solani, a causal fungus of early blight disease in tomato and potato plants 
(as well as other solanaceous plants), '29 is an internationally significant 
phytopathogen due to its worldwide distribution and the economic importance of the 
crops which it affects. ' 30 
Early blight is often more prevalent in older, senescing tissues and particularly in 
plants that have been predisposed by injury, poor nutrition, insect damage, heavy fruit 
load or another type of stress. '29 Initial infection emerges as dark brown lesions on the 
surface of the leaves, fruit and 
29.13 1 As the fungus penetrates, assimilating the 
nutrients from the dead plant cells, the spots enlarge, developing concentric rings of 
raised and depressed necrotic tissue where new spores are produced (Figure 28). 
Eventually, the leaves dry up or fall off and the fruit and tubers become soft and 
shrivelled. 
A. solani produces numerous non-host specific toxins134 (some of which are host 
specific-like) which intensify the symptoms of the disease, helping to degrade and kill 
the host plant cells. These toxins often diffuse into the surrounding tissues causing a 
yellow chlorotic halo to form around the necrotic spots (most evident in the leaves). 
Many of the toxins produced by A. solani are polyketide in origin, displaying 
high degrees of structural diverity (Figure 29). Alternaric acid, isolated by Brian et al. 
in 1949, '35 was found to have remarkably specific antifungal activity, inhibiting the 
germination of Absidia glauca, Myrothecium verrucaria and Stachybotrys atra spores 
but not those of fungi such as Botyrytis allii, Fusarium coeruleum and Penicillium 
digitatum. It was also found to be a host specific-like toxin contributing to disease 
development in the plant host by the fungus. It does this by altering the plasma 
morphological and physiological characteristics of membranes near the 
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Figure 28: Early blight symptoms of Alternaria solani in potato leaves, ' 32 tomato 
fruit' 33 and potatoes. ' 32 
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plasmodesmata (responsible for the transportation of molecules from one cell wall to 
another and intercellular signalling), thereby causing a permeability change that leads 
to leakage of electrolytes (mostly Mgt+) from the plant cells. ' 36 Since intact plasma 
membranes are necessary for the maintenance of ionic and metabolic gradients, the 
modifications caused by alternaric acid effectively kills the plant cells, allowing the 
fungus to infiltrate. 
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OOO/ OMe Alternaric Acid 
H Zinniol 0 OH O 
Me0 
II "OH 
MeO 
ý'OH H\II/ 
OH 0 OH 
Solanapyrone A OH 
OH 0 
Altersolanol A Macrosporin 
Figure 29: Some of the many polyketide metabolites produced by the fungus 
Alternaria solani. 
The biochemical mode of action of the phytotoxin solanapyrone A, isolated in 
1983 by Ichihara et a1., 137 is as yet unknown. However, it has been shown to 
selectively inhibit the activities of mammalian DNA polymerase ß and X in vitro, 
binding to the N -terminal of the protein. 
138 Because of this polymerase species- 
specificity, solanapyrone A is currently being investigated as a potential cancer 
chemotherapy agent. Another interesting feature of this polyketide is the 
enzymatically catalysed Diels-Alder reaction by which it is produced. 
139,1 ° The 
solanapyrones were the first group of natural products to have been proven to contain 
a Diels-Alderase domain within their synthase. 
The phytotoxic tetraketide zinniol, discovered in 1968 by Starratt, 141 is produced 
by several species of Alternaria fungi, including A. zinniae, 141 A. dauci, 142 A. 
tagetica, 143 A. carthamil44 and A. solani. 145,16 It was found to bind to the protoplasts 
(cell from which the outer cell wall or membrane has been removed) and membranes 
of susceptible plants. 
147 Receptor occupancy results in the stimulation of calcium 
uptake by the effected cells and also partially inhibits the effects of calcium-channel 
blockers. Calcium is a secondary messenger and is known to control various 
processes in the plant including intracellular organisation and various enzyme 
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activities. 148,149 A non-regulated increase in cellular calcium therefore may have a 
lethal effect on plant cells. 
The red pigment altersolanol A, isolated by Stoessl in 1967,150 was found to have 
antibiotic151 as well as phytotoxic152 activity. In both instances, activity was attributed 
to stimulation of NADH oxidase by altersolanol A which also acts as an electron 
acceptor in the respiratory chain. This increase in respiration results in the excessive 
generation of reactive oxygen species (such as 02-, H202 and 'OH) which in turn 
causes lipid peroxidation, DNA damage and protein oxidation. '53 
Macrosporin, first isolated in 1957 by Suemitsu et al. from Macrosporiun: 
porri, '54 was also found to be a metabolite of A. solani. 
155 This yellow-orange 
phytotoxin pigment was found to be a biosynthetic derivative of altersolanol A. 145,146 
5.2 Discovery of Alternapyrone 
With such diversity of structure and bioactivity among the polyketide metabolites of 
A. solani, it is little wonder that so much research centres upon their isolation and 
appraisal. To date, however, most of these metabolites and their derivatives have been 
isolated from culture. Extraction and purification of culture isolates can be difficult 
and time consuming, especially if the desired compound is not present in appreciable 
quantities. 
Recently, in an endeavour to explore polyketide biosynthesis in A. solani, Fujii et 
al. adopted a molecular genetic methodology which targeted PKS genes. The group 
designed a new degenerate primer pair, based on a conserved region of PKS DNA and 
used it to obtain a PKS gene fragment from A. solani. 
157 This fragment was then used 
as a probe to screen for other PKS gene clusters within the genome, yielding a cluster 
of five genes, which they designated the alt gene cluster. Homology searching 
indicated that altl, alt2 and alt3 encoded three cytochrome P450s, alto encoded an 
FAD-dependent oxygenase/oxidase and alts encoded an iterative type 1 polyketide 
synthase which the group denoted PKSN. Catalytic domain searching indicated that 
PKSN comprised of KS, AT, DH, MeT, KR, ER and ACP domains. Heterologous 
expression of PKSN in the fungal host Aspergillus oryzae, led to production of a 
novel polyketide metabolite, alternapyrone. 
Elucidation of the structure of alternapyrone by NMR and mass spectrometry led 
to the structure shown in Scheme 90 though the geometries of the three double bonds 
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have not been unequivocally assigned and the configurations of the three stereogenic 
centres have yet to be assigned. Labelling experiments were carried out using 11,2- 
13C,, ] -acetate and [methyl-'3C]-methionine and while the backbone was found to he 
derived entirely from acetate units, the methyl substituents throughout the structure 
were derived from methionine. By analyzing this labelling pattern, the Fujii group 
proposed a biosynthetic pathway for alternapyrone (Scheme 91). 
O OH 'ONa 
" 
-" 
0 
ells vY OH 
O 
NH2 
" _" -13C 
/= 13C_13C 
Scheme 90: Labelling pattern of alternapyrone from [ 1,2-"Ci]-acetate and [methyl- 
3C]-methionine. 156 
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Scheme 91: Proposed biosynthetic pathway to alternapyrone. ' 56 
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Interestingly, alternapyrone is thought to share the same biosynthetic pathway as 
the main chain of alternaric acid for the first four condensation cycles. However, the 
strain of A. solani used by Fujii does not produce alternaric acid and so alternapyrone 
is considered to be the correct product of PKSN and not a malformed or shunt product 
of the PKS for alternaric acid. It is also noteworthy that alternapyrone, or derivatives 
of alternapyrone, have not been detected in A. solani cultures thus far and so it seems 
highly likely that the alternapyrone produced by PKSN undergoes further 
modification by the P450s and FAD-dependent oxygenase/oxidase encoded by the 
rest of the alt gene cluster. This theory is currently under investigation by Fujii. 
5.3 Synthesis of Putative Alternapyrone Precursors 
In order to investigate the proposed biosynthetic pathway (Scheme 91) a partially 
purified cell-free extract was prepared by Fujii et al. with which to conduct feeding 
studies. The advantage of this system is that there is no background metabolite 
production and so any production observed must involve the substrates incubated with 
the extracts. Thus, substrates are not required in isotopically labelled form. The group 
were particularly interested in the C-methylation process which occurs in all but the 
third catalytic cycle of alternapyrone production and hoped to use cell-free extracts of 
PKSN to investigate it further. They also hoped to investigate the substrate specificity 
of the PKS in vitro by employing a host of unnatural starter units (precursor directed 
biosynthesis). 
The initial targets chosen for this work were thiol esters 9,10 and 239-253 
(Figure 30). Of these, 239 is commercially available, 240 was prepared via 
diacetylation of 2-aminoethanthiol hydrochloride and 241-249 were easily accessible 
from a one step DCC/DMAP coupling of the corresponding acids with N- 
acetylcysteamine 42. This work was completed by Kasahara (from the Fujii group, 
Japan) whilst working in Bristol on a summer placement. 
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Figure 30: Substrates required to investigate alternapyrone biosynthesis. 
The route chosen for the synthesis of thiol ester 9 is shown in Scheme 92. 
Starting from commercially available aldehyde 254 and triethyl 2- 
phosphonopropionate 256, Horner-Wadsworth-Emmons reaction provided the 
unsaturated esters 257 and 260 in 65% and 27% yield respectively. Hydrolysis of 260 
proceeded quantitively to produce the acid 263 which was then coupled with N- 
acetylcysteamine 42 to furnish the desired thiol ester 9 in 49% yield. This route was 
used by Kasahara to prepare thiol ester 250 from aldehyde 255 and triethyl 2- 
phosphonopropionate 256, and thiol ester 251 from aldehyde 254 and triethyl 
phosphonoacetate 37. 
0 
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Scheme 92: Synthesis of thiol esters 9,250157 and 251.157 
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It was proposed to synthesise thiol ester 10 from ethyl (Z)-2,4-dimethylhex-2- 
enoate 257 which was a by-product of the synthesis of thiol ester 9 (Scheme 93). 
Following the work of Mon et a1., 158 unsaturated ester 257 was dissolved in methanol 
and stirred under an atmosphere of hydrogen in the presence of palladium on 
activated charcoal. However, 257 was not soluble in methanol and after a day no 
reduction of the olefin was observed. The experiment was repeated using ethyl acetate 
as the solvent, but even after 5 days no saturated ester 266 was observed. Treatment 
of 257 with L-selectride appeared by 
1H NMR and T. L. C. to produce a small quantity 
of the desired ester but the reaction did not go to completion. Sodium borohydride in 
the presence of copper iodide also failed to reduce the olefin. 
TXOEt 
+ 
257R=Me, R'=Me (t) 266R=Me, R'=Me (t) 258R=H, R'- Me 267R=H, R'- Me 259R=Me, R'=H 268A-Me, R'=H 
NaOH 
t 
OO DCC, DMAP OO 
SNAC + SNAC H OH + OH 
R R' R R' ^/ NR R' R R' lir 
(W ) 10 R= Me. R'- Me (_) 
HS (*) 269 R- Me, R'- Me (3) 
252R=H, R'- Me 42 0 270 R-H, R'=Me 
253R=Me, R'=H 271 R- Me, R'- H 
Scheme 93: Proposed route for the synthesis of thiol esters 10,252157 and 253.1sß 
Kasahara, on placement in Bristol, was simultaneously working on the synthesis 
of thiol esters 252 and 253. He did not experience problems during the reduction step 
(and subsequently completed the synthesis of his targets as shown in Scheme 93). As 
his substrates, esters 258 and 259 differed from esters 257 and 260 only in the number 
of methyl substituents, it was proposed that the difficulty we were experiencing with 
our reduction was steric based. It was therefore decided to hydrolyse unsaturated 
esters 257 and 260 prior to reduction in the hope that the less bulky acids might be 
easier to hydrogenate. 
Hydrolysis of unsaturated esters 257 and 260 gave unsaturated acids 263 and 272 
in quantitative yield (Scheme 94). This time hydrogenation in methanol reduced the 
Z-isomer to the saturated acid 269 but failed to convert the E-isomer. Encouraged by 
this result, the hydrogenation was repeated under 7 bar of pressure to furnish the 
-91- 
Chapter 5 Alternapyrone 
desired acid 269 as a 1: 1 pair of diastereomers in quantitative yield. Coupling with N- 
acetylcysteamine in the presence of DCC and DMAP furnished the desired thiol ester 
10 (also as a 1: 1 pair of diastereomers) in 76% yield. 
O0 
NaOH 
+ý OH + OR 100% O OH O OR 
257 260 272 263 
I Pd/C, H2 7 bar 
100% 
O O0 
DCC, DMAP 
0 
-ýSNAC + SNAC H OH + OH 
10 HS,. -N 
N 
269 ýý 
42 0 
76% 
Scheme 94: Optimised route to thiol ester 10. 
It was interesting to speculate whether hydrogenation of esters 257 and 260 was 
possible under the same conditions employed for the acids 263 and 272. A mixture of 
the esters 257 and 260 in methanol was stirred under an atmosphere of hydrogen (7 
bars), in the presence of palladium on carbon for 3 days. Quantitative conversion to 
the desired saturated ester 266 as a 1: 1 pair of diastereomers was observed (Scheme 
95). 
000 
+ OEt Pd/C, H2 OEt + OEt 
O OEt 7 bar 
266 257 260 100% (t) (4 
Scheme 95: Reduction of unsaturated esters 257 and 260 to saturated ester 266. 
Thiol esters 9,10 and 239-253 were sent to Japan for feeding studies. Crude cell- 
free extracts of PKSN were prepared by grinding the fungal mycelia of the host 
fungus in liquid nitrogen and extracting with buffer solution. Unfortunately, feeding 
studies with the crude extracts were unsuccessful for all the substrates. Thus, the 
extracts were partially purified using a his-tag®. 
Acetyl-CoA is the proposed starter unit for alternapyrone biosynthesis and 
therefore would be expected to prime the first round of chain extension. When all the 
correct substrates and co-factors are present (i. e. malonyl Co-A, SAM and NADPH), 
acetyl-CoA should produce alternapyrone when incubated with the PKSN extracts. In 
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the absence of the co-factor NADPH however, the reductive domains of the PKS are 
effectively rendered inactive and the chain might be expected to cyclise early to give 
the truncated product of the first and second rounds of condensation, dimethyltriacetic 
acid lactone (dimethylTAL) 273 (Scheme 96). When acetyl-CoA was incubated with 
the extracts solely in the presence of malonyl-CoA, SAM and buffer, a peak was 
observed by LC-MS which had a retention time of 26.5 minutes and a molecular mass 
of MH+ = 155 (Figure 31). This was found to correspond to a synthetic standard of 
dimethylTAL 273. Despite the lack of reduction in these cycles, C-methylation was 
not disrupted. 
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+ 
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weT(KS 
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4 0` 
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SAM 
Acyl Transferase 
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Scheme 96: Proposed biosynthesis of dimethylTAL 273 in vitro. 
Thiol ester 9 is the proposed precursor of the third condensation cycle of 
alternapyrone biosynthesis. Thus, this compound might be expected to skip the first 
two condensation cycles and prime the third. As before, in the absence of NADPH, a 
truncated lactone would be expected and as the third condensation does not generally 
undergo C-methylation, the mono-methylated lactone 274 would be expected to form 
(Scheme 97). However, thiol ester 9 might also act as an unnatural starter unit priming 
the first condensation cycle in place of acetyl-CoA. In this case, the dimethylated 
lactone 276 would be the expected product. It is also possible that C-methylation 
would be disrupted by the unnatural substrates in either case, leading to the non- 
methylated lactone 275. 
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Figure 31: LC-MS analysis of PKSN cell-free extracts following incubation with 
acetyl-CoA, courtesy of Fujii and Kasahara. 
When thiol ester 9 was incubated with the extracts in the presence of malonyl- 
CoA, SAM and buffer, production of a novel metabolite was observed by LC-MS 
(Figure 32). The new compound, which was not present in the control, had a mass of 
MH+ = 223 and thus is proposed to be lactone 274. No new peaks were observed at 
MH+ = 209 (the expected mass of lactone 275) or MH+ = 237 (the expected mass of 
lactone 276). This implies that thiol ester 9 primed the third condensation cycle and 
the C-methlyation pattern remained intact. 
Unfortunately, due to time constraints on the part of Kasahara (of the Fujii group, 
Japan) and problems with protein degradation, thiol esters 10 and 239-253 were not 
fed to the partially purified PKSN extracts and thus no further results have been 
obtained for these feeding experiments to date. 
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Scheme 97: Two possible sites of incorporation of thiol ester 9 in vitro. 
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Figure 32: LC-MS analysis of PKSN cell-free extracts following incubation with 
thiol ester 9, courtesy of Fujii and Kasahara. 
5.4 Conclusions 
A flexible route to putative alternapyrone precursors was devised and optimised. 
Thiol esters 9 and 10 were prepared via this route and fed to PKSN extracts (in the 
absence of NADPH) by Fujii and Kasahara. The feeding study with thiol ester 9 
resulted in a new metabolite with a mass corresponding to lactone 274. This indicated 
that thiol ester 9 had incorporated during the third condensation cycle and thus is 
likely to be the true substrate of that cycle. The C-methylation pattern was not 
disrupted by the unnatural substrate. 
Thiol ester 10 did not incorporate during the initial feeding study and due to time 
constraints could not be repeated with the partially purified extracts. 
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General Experimental Details 
All commercially available compounds were used without further purification except 
where stated. All moisture or air sensitive reactions were carried out in flame-dried 
glassware under a positive pressure of nitrogen using standard syringe/septa 
techniques. Anhydrous solvents were obtained by passing through a modified Grubbs 
system of alumina columns, manufactured by Anhydrous Engineering. When stated, 
DMF was dried sequentially over three portions of 10% w/v 3A molecular sieve 
beads for 24 h each, and then stored under nitrogen. Petroleum ether is of the 40-60 
°C boiling point range. Routine monitoring of reactions was performed using 
precoated Merck-Keiselgel 60 F254 aluminium backed T. L. C. plates. The spots were 
visualised by UV254 light, or potassium permanganate. Flash column 
chromatography'59 was performed using silica gel (40-63 micron, obtained from 
Fluorochem Ltd. ) as the adsorbent. Melting points were determined on an 
Electrothermal IA6301 melting point apparatus and are uncorrected. Optical rotations 
were recorded using a Bellingham and Stanley ADP220 polarimeter, irradiating with 
the sodium D line (), = 589 nm), and [U]p values are quoted in units 10"1 deg cm2 g''. 
Infrared spectra were recorded on a Perkin Elmer Spectrum One FT-IR spectrometer 
in the solid or liquid state. 1H and 13C NMR spectra were recorded using either a Jeol 
Delta/GX 400 MHz or a Jeol Eclipse 400 MHz spectrometer. The chemical shifts (8) 
are reported in parts per million (ppm) and the coupling constants (J) are in Hertz 
(Hz) and rounded to the nearest half integer. Tetramethylsilane was used as the 
internal reference for proton and carbon chemical shifts. DEPT135, COSY, HMQC 
and HMBC NMR spectra were routinely used to definitively assign the signals of 'H 
and 13C NMR spectra. Electron impact (EI) and chemical ionisation (CI) mass spectra 
were recorded-on a VG Analytical Autospec mass spectrometer. Electrospray (ESI) 
mass spectra were recorded on a Micromass LCT mass spectrometer or a VG Quattro 
mass spectrometer. Methane was the ionisation gas used for chemical ionisation. X- 
ray crystallography data was collected by the EPSRC National Crystallography 
Service and interpreted by Dr. J. P. H. Charmant. Elemental analysis was carried out 
using a Eurovector EA3000 elemental analyser or a Carolerba NA2500 elemental 
analyser. Unless stated, data for all known compounds are in agreement with 
published data. 
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7-Nitroheptan-1-ol 44160 
HO"ýA Br 
DBU 
CH N0 
HO ýNO2 
32 
33 44 
1,8-Diazabicyclo[5.4.0]undec-7-ene (0.42 g, 2.76 mmol) was added to nitromethane 
(83 mL) at 0 °C and stirred for 10 minutes. 6-Bromo-l-hexanol 33 (0.50 g, 2.76 
mmol) was added and the solution was heated to reflux for 3 days. The solvent was 
then removed in vacuo. Water (110 mL) and diethyl ether (80 mL) were added and 
the organic layer was separated. The aqueous layer was extracted with diethyl ether (2 
x 80 mL) and the combined organic layers were washed with hydrochloric acid (1.0 
M, 80 mL) and brine (80 mL). The solution was dried over magnesium sulfate, filtered 
and concentrated in vacuo. The crude product was then purified by flash 
chromatography (Si02, 5% methanol/ethyl acetate) to furnish alcohol 44 (0.18 g, 
40%) as a yellow oil. 1m(neat)/cm' 3350 (OH), 2930,2840,1550 (NO2), 1380 
(N02); 6H(400 MHz) 1.39-1.63 (8H, m, 4x CH2), 1.97-2.06 (2H, m, CH2), 3.65 (2H, 
t, J 6.5, CH2OH), 4.39 (2H, t, J 7.0, CH2NO2); m/z (EI) 161 (M+, 13%), 145 (19), 105 
(100), 91 (40), 83 (12), 77 (41), 69 (15) and 57 (45). 
6-(1'-Tetrahydropyran-2-y1)oxy-l-bromohexane 45161 
HýBr 
DHP, pTSA O 
OO'-'" 
33 
^Br 
45 
To a stirred solution of 6-bromo-l-hexanol 33 (0.50 g, 2.76 mmol) in diethyl ether 
(2.5 mL) was added dihydropyran (0.23 g, 2.76 mmol) in diethyl ether (1 mL) and p- 
toluenesulfonic acid (0.05 g, 0.27 mmol). The mixture was stirred at room 
temperature for 24 hours and then quenched with water (12 mL) prior to extraction 
with ethyl acetate (3 x 15 mL). The combined organic extracts were dried over 
magnesium sulfate, filtered and concentrated in vacuo to afford tetrahydropyran 45 
(0.71 g, 97%) as a colourless oil. This was used without further purification. SH(400 
MHz) 1.35-1.92 (14H, in, 7x CH2), 3.39 (1H, dt, J 9.5,7.0, CHHO), 3.41 (2H, t, J 
7.0, CH2Br), 3.52 (1H, m, CHHO), 3.74 (IH, dt, J 10.0,7.0, CHHO), 3.86 (IH, m, 
CHHO), 4.57 (IH, m, OCHO); 8ß(100 MHz) 19.7 (CH2), 25.5 (CH2), 25.5 (CH2), 
28.0 (CH2), 29.6 (CH2), 30.8 (CH2), 32.8 (CH2), 33.8 (CH2), 62.4 and 67.4 (2 x 
CH2O), 98.9 (OCHO), m/z (CI) 267/265 (M+, 25/27%), 169 (22), 165/163 (7/7) and 
85 (100). 
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7-(1'-Tetrahydropyran-2-yl)-oxy-l-nitroheptane 46162 
(a) via protection of 7-nitroheptan-1-o144 
HO \NO2 DHP, pTSA 
a 
, _/5 NOZ 
44 46 
To a stirred solution of alcohol 44 (0.82 g, 5.09 mmol) in diethyl ether (5 mL) was 
added dihydropyran (0.43 g, 5.09 mmol) in diethyl ether (2 mL) and a catalytic 
amount of p-toluenesulfonic acid (0.1 g, 0.53 mmol). The mixture was stirred at room 
temperature for 27 hours and was then quenched with water (30 mL) and extracted 
with ethyl acetate (3 x 15 mL). The combined organic extracts were dried over 
magnesium sulfate, filtered and concentrated in vacuo to afford tetrahydropyran 46 
(0.88 g, 70%) as an orange oil. This was used without further purification. 
i(neat)/cm' 3400,2950,2850,1550 (NO2), 1395 (NO2), 1020; SH(400 MHz) 1.35- 
1.93 (14H, m, 7x CH2), 1.97-2.09 (2H, m, CH2), 3.40 (IH, m, CHHO), 3.52 (1H, m, 
CHHO), 3.74 (1H, m, CHHO), 3.87 (1H, m, CHHO), 4.38 (2H, t, J 7.0, CH2NO2), 
4.58 (1H, m, OCHO); 8ß(100 MHz) 19.7 (CH2), 25.5 (CH2), 25.7 (CH2), 26.1 (CH2), 
27.4 (CH2), 29.4 (CH2), 30.7 (CHZ), 30.8 (CH2), 62.5 (CH2O), 63.0 (CH2O), 75.7 
(CH2NO2)9 99.0 (OCHO). 
(b) via nitration of 6-(1'-tetrahydropyran-2-yl)oxy-l-bromohexane 45 
DBU 
OJJýýO""(_/ 0""f-)''Br CH N3 OZ 
O Oý NO2 
451 46 
1,8-Diazabicyclo[5.4.0]undec-7-ene (1.46 g, 9.58 mmol) was added to nitromethane 
(20 mL) at 0 °C and was stirred for 10 minutes. Tetrahydropyran 45 (2.54 g, 9.58 
mmol) was added and the solution was heated to reflux for 25 hours. The solvent was 
then removed in vacuo. Water (200 mL) and ethyl acetate (200 mL) were added and 
the organic layer was separated. The aqueous layer was extracted with diethyl ether (2 
x 200 mL) and the combined organic layers were washed with hydrochloric acid (1.0 
M, 100 mL) and brine (100 mL). The solution was then dried over magnesium sulfate, 
filtered and concentrated in vacuo to yield the crude product. Attempts to separate the 
desired product from the mixture of products formed were unsuccessful. However, 
spectral analysis confirmed the presence of tetrahydropyran 46. Spectral data as 
quoted above. 
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7-(1'-Tetrahydropyran-2-yl)oxy-heptan-1-al 36162 
KOH, KMnO4 
a_ O C010' 
5erNOZ 
0 
5 ß'J5 
46 36 
Tetrahydropyran 46 (1.93 g, 7.88 mmol) in methanol (55 mL) was cooled to 0 °C 
under an atmosphere of nitrogen. A solution of potassium hydroxide (0.66 g, 11.82 
mmol) in methanol (80 mL) was added dropwise over 35 minutes and the solution 
was stirred for an additional 15 minutes. A solution of potassium permanganate (1.25 
g, 7.88 mmol) and magnesium sulfate (1.42 g, 11.82 mmol) in water (120 mL) was 
slowly added, maintaining the reaction temperature at 0 °C. Upon complete addition, 
the reaction mixture was stirred for a further 30 minutes and then filtered through a 
layer of florisil®. The filtrate was evaporated to remove most of the methanol and the 
resulting aqueous phase was extracted with ethyl acetate (3 x 40 mL). The combined 
organic phases were dried over magnesium sulfate, filtered and concentrated in vacuo 
to afford aldehyde 36 (1.23 g, 78%) as a yellow oil. This was used without further 
purification. SH(400 MHz) 1.35-1.90 (14H, in, 7x CH2), 2.45 (2H, td, J 7.0,2.0,2- 
H2), 3.40 (IH, in, CHHO), 3.50 (IH, in, CHHO), 3.65 (1H, in, CHHO), 3.74 (IH, in, 
CHHO), 4.58 (IH, in, OCHO), 9.77 (IH, t, J 2.0, CHO); 8(100 MHz) 19.8 (CH2), 
25.5 (CH2), 26.0 (CH2), 26.2 (CH2), 29.7 (CH2), 30.8 (CH2), 32.7 (CH2), 43.9 (C-2), 
63.0 (CH2O)9 67.6 (CH2O), 98.9 (OCHO), 162.8 (C-1). 
Triethyl Phosphonoacetate 37163 
0 (EtO)3P Et0, i00 'I 
Br--IAOEt _-' 
EtÖOEt 
49 37 
Triethylphosphite (3.32 g, 20.00 mmol) was added to a solution of ethyl bromoacetate 
49 (2.80 g, 16.76 mmol) in dry toluene (40 mL) and the reaction mixture was heated 
to reflux for 48 hours. The solvent was then removed in vacuo to yield triethyl 
phosphonoacetate 37 (3.65 g, 97%) as a colourless oil. This was used without further 
purification. SH(400 MHz) 1.29 (3H, t, J 7.0, CH3CH2000), 1.35 (6H, t, J 7.0,2 x 
CH3CH2OP), 2.97 (2H, d, J 21.5, CH2P), 4.08-4.23 (6H, m, 3x CH3CH2O); Sc(100 
MHz) 14.1 (CH3CH2O00), 16.2 and 16.4 (each d, J 6.0,2 x CH3CH2OP), 34.5 (d, J 
134.5, CH2P), 61.6 (CH3CH2000), 62.7 and 63.7 (each d, J 6.0,2 x CH3CH2OP), 
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165.8 (d, J 6.0, CO); mlz (EI) 224 (M+, 17%), 197 (79), 179 (90), 169 (48), 151 (80), 
123 (100), 109 (60), 88 (42) and 81 (62). 
[1,2-13C2]-Triethyl Phosphonoacetate 51164 
The above procedure was repeated using ethyl [1,2-13C2]-bromoacetate 50 (0.25 g, 
1.50 mmol) to yield [1,2-13C2]-triethyl phosphonoacetate 51 (0.33 g, 100%) as a 
colourless oil. 5H(400 MHz) 1.29 (3H, t, J 7.0, CH3CH2000), 1.35 (6H, t, J 7.0,2 x 
CH3CH2OP), 2.96 (2H, ddd, J 130.0,21.5,8.0, CH2P), 4.08-4.24 (6H, m, 3x 
CH3CH2O); Sß(100 MHz) signals assigned to C-1 (166.2 ppm) and C-2 (34.5 ppm) 
show an enhancement of >95% (based on 'H NMR and MS data) 14.5 (d, J 2.0, 
CH3CH2000), 16.5 and 16.7 (each d, J 6.0, CH3CH2OP), 34.5 (dd, J 134.0,58.5, C- 
2), 61.9 (d, J 2.0, CH3CH2O00), 63.0 and 64.0 (d, J 6.0,2 x CH3CH2OP), 166.2 (dd, 
J 58.5,6.0, C-1); mlz (CI) 227 (MH+, 100), 199 (26), 181 (28), 153 (7), 86 (9) and 84 
(15). 
Ethyl (2E)-9-(1'-tetrahydropyran-2-yl)oxynon-2-enoate 38165 
0 
a-, ß- EEd NaH O SH 0+ 
ESP OEt --º 
aoo 
AOEt 
36 37 38 
Sodium hydride (60% dispersion in oil prewashed in hexane, 0.11 g, 4.69 mmol) was 
stirred in THE (80 mL) under an atmosphere of nitrogen. Triethyl phosphonoacetate 
37 (0.85 g, 3.80 mmol) in THE (10 mL) was added dropwise at 0 °C and stirred for 30 
minutes. Aldehyde 36 (0.72 g, 3.36 mmol) in THE (10 mL) was added dropwise at 0 
°C and the resulting solution was stirred overnight at room temperature. The reaction 
mixture was quenched with water (200 mL) and was extracted with ethyl acetate (3 x 
200 mL). The combined organic extracts were dried over magnesium sulfate, filtered 
and concentrated in vacuo. Purification by flash column chromatography (Si02,10% 
ethyl acetate/petroleum ether 40-60 °C) afforded unsaturated ester 38 (0.28 g, 30%) as 
a pale yellow oil. 5H(400 MHz) 1.29 (3H, t, J 7.0, CH3CH2O), 1.35-1.90 (14H, m, 7x 
CH2), 2.22 (2H, app. qd, J 7.0,1.5,4-H2), 3.38 (IH, m, CHHO), 3.50 (IH, m, 
CHHO), 3.73 (1H, dt, J 9.5,7.0, OCHH), 3.87 (1H, m, OCHH), 4.18 (2H, q, J 7.0, 
CH3CH2O), 4.57 (1 H, in, OCHO), 5.82 (1 H, dt, J 15.5,1.5,2-H), 6.96 (1 H, dt, J 15.5, 
7.0,3-H); Sc(100 MHz) 14.3 (CH3CH2O), 19.7 (CH2), 25.5 (CH2), 25.8 (CH2), 26.1 
(CH2)9 27.9 (CH2), 29.7 (CH2), 30.8 (CH2), 32.1 (CH2), 60.1 (CH3CH2O), 62.4 
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(CH2O)9 67.6 (CH2O), 98.8 (OCHO), 121.4 (C-2), 149.2 (C-3), 166.8 (C-1); m/z (CI) 
285 (MH+, 20%), 271 (71), 255 (19) 241 (28), 225 (40), 216 (19), 203 (19), 187 (26) 
and 85 (100). 
Ethyl 9-(1'-tetrahydropyran-2-yl)oxynonanoate 3967 
O H2, Pd/C O 
O of OEt 
clO)JLOE 
Nzý t 
5 
38 39 
To a solution of unsaturated ester 38 (0.10 g, 0.46 mmol) in methanol (5 mL) was 
added palladium on activated charcoal (; z40 mg) and the reaction mixture was stirred 
at room temperature under an atmosphere of hydrogen for 4 hours. The solution was 
then filtered in order to remove the catalyst and the solvent was removed in vacuo to 
afford saturated ester 39 as a pale yellow oil (0.10 g, 100%). This was used without 
further purification. SH(400 MHz) 1.25 (3H, t, J 7.0, CH3CH2O), 1.30-1.90 (18H, in, 9 
x CH2), 2.29 (2H, t, J 7.5,2-H2), 3.38 (IH, m, CHHO), 3.50 (IH, in, CHHO), 3.72 
(IH, in, CHHO), 3.87 (IH, m, CHHO), 4.12 (2H, q, J 7.0, CH3CH2O), 4.58 (IH, m, 
OCHO); 6c(100 MHz) 14.3 (CH3CH2O), 19.7 (CH2), 24.9 (CH2), 25.5 (CH2), 26.1 
(CH2), 26.2 (CH2), 29.1 (CH2), 29.1 (CH2), 29.7 (CH2), 30.8 (CH2), 34.3 (CHI), 60.1 
(CH3CH2O), 62.3 (CH2O)9 67.5 (CH2O)9 98.8 (OCHO), 173.8 (C-1); m/z (CI) 286 
(M+, 1%), 271 (21), 227 (11), 125 (15), 119 (50), 111 (17), 85 (100), 83 (35) and 55 
(21). 
7-Hydroxyheptanal 48166,167 
O OH O 
Nal04 
HO 
OH 
-" HO H 
755 
OH 
47 48 
Aleuritic acid 47 (6.2 g, 20.00 mmol) and sodium periodate (6.40 g, 30.00 mmol) 
were dissolved in a solution of THE (150 mL) and water (40 mL). A white precipitate 
began to form almost immediately. The solution was stirred overnight at room 
temperature. Water (50 mL) was then added and the solution was extracted with ethyl 
acetate (3 x 150 mL). The combined organic extracts were subsequently washed with 
saturated aqueous sodium hydrogen carbonate solution (3 x 150 mL) and water (100 
mL) and then dried over magnesium sulfate, filtered and concentrated in vacuo to 
yield a yellow oil, which solidified upon cooling. Recrystallisation from ethyl acetate 
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and petroleum ether 40-60 °C furnished aldehyde 48 (2.02 g, 76%) as a white 
crystalline solid. m. p. 68-70 °C (from ethyl acetate/petroleum ether 40-60 °C), lit. 167 
65-67 °C, SH(400 MHz) 1.30-1.42 (4H, m, 2x CH2), 1.54-1.70 (4H, m, 2x CH2), 
1.85 (1 H, br s, OH), 2.45 (2H, td, J 7.0,2.0,2-H2), 3.64 (2H, t, J 7.0,7-H2), 9.77 (1 H, 
t, J 2.0,1-H); Sß(100 MHz) 22.0 (CH2), 25.5 (CH2), 28.9 (CH2), 32.5 (CH2), 43.8 (C- 
2), 62.8 (C-7), 202.7 (C-1); m/z (CI) 131 (MH', 2%), 113 (21), 95 (100), 69 (23) and 
57 (9). 
Ethyl (E)-9-Hydroxynon-2-enoate 52165 
OO0 
EtO, /o II 
nBuU HO H+ 
EOPý% OEt -º 
HOiAOEt 
48 37 5 
52 
Triethyl phosphonoacetate 37 (1.8 mL, 8.96 mmol) in dry THE (48 mL) was cooled to 
0 °C under an atmosphere of nitrogen. n-Butyllithium (2.5 M in hexanes, 3.6 mL, 8.96 
mmol) was added and the reaction was stirred for 1 hour. Aldehyde 48 (1.74 g, 13.44 
mmol) in dry THE (6 mL) was then added dropwise very slowly (in order to prevent a 
gum like precipitate which had previously been observed). The resulting solution was 
stirred for 18 hours at room temperature. The reaction was quenched with water (50 
mL) and was extracted with ethyl acetate (3 x 100 mL). The combined organic 
extracts were dried over magnesium sulfate, filtered and concentrated in vacuo. 
Purification by flash column chromatography (Si02,20% ethyl acetate/petroleum 
ether 40-60 °C) afforded unsaturated ester 52 (1.47 g, 82%) as a pale yellow oil. 
SH(400 MHz) 1.29 (3H, t, J 7.0, CH3), 1.34-1.61 (8H, in, 4x CH2), 2.19 (2H, app. qd, 
J 7.5,1.5,4-H2), 3.64 (2H, t, J 6.5,9-H2), 4.19 (2H, q, J 7.0, CH3CH2O), 5.82 (1 H, dt, 
J 15.5,1.5,2-H), 6.96 (IH, dt, J 15.5,7.5,3-H); Sß(100 MHz) 14.3 (CH3), 25.6 
(CH2), 28.0 (CH2), 28.9 (CH2), 32.1 (CH2), 32.7 (CH2), 60.2 (CH3CH2O), 63.0 (C-9), 
121.4 (C-2), 149.2 (C-3), 166.8 (C-1); mlz (CI) 201 (MH+, 12%), 197 (15), 155 (100), 
137 (27), 127 (13), 109 (75), 95 (20) and 84 (17). 
Ethyl [1,2-13C2]-(E)-9-Hydroxynon-2-enoate 53 
The above reaction was repeated using [1,2-13C2]-triethyl phosphonoacetate 51 (0.25 
g, 1.12 mmol) to give unsaturated ester 53 (0.20 g, 91%). SH(400 MHz) 1.29 (3H, t, J 
7.0, CH3)9 1.34-1.40 (4H, m, 2x CH2), 1.43-1.52 (2H, m, CH2), 1.52-1.61 (2H, in, 
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CH2), 2.20 (2H, app. quint., J 7.0,4-H2), 3.61-3.66 (2H, m, 9-H2), 4.14-4.22 (211, m, 
CH3CH2O), 5.82 (1H, ddm, J 162.0,15.5,2-H), 6.96 (IH, m, 3-H); Sß(100 MHz) 
signals assigned to C-1 (166.8 ppm) and C-2 (121.4 ppm) appear as doublets (J 75.0) 
and show an enhancement of >95% (based on 'H NMR and MS data); in/z (CI) 203 
(MH+, 94%), 185 (26), 157 (53), 139 (20), 110 (72), 85 (68) and 83 (100). 
Ethyl 9-Hydroxynonanoate 54168 
00 
H2, Pd/C 
HO'1ýýU'OEt -º HO OEt 
57 
52 54 
To a solution of unsaturated ester 52 (0.17 g, 0.60 mmol) in methanol (5 mL) was 
added palladium on activated charcoal (=30 mg) and the reaction was stirred at room 
temperature under an atmosphere of hydrogen for 22 hours. The solution was then 
filtered in order to remove the catalyst and the solvent was removed in vacuo to afford 
saturated ester 54 as a colourless oil (0.17 g, 100%). This was used without further 
purification. 8H(400 MHz) 1.26 (3H, t, J 7.0, CH3), 1.29-1.42 (8H, m, 4x CH2), 1.55- 
1.68 (4H, m, 2x CH2), 2.29 (2H, t, J 7.5,2-H2), 3.64 (2H, t, J 6.5,9-H2), 4.13 (2H, q, 
J 7.0, CH3CH2O); Sß(100 MHz) 14.29 (CH3), 25.0 (CH2), 25.7 (CH2), 29.1 (CH2), 
29.2 (2 coincident signals, 2x CH2), 32.8 (CH2), 34.4 (C-2), 60.2 (CH3CH2O), 63.1 
(C-9), 173.9 (C-1); m/z (CI) 203 (MH+, 49%), 185 (39), 157 (45), 139 (100), 121 (21), 
115 (15), 97 (16) and 84 (30). 
Ethyl [1,2-13C21-9-Hydroxynonanoate 55 
The above reaction was repeated using ester 53 (0.16 g, 0.79 mmol) to give ester 55 
(0.16 g, 100%). SH(400 MHz) 1.25 (3H, t, J 7.0, CH3)9 1.29-1.39 (8H, m, 4x CH2), 
1.51-1.63 (4H, m, 2x CH2), 2.29 (2H, dm, 1 127.5,2-H2), 3.60-3.67 (2H, m, 9-H2), 
4.08-4.17 (2H, m, CH3CH2O); Sc(100 MHz) signals assigned to C-1 (173.9 ppm) and 
C-2 (34.4 ppm) appear as doublets (J 57.0) and show an enhancement of >95% (based 
on 1H NMR and MS data); m/z (CI) 205 (MH+, 12 %), 187 (18), 159 (33), 141 (100), 
123 (15) and 83 (23). 
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9-Hydroxynonanoic Acid 4167 
O0 
HO OEt 
NaOH 
yº HO""ýOH 
7 
54 41 
Ethyl 9-hydroxynonanoate 54 (0.2 g, 0.99 mmol) dissolved in ethanol (1 mL) was 
added dropwise to sodium hydroxide (2.0 M, 10 mL) and heated to reflux for 24 
hours. The mixture was quenched with water (70 mL) and acidified to pH 2 with 
hydrochloric acid (2.0 M). The solution was then extracted with ethyl acetate (3 x 100 
rnL), dried over sodium sulfate, filtered and concentrated in vacuo to yield acid 41 
(0.17 g, 100%) as a white solid. m. p. 42-44 °C (from ethyl acetate/petroleum ether 40- 
60 °C), lit. 7 43-44 °C; SH(400 MHz) 1.28-1.40 (8H, m, 4x CH2), 1.52-1.70 (4H, m, 2 
x CH2), 2.34 (2H, t, J 7.5,2-H2), 3.65 (2H, t, J 6.5,9-H2), 6.61 (1 H, br s, COOH); 
8ß(100 MHz) 24.7 (CH2), 25.7 (CH2), 29.0 (CH2), 29.2 (CH2), 30.8 (CH2), 32.5 
(CH2), 34.1 (C-2), 63.0 (C-9), 179.3 (C-1); m/z (ES» 197 (MNa, 100%), 185 (20), 
123 (11) and 96 (12). 
[1,2.13C2]-9-Hydroxynonanoic Acid 5667 
The above reaction was repeated using [1,2- 13 C21-9-hydroxynonanoate 55 (0.16 g, 
0.79 mmol) to give acid 56 (0.14 g, 100%). SH(400 MHz) 1.28-1.40 (8H, m, 4x CH2), 
1.50-1.70 (4H, m, 2x CH2), 2.34 (2H, app. dq, J 127.5,7.5,2-H2), 3.65 (2H, br s, 9- 
H2), 7.59 (1H, br s, COOH); Sß(100 MHz) signals assigned to C-1 (179.3 ppm) and 
C-2 (34.1 ppm) appear as doublets (J 75.0) and show an enhancement of >95% (based 
on 'H NMR and MS data); m/z (CI) 177 (MH+, 38%), 159 (24), 141 (100), 123 (27), 
97 (37), 85 (22), 83 (37) and 69 (19). 
S-2-(Acetylamino)ethyl Ethanethioate (N, S-Diacetylcysteamine) 240169 
0 
HS^, 
NH3 CIS 
KOAc20tt 
AS,, 
-\/H 
277 240 0 
To a 3-necked flask at 0 °C containing 2-aminoethanethiol hydrochloride 277 (20.00 
g, 176.0 mmol) in water (174 mL) was attached two dropping funnels and a pH probe. 
In one funnel was placed potassium hydroxide (8.0 M, 170 mL) and in the other was 
placed acetic anhydride (51 mL). The solution was adjusted to pH 8.0 with potassium 
hydroxide. A slight pink tinge was observed. The acetic anhydride and the potassium 
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hydroxide were then added dropwise at such a rate that the pH was maintained at 
approximately 8.0. The solution gradually became colourless. When all the acetic 
anhydride had been added, the pH of the solution was adjusted to pH 7.0 with 
hydrochloric acid (2.0 M) and the mixture was stirred at room temperature for 1 hour. 
The reaction solution was then saturated with sodium chloride and extracted with 
DCM (4 x 175 mL). The combined organic extracts were dried over magnesium 
sulfate, filtered and concentrated in vacuo to furnish N, S-diacetylcysteamine 240 
(26.19 g, 92%) as a colourless oil. This was used without further purification. 611(400 
MHz) 1.76 (3H, s, CH3CON), 2.12 (3H, s, CH3COS), 2.79 (2H, t, J 7.0, CH2S), 3.40 
(2H, td, J 7.0,6.0, CH2N), 7.42 (IH, br s, NH); Sß(100 MHz) 23.0 (CH2S), 28.7 
(CH2N), 30.5 (CH3COS), 39.4 (CH3CON), 170.3 (CON), 196.1 (COS); m/z (EI) 162 
(MH+, 100%), 120 (45), 102 (24), 86 (34), 75 (24) and 59 (26). 
S-2-(Acetylamino)ethanethiol (N-Acetylcysteamine) 42169 
OH 
S^/Ný 
240 O 
H 
KOH 
HS,. -ýN( 
42 
0 
N, S-Diacetylcysteamine 240 (1.00 g, 6.2 mmol) in water (15 mL) was cooled to 0 °C. 
Solid potassium hydroxide (1.05 g, 18.8 mmol) was added and the mixture was stirred 
under an atmosphere of nitrogen at 0 °C for 50 minutes. The pH was adjusted to 7.0 
with hydrochloric acid (2.0 M) and the reaction mixture was saturated with sodium 
chloride and extracted with DCM (3 x 50 mL). The organic extracts were dried over 
magnesium sulfate, filtered and concentrated in vacuo to afford N-acetylcysteamine 
42 (0.71 g, 96%) as a colourless oil. This was used without further purification. 
8H(400 MHz) 1.37 (1H, t, J 8.5, SH), 2.01 (3H, s, CH3CO), 2.67 (2H, m, CH2S), 3.44 
(2H, td, J 8.5,6.5, CH2N), 6.01 (IH, br s, NH); 8ß(100 MHz) 23.3 (CH2N), 24.7 
(CH2S), 42.5 (CH3CON), 170.2 (CON); mlz (EI) 119 (M+, 48%), 88 (11), 86 (64), 84 
(71), 75 (7), 71 (29) and 59 (100). 
9-Hydroxynonanoic Acid N-Acetylcysteamine Thiol Ester 4323'67 
OH DCC, DMAP 
-IIN 
HO OH + HS " 'j( HO'`_ý/'/`S^i 
y 
41 42 
0 43 
0 
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Freshly prepared N-acetylcysteamine 42 (0.43 g, 3.60 mmol) in DCM (50 mL) was 
stirred at 0 °C under an atmosphere of nitrogen. DCC (0.58 g, 2.80 mmol) in DCM (1 
mL) was added followed by DMAP (0.03 g, 0.20 mmol) in DCM (1 mL). This was 
stirred for 10 minutes before addition of 9-hydroxynonanoic acid 41 (0.43 g, 2.30 
mmol). The solution was left at 0 °C for 2 hours and was allowed to warm to room 
temperature overnight. The reaction was subsequently quenched with saturated 
ammonium chloride (100 mL) and was extracted with DCM (3 x 100 mL). The 
combined organic extracts were dried over magnesium sulfate, and copper sulfate 
impregnated silica (prepared by stirring flash silica in a saturated solution of copper 
sulfate for 10 minutes and then drying in vacuo to a free flowing powder) 170 was 
added to remove any unreacted N-acetylcysteamine 42. The solution was then filtered 
and concentrated in vacuo to yield a white solid. Ethyl acetate was added (3 mL) to 
dissolve the product and the insoluble urea by-product was then filtered off. 
Evaporating off the filtrate in vacuo furnished the thiol ester 43 (0.40 g, 59%) as a 
white powdery solid. m. p. 63-64 °C (from ethyl acetate/petroleum ether 40-60 °C), 
(previously characterised as an oil)67; SH(400 MHz) 1.23-1.40 (8H, m, 4x CH2), 1.50- 
1.76 (4H, m, 2x CH2), 1.97 (3H, s, CH3), 2.57 (2H, t, J 7.5,2-H2), 3.03 (2H, t, J 6.5, 
CH2S), 3.44 (2H, app. q, J 6.5, CH2NH), 3.64 (2H, t, J 6.5,9-H2), 5.84 (IH, br s, 
NH); Sc(100 MHz) 23.3 (CH3), 25.6 (CH2), 28.5 (CH2), 28.8 (CH2), 29.1 (2 
coincident signals, 2x CH2), 32.7 (CH2), 34.0 (CH2), 39.8 (CH2N), 44.1 (C-2), 63.0 
(C-9), 170.3 (CON), 200.3 (C-1); nz/z (ESI) 298 (MNa+, 100%) and 215 (30). 
[1,2.13C2]-9-Hydroxynonanoic Acid N-Acetylcysteamine Thiol Ester 1 
The above reaction was repeated using acid 56 (0.17 g, 0.95 mmol) to give thiol ester 
1 (0.08 g, 30%). SH(400 MHz) 1.24-1.38 (8H, m, 4x CH2), 1.52-1.72 (4H, m, 2x 
CH2), 1.97 (3H, s, CH3), 2.57 (2H, ddt, J 129.0,7.5,6.5,2-H2), 3.02 (2H, dt, J 6.5, 
5.0, CH2S), 3.43 (2H, app. q, J 6.5, CH2NH), 3.63 (2H, t, J 6.5,9-H2), 6.09 (1H, br s, 
NH); Sc(100 MHz) signals assigned to C-1 (200.3 ppm) and C-2 (44.1 ppm) appear as 
doublets (J 75.0) and show an enhancement of >95% (based on 'H NMR and MS 
data); mlz (ESI) 300 (MNa, 12%), 278 (100), 225 (34), 145 (6) and 101 (12). 
-107- 
Chapter 6 Experimental 
(1S)-1,10-(Camphorsulfonyl)imine 279171 
(i) SOCI2 
O 
(ii) 1,4 dioxane, conc. NH3 
10 
S-ýN öZ`% OH 
OzS\ 
278 279 
Thionyl chloride (38.0 mL, 516.4 mmol) was added dropwise to (1S)-10- 
camphorsulfonic acid 278 (20.00 g, 86.00 mmol) and the mixture was heated to reflux 
for 4 hours. Once cooled, toluene (100 mL) was added and the remaining thionyl 
chloride was evaporated off in vacuo azeotroping with the toluene. The resulting 
orange oil was dissolved in 1,4-dioxane (50 mL) and added dropwise to concentrated 
ammonia solution (300 mL) at 0 °C. The solution was then stirred at room 
temperature for 14 hours. The resulting precipitate was filtered off and washed with 
water (2 x 20 mL) to yield (1S)-1,10-(camphorsulfonyl)imine 279 as an off-white 
solid (17.78 g, 97%). This was used without further purification. [a] ö 15 -32.0 (c 1.00, 
CHC13), lit. '7' [a] D -32.7 (c 1.89, CHC13); m. p. 235-237 °C, lit. 
'7' 225-228 °C; 
SH(400 MHz) 0.87 and 1.09 (each 3H, each s, 8-H3 and 9-H3), 1.48 and 1.78 (each 1H, 
each t, J 9.0,5-HH and 6-HH), 2.02-2.12 (2H, m, 5-HH and 6-HH), 2.26 (1 H, t, J 4.5, 
4-H), 2.39 (1 H, d, J 19.5,3-HH), 2.78 (1 H. ddd, J 19.5,4.5,2.0,3-HH), 2.98 (1 H, d, J 
13.0,10-HH), 3.19 (1H, d, J 13.0,10-HH); &2(100 MHz) 19.0 and 19.4 (C-8 and C- 
9), 26.6 and 28.4 (C-5 and C-6), 35.9 (C-3), 44.6 (C-4), 48.0 (C-7), 49.4 (C-10), 64.5 
(C-1), 195.4 (C-2); mlz (CI) 214 (MH+, 100%), 150 (14), 134 (8), 109 (25), 108 (23) 
and 93 (6). 
(1S, 2R)-Bornane-10,2-camphorsultam 76171 
NaBH4 
NH 
0; ý NN O O 
279 76 
(1S)-1,10-(Camphorsulfonyl)imine 279 (7.98 g, 37.1 mmol) was suspended in 
methanol (85 mL) and water (15 mL) and cooled to 0 °C. Sodium borohydride (3.46 
g, 91.4 mmol) was added portionwise and the reaction was stirred at room 
temperature for 4 hours. The methanol was evaporated in vacuo and the resulting 
residue was suspended in DCM (70 mL) and acidified with sulfuric acid (1.0 M, 60 
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mL). The organic layer was separated and the aqueous layer was extracted with DCM 
(3 x 50 mL). The organic layers were combined, washed with brine (50 mL), dried 
over magnesium sulfate, filtered and concentrated in vacuo. The resulting solid was 
recrystallised from ethanol to furnish camphorsultam 76 (7.11 g, 88%) as an off white 
solid. [a] ö 11 -32.0 (c 1.00, CHC13, lit. 
171 [a] D -30.5 (c 4.00, CHC13); m. p. 182-184 
°C, 1it. 171 183-184 °C; SH(400 MHz) 0.94 and 1.13 (each 3H, each s, 8-H3 and 9-13), 
1.23-1.51 (2H, m, 5-HH and 6-HH), 1.83-2.02 (5H, m, 3-H2,4-H, 5-HH and 6-HH), 
3.10 (IH, d, J 13.5,10-HH), 3.14 (IH, d, J 13.5,10-HH), 3.43 (IH, m, 2-H), 4.16 
(1 H, br s, NH); 8(100 MHz) 20.5 and 20.5 (C-8 and C-9), 26.8 and 31.9, (C-5 and C- 
6), 36.1 (C-3), 44.7 (C-4), 47.5 (C-7), 50.4 (C-10), 55.1 (C-1), 62.9 (C-2); m/z (CI) 
216 (MH+, 100%), 199 (13), 151 (47), 135 (82), 119 (19), 109 (34), 93 (20) and 84 
(28). 
(1S, 2R)-N-Acetyl-bornane-10,2-sultam 77172 
NaH, McCOC7 
0 
OO"NH OOO, 
N 
76 77 
(1S)-(-)-Camphorsultam 76 (1.50 g, 7.00 mmol) in dry toluene (5 mL) was added 
dropwise to a stirred suspension of sodium hydride (60% dispersion in oil prewashed 
with petrol, 0.95 g, 24.0 mmol) in dry toluene (40 mL) at room temperature for 1 
hour. Acetyl chloride (0.50 mL, 7.00 mmol) was added dropwise and the mixture was 
stirred for 2 hours at room temperature. The reaction was quenched with ammonium 
chloride (10 mL) and left to stir for a further 10 minutes. The organic layer was then 
separated and the aqueous layer was extracted with ethyl acetate (3 x 50 mL). The 
combined organic layers were dried over magnesium sulfate, filtered and concentrated 
in vacuo to yield sultam 77 (1.73 g, 97%) as a white solid. m. p. 135-136 °C, lit. 172 
130-132 °C; [a] 22 -117.0 (c 3.50, CH2C12)9 [a] D lit* 
172 
-116.1 (c 3.20, CH2C12); 
6H(400 MHz) 0.97 and 1.16 (each 3H, each s, 8-H3 and 9-H3), 1.30-1.45 (2H, m, 5- 
HH and 6-HH), 1.83-1.97 (3H, m, 4-H, 5-HH and 6-HH), 2.08 (1H, dd, J 14.0,8.0,3- 
HH), 2.12-2.20 (1 H, m, 3-HH), 2.41 (3H, s, 2'-H3), 3.44 (1 H, d, J 14.0,10-HH), 3.51 
(1 H, d, J 14.0,10-HH), 3.86 (1 H, dd, J 8.0,5.0,2-H); Sß(100 MHz) 19.8 and 20.8 (C- 
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8 and C-9), 23.2 (C-2'), 26.5 and 32.9 (C-5 and C-6), 38.5 (C-3), 44.8 (C-4), 47.8 and 
48.4 (C-7 and C-1), 52.9 (C-10), 65.3 (C-2), 168.6 (C-1'). 
(1S, 2R)-N-(3'-Hydroxypropionyl)-bornane-10,2. sultam 78 
(i) TiClq, 1Pr2NEt 
OO 
SIN (ii)TiCl4, ýo1 ýN 
OH NO 
ý0 Oc ýS\ 78 cý 
S% 
79 oii 
A solution of titanium (IV) chloride (1.0 M in DCM, 3.8 mL, 3.8 mmol) was added to 
a stirred solution of acetylsultam 77 (0.50 g, 1.94 mmol) in dry DCM (11 mL) at -78 
°C under nitrogen. After 10 minutes ethyldiisopropylamine (0.66 mL, 3.8 mmol) was 
added, followed 1 hour later by trioxane (0.18 g, 1.98 mmol) and titanium (IV) 
chloride (1.0 M in DCM, 3.8 mL, 3.8 mmol). The reaction was maintained at -78 °C 
for 6 hours and was then allowed to warm to room temperature overnight. The 
solution was extracted with DCM (3 x 50 mL), dried over magnesium sulfate, filtered 
and concentrated in vacuo to yield a yellow oil. Purification by flash column 
chromatography (Si02,20% ethyl acetate/petroleum ether 40-60 °C) afforded the 
desired alcohol 78 (0.16 g, 29% (isolated yield)) as well as a 1: 3 mixture of 78 and a 
dimer side-product 79 (0.13 g). Despite several attempts, it was never possible to 
separate more than an analytical quantity of the latter compound. Alcohol 78: Found: 
C, 54.52; H, 7.37; N, 4.96; S, 10.83; C13H21NO4S requires C, 54.33; H, 7.37; N, 4.87; 
S, 11.16; m. p. 140 °C (from chloroform); [a]23 ö -110.13 (c 1.05, CHC13); 
v,,. (neat)/cm 1 3549 (OH, H-bonded), 2952,2922,2882,1683 (C=O), 1318,1065, 
770; SH(400 MHz) 0.98 and 1.16 (each 3H, each s, 8-H3 and 9-H3), 1.20-1.48 (2H, in, 
5-HH and 6-HH), 1.84-1.98 (3H, m, 4-H, 5-HH and 6-HIT), 2.08 (1H, dd, J 14.0,8.0, 
3-HIS, 2.18 (IH, m, 3-HH), 2.51 (IH, t, J 6.5, OH), 2.99 (2H, t, J 5.5,2'-H2), 3.45 
(1H, d, J 14.0,10-HH), 3.52 (1H, d, J 14.0,10-HH), 3.85-3.97 (3H, m, 2-H and 3'- 
H2); Sc(100 MHz) 19.9 and 20.8 (C-8 and C-9), 26.5 and 32.9 (C-5 and C-6), 37.9 (C- 
2'), 38.4 (C-3), 44.7 (C-4), 47.8 and 48.6 (C-1 and C-7), 52.9 (C-10), 58.1 (C-3'), 65.2 
(C-2), 171.4 (C-1'); m/z (CI) 288 (MH+, 21%), 270 (12), 216 (100), 151 (8), 135 (37) 
and 84 (9); Found (Cl): 288.1261 (MH), (C13H22NO4S requires 288.1270). Dinier 79: 
Found: C, 55.39; H, 7.37; N, 4.86; S, 10.72; C27H42N208S2 requires C, 55.27; H, 7.21; 
N, 4.77; S, 10.93; m. p. 159-160 °C (from chloroform); [a] ö -101.46 (c 3.43, CHC13); 
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vmax(neat)/cm"1 2954,2893,1687 (C=O), 1325,1278,1167,1132,1119,1021,777; 
SH(400 MHz) 0.97 and 1.16 (each 6H, each s, 2x 8-H3 and 9-H3), 1.30-1.45 (4H, m, 2 
x 5-HH and 2x 6-HH), 1.82-1.97 (6H, m, 2x 4-H, 2x 5-HH and 2x 6-HH), 2.07 
(2H, dd, J 13.5,7.5,2 x 3-HH), 2.11-2.20 (2H, m, 2x 3-HH), 2.89-3.11 (4H, m, 2x 
2'-H2), 3.43 (2H, d, J 14.0,2 x 10-HH), 3.50 (2H, d, J 14.0,2 x 10-HH), 3.79-3.93 
(6H, m, 2x 2-H and 2x 3'-H2), 4.67 (2H, s, OCH2O); Sß(100 MHz) 19.9 and 20.8 (2 
x C-8 and 2x C-9), 26.5 and 32.8 (2 x C-5 and 2x C-6), 35.9 (2 x C-2'), 38.4 (2 x C- 
3), 44.7 (2 x C-4), 47.8 and 48.5 (2 x C-1 and 2x C-7), 52.9 (2 x C-10), 62.5 (2 x C- 
3'), 65.2 (2 x C-2), 95.1 (OCH2O) and 169.6 (2 x C-1'); m/z (ES I) 609 (MNa, 100%), 
387 (6), 380 (7), 300 (37) and 203 (11); Found (ESI): 609.2275 (MNa+), 
(C27H42N2O8S2Na requires 609.2275). 
3-Hydroxypropanoic Acid 8067 
OO LiOH, H202 
NIýOH 'NH + HO! 
`ý\OH 
S\ 78 Oý 80 
OO 
76 
Lithium hydroxide monohydrate (0.024 g, 0.58 mmol) and hydrogen peroxide 
solution (30% solution in water, 0.10 mL, 0.87 mmol) were added successively to a 
solution of sultam 78 (0.085 g, 0.29 mmol) in THE (3 mL) and water (1 mL) at 0 °C. 
The mixture was stirred at room temperature overnight. A white precipitate formed. 
The reaction was again cooled to 0 °C and quenched with sodium sulfite solution 
(1.45 mL, 0.87 mmol). After 10 minutes the pH was adjusted to 10 with saturated 
aqueous sodium hydrogen carbonate. The organic solvent was removed in vacuo and 
then water (5 mL) was added and the solution was extracted with DCM (3 x 30 mL) 
to retrieve auxiliary 76. The aqueous layer was acidified to pH 2 with hydrochloric 
acid (6.0 M) and extracted with diethyl ether (4 x 50 mL). The combined layers were 
dried over sodium sulfate, filtered and concentrated in vacuo to yield the acid 80 
(0.027 g, 100%) as a colourless oil. SH(400 MHz, D20) 2.61 (2H, t, J 6.0,2-H2), 3.85 
(2H, t, J 6.0,3-H2); 6c(100 MHz, D20) 39.4 (C-2), 60.0 (C-3), 179.2 (C-1). 
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N-Acetyl-4-isopropyl-2-oxazolidinone 6489 
000 
(i) nBuLi 
HN O (ii) MeCOCI "kN O 
63 64 
A solution of oxazolidinone 63 (5.00 g, 38.71 mmol) in dry THE (80 mL) was cooled 
to -10 °C under an atmosphere of nitrogen and treated with n-butyllithium (2.5 M in 
hexanes, 24.78 mL, 61.94 mmol). After 30 minutes, acetyl chloride (9.6 mL, 135.49 
mmol) was added dropwise. The mixture was allowed to warm to room temperature 
overnight and was then quenched with water (50 mL). The mixture was extracted with 
ethyl acetate (3 x 75 mL) and the combined organic layers were then washed with 
saturated sodium hydrogen carbonate solution (20 mL) and water (20 mL), dried over 
magnesium sulfate, filtered and concentrated in vacuo to afford a yellow/orange oil. 
Purification by flash column chromatography (Si02,30% ethyl acetate/petroleum 
ether 40-60 °C) furnished the acylated oxazolidinone 64 (6.05 g, 91%) as a yellow oil. 
5H(400 MHz) 0.88 and 0.92 (each 3H, each d, J 7.0, CH(CH3)2), 2.40 (1H, app. 
quint. d, J 7.0,4.0, CH(CH3)2), 2.54 (3H, s, CH3CO), 4.22 (1H, dd, J 9.5,3.0,5-HH), 
4.27 (IH, dd, J 9.5,8.5,5-HH), 4.43 (IH, br dt, J 8.5,3.5,4-H); Sc(100 MHz) 14.6 
(CHCH3)9 18.0 (CHCH3), 23.8 (CH3CO), 28.3 (CH(CH3)2)9 58.4 (C-4), 63.3 (C-5), 
154.3 (C-2), 170.3 (CH3CO). 
N-(3'-Hydroxypropionyl)-4-isopropyl-2-oxazolidinone 6676 
o000 
(i) TiCI4, IPr2NEt ^vý HO" NO NO (ii) T; CI4, O 
OHO 
64 66 
A solution of titanium (IV) chloride (1.0 M in DCM, 69.4 mI., 69.4 mmol) was added 
to a stirred solution of oxazolidinone 64 (6.05 g, 35.34 mmol) in dry DCM (150 mL) 
at -78 °C under an atmosphere of nitrogen. 
After 10 minutes ethyldiisopropylamine 
(12.5 mL, 71.50 mmol) was added, followed 1 hour later by trioxane (3.26 g, 36.10 
mmol) and titanium (N) chloride (1.0 M in DCM, 69.4 mL, 69.4 mmol). The reaction 
was maintained at -78 °C for 6 hours and was then allowed to warm to room 
temperature overnight. Saturated aqueous ammonium chloride solution (150 mL) was 
added and the solution was extracted with DCM (3 x 150 mL), dried over magnesium 
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sulfate, filtered and concentrated in vacuo to yield the crude product (9.55 g) as a 
yellow oil. After several attempts, purification by flash column chromatography 
(Si02,20-30% ethyl acetate/petroleum ether 40-60 °C) failed to separate the mixture 
of products but did provide a small sample of the desired alcohol 66 as a colourless 
oil. 8H(400 MHz) 0.89 and 0.94 (each 3H, each d, J 7.0, CH(CH3)2), 1.55 (1H, br s, 
OH), 2.39 (1H, m, CH(CH3)2), 3.08 and 3.16 (each 1H, each ddd, J 18.0,6.0,4.5,2'- 
H2), 3.94 (1 H. m, 3'-H2), 4.24 (1 H, dd, J 9.0,3.0,5-HH), 4.30 (1 H, dd, J 9.0,8.0,5- 
HH), 4.45 (1H, ddd, J 8.0,4.0,3.0,4-H); Sc(100 MHz) 14.7 (CH(CH3)2), 18.0 
(CH(CH3)z), 28.4 (CH(CH3)2), 38.3 (C-2'), 58.1 and 58.4 (C-3' and C-4), 63.6 (C-5), 
154.1 (C-2), 172.8 (C-1'). 
3. (tert-Butyldiphenylsilyloxy)propano183103,173 
nBuLi, TBDPSCI 
HO"-SOH TBDPSO""-"^"OH 
82 83 
n-Butyllithium (2.5 M in hexanes, 18.5 mL, 46.25 mmol) was added to a solution of 
propane-1,3-diol 82 (3.32 mL, 46.00 mmol) in dry THE (75 mL) at -78 °C under an 
atmosphere of nitrogen. tert-Butylchlorodiphenylsilane (11.96 mL, 46.00 mmol) was 
then added and the mixture was stirred at -78 °C for 15 minutes, followed by 15 
minutes at room temperature and then refluxed for 21 hours. The solvent was 
removed in vacuo to give a white oily suspension. Purification by flash column 
chromatography (Si02,5-10% ethyl acetate/petroleum ether 40-60 °C) yielded silyl 
ether 83 (12.31 g, 85%) as a colourless oil which crystallised upon trituration. m. p. 
38-40 °C, lit. '03 36-39 °C; SH(400 MHz) 1.06 (9H, s, SiC(CH3)3), 1.81 (2H, app. 
quint., J 5.5,2-H2), 2.45 (1H, t, J 5.5, OH), 3.81-3.87 (4H, m, 1-H2 and 3-H2), 7.36- 
7.46 (6H, m, 6x Ar-H), 7.66-7.71 (4H, m, 4x Ar-H); 8ß(100 MHz) 19.1(SiC(CH3)3), 
26.8 (SiC(CH3)3), 34.3 (C-2), 61.9 and 63.3 (C-i and C-3), 127.8 (4 x Ar-C), 129.8 (2 
x Ar-C), 133.3 (2 x Ar-Cips0), 135.6 (4 x Ar-C). 
[1,1,3,3- Ha]-3-(tert-Butyldiphenylsilyloxy)propano188 
The above reaction was repeated using deuterated diol 87 (0.63 g, 7.86 mmol) to 
furnish silyl ether 88 (2.30 g, 92%) as a colourless oil which crystallised upon 
cooling. SH(400 MHz) 1.05 (9H, s, SiC(CH3)3), 1.78 (2H, s, 2-H2), 2.36 (1H, s, OH), 
7.37-7.46 (6H, m, 6x Ar-H), 7.66-7.70 (4H, m, 4x Ar-H); Sß(100 MHz) 19.1 
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(SiC(CH3)3), 26.8 (SiC(CH3)3), 33.8 (C-2), 61.2 and 62.5 (each quint., J 21.5, C-1 and 
C-3), 127.7 (4 x Ar-C), 129.8 (2 x Ar-C), 133.3 (2 x Ar-C1 0), 135.5 (4 x Ar-C); m/z 
(CI) 319 (MH+, 6%), 261 (25), 241 (21), 199 (39), 183 (62), 163 (30), 121 (100), 93 
(21) and 75 (13). 
3-(tert-Butyldiphenylsilyloxy)propana184173 
O 
TBDPSOýOH 
CICOCOCI, DMSO, NEt3 
83 TBDPSO H 
84 
Dimethylsulfoxide (1.8 mL, 25.31 mmol) was added dropwise to oxalyl chloride (1.1 
mL, 12.66 mmol) in dry DCM (60 mL) at -78 °C under nitrogen. After 1 hour alcohol 
83 (2.00 g, 6.36 mmol) in dry DCM (10 mL) was added dropwise. An hour later 
triethylamine (7.1 mL, 50.63 mmol) was added and after 20 minutes the mixture was 
allowed to warm to room temperature. Water (75 mL) was then added to quench the 
reaction. The layers were separated and the aqueous layer was extracted with DCM (3 
x 100 mL) The combined organic extracts were washed with hydrochloric acid (2.0 
M, 50 mL), dried over magnesium sulfate, filtered and concentrated in vacuo to afford 
a yellow oil. Purification by flash column chromatography (Si02,10% ethyl 
acetate/petroleum ether 40-60 °C) furnished aldehyde 84 (1.90 g, 95%) as a very pale 
yellow oil. SH(400 MHz) 1.04 (9H, s, SiC(CH3)3), 2.59 (2H, dt, J 6.0,2.0,2-H2), 4.01 
(2H, t, J 6.0,3-H2), 7.34-7.45 (6H, m, 6x Ar-H), 7.64-7.73 (4H, m, 4x Ar-H), 9.80 
(1H, t, J 2.0,1-H); Sc(100 MHz) 19.1 (SiC(CH3)3), 26.7 (SiC(CH3)3), 46.4 (C-2), 58.3 
(C-3), 127.8 (4 x Ar-C), 129.8 (2 x Ar-C), 134.8 (2 x Ar-Cips°), 135.5 (4 x Ar-C), 
201.9 (C-1). 
[1,3,3_2 H3]-3-(tert-Butyldiphenylsilyloxy)propana189 
The above reaction was repeated using deuterated alcohol 88 (2.30 g, 7.22 mmol) to 
afford aldehyde 89 (1.84 g, 81%) as a pale yellow oil. 
SH(400 MHz) 1.05 (9H, s, 
SiC(CH3)3), 2.59 (2H, s, 2-H2), 7.36-7.47 (6H, m, 6x Ar-H), 7.63-7.69 (4H, m, 4x 
Ar-H); Sc(100 MHz) 19.1 (SiC(CH3)3), 26.7 (SiC(CH3)3), 46.0 (C-2), 57.6 (quint., J 
21.5, C-3), 127.7 (4 x Ar-C), 129.8 (2 x Ar-C), 133.2 (2 x Ar-C1 0), 135.5 (4 x Ar-C), 
201.6 (t, J 26.0, C-1); m/z (ESI) 338 (MNa+, 100%) and 123 (70). 
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3. (tert-Butyldiphenylsilyloxy)propanoic acid 7076 
OO 
TBDPSO H 
NaCIO, Me2CCHMe 
TBDPSO/-_ vOH 
84 Buffer 70 
Aldehyde 84 (0.50 g, 1.60 mmol) was dissolved in tert-butanol (20 mL) and 2- 
methylbut-2-ene (9 mL). A solution of sodium chlorite (1.72 g, 19.00 mmol) and 
sodium dihydrogen phosphate (1.44 g, 1.20 mmol) in water (10 mL) was then added. 
The mixture was stirred vigorously for 1 hour and was then extracted with ethyl 
acetate (3 x 50 mL). The combined organic extracts were dried over magnesium 
sulfate and concentrated in vacuo. Chloroform (2 x 40 mL) was added to azeotrope 
with the remaining tert-butanol furnishing the acid 70 (0.53 g, 100%) as a white solid. 
No further purification was required, however a small sample was recrystallised from 
ethanol for characterisation. m. p. 104-106 °C (from ethanol), (previously 
characterised as an oil)76; SH(400 MHz) 1.04 (9H, s, SiC(CH3)3), 2.60 (2H, t, J 6.0,2- 
H2), 3.94 (2H, t, J 6.0,3-H2), 7.35-7.45 (6H, m, 6x Ar-H), 7.65-7.73 (4H, m, 4x Ar- 
H); Sc(100 MHz) 19.2 (SiC(CH3)3), 26.7 (SiC(CH3)3), 37.5 (C-2), 59.6 (C-3), 127.8 
(4 x Ar-C), 129.8 (2 x Ar-C), 134.8 (2 x Ar-C1 0), 135.6 (4 x Ar-C), 177.3 (C-1). 
[3,3 2H2]-3-(tent-Butyldiphenylsilyloxy)propanoic acid 90 
The above reaction was repeated using deuterated aldehyde 89 (1.84 g, 5.85 mmol) to 
furnish acid 90 (1.93 g, 100%) as a white solid. SH(400 MHz) 1.04 (9H, s, 
SiC(CH3)3), 2.59 (2H, s, 2-H2), 7.34-7.46 (6H, m, 6x Ar-H), 7.64-7.69 (4H, m, 4x 
Ar-H); 6D(400 MHz, CHC13) 3.96 (2D, s, 3-D2); 6c(100 MHz) 19.4 (SiC(CH3)3), 27.0 
(SiC(CH3)3), 37.6 (C-2), 59.1 (quint., J 21.5, C-3), 127.9 (4 x Ar-C), 129.9 (2 x Ar- 
C), 133.4 (2 x Ar-C; ps0), 135.7 (4 x Ar-C), 177.6 (C-1); m/z (CI) 331 (MH+, 13%), 
313 (12), 273 (45), 253 (100), 199 (16), 85 (17) and 83 (25). 
3-(tent-Butyldiphenylsilyloxy)propanoic Acid N-Acetylcysteamine Thiol Ester 
7276 
0H0 
^ý 
1` 
/ 
EDCI, DMAP 
TBDPSO" v OH + HS^ýN l TBDPSO SNAC 
70 42 01 72 
Acid 70 (0.52 g, 1.59 mmol) was dissolved in DCM (25 mL) at 0 °C. EDCI (0.34 g, 
1.84 mmol) and DMAP (0.024 g, 0.12 mmol) in DCM (1 mL) were added, followed 
by N-acetylcysteamine 42 (freshly prepared, 0.27 g, 2.28 mmol) in DCM (1 mL) 10 
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minutes later. The solution was allowed to warm to room temperature overnight and 
was then quenched with saturated ammonium chloride solution (50 mL). The layers 
were separated and the aqueous layer was extracted with DCM (3 x 50 mL). The 
combined organic extracts were dried over magnesium sulfate, filtered and 
concentrated in vacuo to give a pale yellow oil. Purification by flash column 
chromatography (Si02 topped with a layer of copper sulfate impregnated silica 
prepared by stirring flash silica in a saturated solution of copper sulfate for 10 minutes 
and then drying in vacuo to a free flowing powder), 170 50-60% ethyl 
acetate/petroleum ether 40-60 °C) furnished thiol ester 72 (0.45 g, 66%) as a white 
solid. m. p. 84-86 °C (from chloroform), (previously characterised as an oil)76; 3H(400 
MHz) 1.04 (9H, s, SiC(CH3)3), 1.92 (3H, s, CH3CON), 2.79 (2H, t, J 6.0,2-H2), 3.04 
(2H, t, J 6.5, CH2S), 3.43 (2H, td, J 6.5,6.0, CH2N), 3.97 (2H, t, J 6.0,3-H2), 5.99 
(1H, br s, NH), 7.36-7.46 (6H, m, 6x Ar-H), 7.64-7.67 (4H, in, 4x Ar-H); 8ß(100 
MHz) 19.2 (SiC(CH3)3), 23.1 (CH3CON), 26.7 (SiC(CH3)3), 28.6 (CH2S), 39.6 
(CH2N)9 46.9 (C-2), 60.0 (C-3), 127.7 (4 x Ar-C), 129.8 (2 x Ar-C), 133.2 (2 x Ar- 
C; p, a), 135.5 
(4 x Ar-C), 170.3 (CON), 198.2 (C-1). 
[3,3_2 H2]-3-(tert-Butyldiphenylsilyloxy)propanoic Acid N-Acetylcysteamine Thiol 
Ester 91 
The above reaction was repeated using deuterated acid 90 (1.84 g, 5.57 mmol) to 
afford thiol ester 91 (1.89 g, 79%) as a white solid. SH(400 MHz) 1.04 (9H, s, 
SiC(CH3)3)9 1.93 (3H, s, CH3CON), 2.77 (2H, s, 2-H2), 3.04 (2H, t, J 6.5, CH2S), 3.40 
(2H, td, J 6.5,6.0, CH2N), 6.76 (1H, br t, J 6.0, NH), 7.33-7.44 (6H, m, 6x Ar-H), 
7.63-7.70 (4H, m, 4x Ar-H); 8D(400 MHz, CHC13) 3.93 (2D, s, 3-D2); Sß(100 MHz) 
18.8 (SiC(CH3)3)9 22.7 (CH3CON), 26.4 (SiC(CH3)3), 28.2 (CH2S), 39.1 (CH2N), 46.4 
(C-2), 59.1 (quint., J 21.5, C-3), 127.4 (4 x Ar-C), 129.5 (2 x Ar-C), 132.9 (2 x Ar- 
C; pso), 135.1 
(4 x Ar-C), 170.3 (CON), 197.5 (C-1); m/z (ESI) 454 (MNa+, 100%), 354 
(7) and 151 (10); Found (ESI): 454.1821 (MH+), (C23H29D2NO3SSiNa requires 
454.1812). 
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3-Hydroxypropanoic Acid N-Acetylcysteamine Thiol Ester 7476 
O 
TBDPSO" v 'SNAC 
72 
O 
HF. Pyr 
HO SNAG 
74 
Hydrogen fluoride pyridine complex (65-70% hydrogen fluoride, 0.2 mL, -1.16 
mmol) was added to a solution of thiol ester 72 (0.50 g, 1.16 mmol) in dry THE (25 
mL) at 0 °C under nitrogen. The reaction was stirred for 4 hours and then quenched 
with water (20 mL). The organic layer was removed and the aqueous layer was 
extracted with DCM (3 x 50 mL). The combined organic layers were dried, filtered 
and concentrated in vacuo. The crude product was then purified by flash column 
chromatography (Si02,100% ethyl acetate) to give thiol ester 74 (0.08 g, 38%) as a 
white solid. m. p. 76-78 °C (from chloroform), (previously characterised as an oil)76; 
$H(400 MHz) 1.98 (3H, s, CH3), 2.84 (2H, t, J 5.5,2-H2), 3.06 (2H, t, J 6.0, CH2S), 
3.47 (2H, app. q, J 6.0, CH2N), 3.93 (2H, t, J 5.5,3-H2), 6.00 (IH, br s, NH); Sc(100 
MHz) 23.2 (CH3), 28.8 (CH2S), 39.2 (CH2N), 46.6 (C-2), 58.8 (C-3), 170.7 (CON), 
199.3 (C-1). 
[3,3 2H2]-3-Hydroxypropanoic Acid N-Acetylcysteamine Thiol Ester 2 
The above reaction was repeated using deuterated thiol ester 91 (1.80 g, 4.17 mmol) 
to give thiol ester 2 (0.30 g, 38%) as a white solid. SH(400 MHz) 2.00 (3H, s, CH3), 
2.40 (IH, br d, J 16.5, OH), 2.85 (2H, s, 2-H2), 3.08 (2H, t, J 6.0, CH2S), 3.49 (2H, 
app. q, J 6.0, CH2N), 5.87 (1H, br s, NH); SD(400 MHz) 3.92 (2D, s, 3-D2); 8ß(100 
MHz) 23.2 (CH3), 28.8 (CH2S), 39.2 (CH2N), 46.4 (C-2), 58.1 (quint., J 21.5, C-3), 
170.5 (CON), 199.3 (C-1); m/z (CI) 194 (MH+, 97%), 176 (8), 120 (100), 119 (12), 86 
(19) and 75 (11). Found (Cl): 194.0822 (MH+), (C7H12D2NO3S requires 194.0820). 
1,3-Propanediol 82174 
o0 
liAIH4 
EtO OEt -º HO^ýOH 
85 82 
Diethyl malonate 85 (1.00 g, 12.48 mmol) in dry diethyl ether (10 mL) was added 
dropwise to a slurry of lithium aluminium hydride (2.31 g, 62.4 mmol) in dry diethyl 
ether (190 mL) under an atmosphere of nitrogen at 0 °C. After 10 minutes, the 
solution was allowed to warm to room temperature and was stirred overnight. A 
condenser was attached and then the reaction was quenched using the method of 
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Leonard et al. l75 - water (2.31 mL), aqueous sodium hydroxide solution (15% wt/vol, 
2.31 mL) and water (6.93 mL) added dropwise sequentially. Magnesium sulfate was 
added, the soliuds were allowed to settle and the solution was decanted off and 
filtered through celite®. The solids remaining in the reaction vessel were washed with 
THE (2 x 150 mL) and the washings were again decanted off and filtered through 
celite®. The combined washings were then concentrated in vacuo to afford the alcohol 
82 (0.24 g, 51%) as a pale yellow oil. 8H(400 MHz, D20) 1.71 (2H, quint., J 6.5,2- 
H2), 3.60 (4H, t, J 6.5,1-H2 and 3-H2); Sß(100 MHz, D20) 33.8 (C-2), 58.6 (C-1 and 
C-3). 
[1,1,3,3- H41-1,3-Propanediol 87176 
The above reaction was repeated using diethyl malonate 85 (2.00 g, 24.96 mmol) and 
lithium aluminium deuteride (2.31 g, 54.91 mmol) to afford the alcohol 87 (0.64 g, 
64%) as a colourless oil. SH(400 MHz, D20) 1.69 (2H, s, 2-H2); Sc(lOO MHz, D20) 
33.4 (C-2), 57.9 (quint., J 21.5, C-1 and C-3). mlz (CI) 81 (MH, 26%), 73 (39), 63 
(100) and 55 (36). 
(1S, 2R)-N-Propionyl-bornane-10,2-sultam 104177,178 
O 
(i) NaH, toluene 
NH (ii) EtCOCI, toluene N 
\ O' o\\O 
76 104 
(1S)-(-)-Camphorsultam 76 (2.00 g, 9.33 mmol) in toluene (15 mL) was added 
dropwise to a stirred suspension of sodium hydride (60% dispersion in oil prewashed 
with petrol, 0.75 g, 31.7 mmol) in toluene (7 mL) at room temperature for 1 hour. 
Propionyl chloride (8.10 mL, 93.33 mmol) was added dropwise and the mixture was 
stirred for 2 hours at room temperature. The reaction was quenched with saturated 
aqueous ammonium chloride solution (75 mL) and was left to stir for a further 35 
minutes. The organic layer was then separated and the aqueous layer was extracted 
with ethyl acetate (3 x 50 mL). The combined organic layers were dried over 
magnesium sulfate, filtered and concentrated in vacuo to yield propionylsultam 104 
(2.52 g, 100%) as a white solid. This was then recrystallised from methanol, 
redissolved in chloroform and evaporated to dryness twice (to remove any residual 
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methanol) and dried in the oven (due the moisture sensitivity of the next reaction). 
[a] ö 25 -116.8 (c 2.69, CHC13); lit. 
'78 [a] D -108.4 (c 2.65, CHC13); m. p. 149-152 °C 
(from ethyl acetate/petroleum ether 40-60 °C), lit. '78 153-154 °C; 6H(400 MHz) 0.97 
and 1.16 (each 3H, each s, 8-H3 and 9-H3), 1.16 (3H, t, J 7.5,3'-H3), 1.24-1.45 (2H, 
m, 5-HH and 6-HH), 1.83-1.97 (3H, m, 4-H, 5-HH and 6-HH), 2.06 (1 H, dd, J 14.0, 
8.0,3-HH), 2.12 (1 H, m, 3-HH), 2.72 and 2.80 (each 1 H, each dq, J 17.0,7.5,2'-H2), 
3.43 (1H, d, J 14.0,10-HH), 3.50 (1 H, d, J 14.0,10-HH), 3.87 (1 H, dd, J 7.5,5.0,2- 
H); Sc(100 MHz) 8.3 (C-3'), 19.9 and 20.9 (C-8 and C-9), 26.4 and 28.9 (C-5 and C- 
6), 32.8 (C-3), 38.5 (C-4), 44.6 (C-2'), 47.7 and 48.5 (C-1 and C-7), 52.9 (C-10), 65.2 
(C-2), 172.7 (C-1'); nVz (CI) 272 (MH+, 100%), 216 (8), 207 (14), 151 (10), 135 (57), 
108 (12), 74 (9) and 57 (19). 
(1S, 2R)-N-[(2'S, 3'S)-3-Hydroxy-2-methylbutanoyl]-bornane-10,2-sultam 105179 
0 (i) Et3N, TBDMSOTf 
" Nl'ý 
, sow' 
(ii) MeCHO, TiCl4 
0 104 
_ýý 
O OH 
oo*, OX 11 O 105 
0 
0 
ýN 
o*s\\ 0 110 
Propionyl sultam 104 (1.00 g, 3.68 mmol) was stirred in dry DCM (7 mL) under an 
atmosphere of nitrogen at room temperature. Triethylamine (freshly distilled over 
calcium hydride, 1.5 mL, 11.04 mmol) was added and the reaction was stirred for 5 
minutes. tert-Butyldimethylsilyltrifluoromethane sulfonate (new bottle, 1.3 mL, 5.52 
mmol) was then added and the reaction was stirred for 20 hours. The solution was 
cooled to -78 
°C and acetaldehyde (0.45 mL, 8.10 mmol) was added. After cooling, 
titanium (IV) chloride (1.0 M in DCM, 8.1 mL, 8.10 mmol) was added slowly and the 
solution was stirred for 2 hours. The reaction was then quenched with saturated 
aqueous ammonium chloride solution (50 mL) and was allowed to warm to room 
temperature prior to extraction with ethyl acetate (3 x 100 mL). The combined 
organic layers were dried over magnesium sulfate, filtered and concentrated in vacuo 
to yield an orange-brown oil which solidified upon cooling. Purification by flash 
chromatography (Si02,30% ethyl acetate/petroleum ether 40-60 °C) gave alcohol 105 
as a white solid (1.91 g, 82%). A substantial quantity of acetate 110 (40-66%) was 
observed whenever an excess of acetaldehyde (relative to the quantity of titanium 
tetrachloride) was used. Alcohol 105: [a] ö 25 -72.0 (c 1.00, CHC13)9 lit. 
179 [a]20 ö -62.2 
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(c 0.20, CHC13); m. p. 123-125 °C, lit. 179 125-126 °C; SH(400 MHz) 0.98 and 1.18 
(each 3H, each s, 8-H3 and 9-H3), 1.21 (3H, d, J 7.0,2'-CH3), 1.26 (311, d, J 6.5,4'- 
H3), 1.30-1.43 (2H, m, 5-HH and 6-HH), 1.60 (1H, m, OH), 1.84-1.97 (3H, m, 4-11,5- 
HH and 6-HH), 2.04-2.22 (2H, m, 3-H2), 3.12 (1 H, app. quint., J 7.0,2'-H), 3.46 (111, 
d, J 14.0,10-HH), 3.54 (111, d, J 14.0,10-HH), 3.84 (IH, m, 3'-H), 3.91 (111, dd, J 
7.5,5.0,2-H); Sß(100 MHz) 14.2 (2'-CH3), 19.9 and 20.8, (C-8 and C-9), 22.0 (C-4'), 
26.4 and 33.0 (C-5 and C-6), 38.5 (C-3), 44.7 (C-4), 47.0 (C-2'), 47.8 and 48.3 (C-1 
and C-7), 53.2 (C-10), 65.4 (C-2), 71.7 (C-3'), 175.2 (C-1'); m/z (CI) 316 (MH, 
100%), 298 (24), 254 (13), 217 (19), 216 (75), 151 (31) and 135 (34). Acetate 110: 
[a] ö 25 -46.8 (c 1.93, CHC13)9 m. p. 146-148 °C (from CHC13), v,,, a, ý(neat)/cm'' 2942, 
1735 (C=O), 1686 (C=O), 1455,1395,1327,1234,1215,1135,1065,944,776; 
SH(400 MHz) 0.97 (3H, s, 8-113 or 9-113), 1.17 (3H, d, J 7.0,2'-CH3), 1.19 (311, s, 8-113 
or 9-H3), 1.27 (311, d, J 6.5,4'-H3), 1.31-1.44 (2H, m, 5-HH and 6-HH), 1.83-1.95 
(3H, m, 4-H, 5-HH and 6-HH), 1.95 (31-1, s, C(O)CH3), 1.99 (1 H, m, 3-HH), 2.06 (1 H, 
m, 3-HH), 3.28 (1 H, dq, J 9.0,7.0,2'-H), 3.44 (1 H, d, 13.5,10-HH), 3.53 (1 H, d, j 
13.5,10-HH), 3.88 (111, dd, J 7.5,5.0,2-H), 5.04 (1119 dq, J 9.0,6.5,3'-H); Sc(100 
MHz) 13.5 (2'-CH3), 17.4 (C-4'), 19.8 and 20.8 (C-8 and C-9), 21.0 (C(O)CH3)9 26.4 
and 32.8 (C-5 and C-6), 38.5 (C-3), 44.7 (C-4), 45.1 (C-2'), 47.7 and 48.2 (C-1 and C- 
7), 53.1 (C-10), 65.2 (C-2), 73.5 (C-3'), 169.8 (C(O)CH3)9 173.5 (C-l'); 'n/z (ESI) 380 
(MNa+, 100%), 358 (57), 298 (32), 190 (9) and 127 (11); Found (ESI): 380.1514 
(MH+), (C17H27NO5SNa requires 380.1502). 
(1S, 2R)-N-[(2'S, 3'S)-3-(tert-Butyldimethylsilanyloxy)-2-methylbutanoyl]- 
bornane-10,2-sultam 10688 
O OH 7O OTBDMS 
TBDMSOTf 
Oýý$ý 
Pyridine O" 
OO 
105 106 
Alcohol 105 (0.90 g, 2.85 mmol), was dissolved in DCM (10 mL) and cooled to 0 °C. 
Pyridine (0.5 mL, 0.04 mmol) and tert-butyldimethylsilyltrifluoromethane sulfonate 
(1.0 mL, 4.35 mmol) were added and the mixture was stirred at room temperature for 
2 hours. The reaction mixture was quenched with saturated aqueous ammonium 
chloride solution and left to stir for 35 minutes. The organic layer was removed and 
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the aqueous layer was extracted with DCM (3 x 50 mL). The combined organic layers 
were dried over magnesium sulfate, filtered and concentrated in vacuo to furnish silyl 
ether 106 as a white crystalline solid (1.23 g, 100%). [a] ö -16 (c 1.00, CHC13)9 lit' 
8 
[a] D -14.9 (c 0.96, CHC13); m. p. 143-144 °C (from MeOH), lit. 
88 143-144 °C; ö11(400 
MHz) 0.04 and 0.05 (each 3H, each s, 2x SiCH3), 0.86 (9H, s, SiC(CH3)3), 0.96 (311, 
s, 8-H3 or 9-H3), 1.10 (3H, d, J 6.0,4'-H3), 1.12 (3H, d, J 7.0,2'-CH3), 1.16 (3H, s, 8- 
H3 or 9-H3), 1.30-1.43 (2H, m, 5-HH and 6-HH), 1.83-1.95 (3H, m, 4-H, 5-HH and 6- 
HH), 2.04-2.08 (2H, m, 3-H2), 3.16 (1 H, app. quint., J 7.0,2'-H), 3.42 (1 H, d, J 13.5, 
10-HH), 3.49 (1 H, d, J 13.5,10-HH), 3.88 (IH, t, J 6.5,2-H), 4.16 (IH, app. quint., J 
7.0,3'-H); ßc(100 MHz) -4.8 and -4.5 (2 x SiCH3), 11.9 (2'-CH3), 18.0 (SiCCH3), 
19.9 and 20.1 (C-8 and C-9), 21.0 (C-4'), 25.8 (3 x SiCCH3), 26.5 and 32.9 (C-5 and 
C-6), 38.7 (C-3), 44.8 (C-4), 47.7 (C-2'), 48.1 and 48.1 (C-1 and C-7), 53.2 (C-10), 
65.5 (C-2), 70.0 (C-3'), 174.5 (C-1'); mlz (CI) 430 (M+, 54%), 414 (68), 372 (100), 
330 (66), 298 (32), 215 (46), 159 (33), 115 (32) and 107 (58). 
Ethyl (2E, 4R, 5S)-5-(tert-Butyldimethylsilanyloxy)-4-methylhex-2-enoate 10888 
O OTBDMS (i) DIBALH 
`/'ý 
(ii) NaH, (Et0)2P(O)CH2CO2Et 
N S, NH 
106 0 
6 
OTBDMS 0 
108 
Silyl ether 106 (1.00 g, 2.33 mmol) was dissolved in dry DCM (10 mL) under an 
atmosphere of nitrogen and cooled to -78 °C. Diisobutylaluminium hydride (1.0 M in 
hexanes, 2.3 mL, 2.33 mmol) was added dropwise and the mixture was stirred for 1 
hour. The reaction was then quenched with saturated aqueous potassium sodium L- 
tartrate tetrahydrate solution (6 mL) and was stirred vigorously for 3 hours at room 
temperature to break up the aluminium complex. The reaction mixture was extracted 
with DCM (3 x 50 mL) and the combined organic layers were dried over magnesium 
sulfate, filtered and concentrated in vacuo. The resulting oil was triturated with 
petroleum ether 40-60 °C and filtered to remove the precipitated auxiliary. The filtrate 
was concentrated in vacuo to yield a colourless oil. This was then dissolved in dry 
THE (3 mL) and added dropwise to a solution of triethyl phosphonoacetate (1.4 mL, 
5.70 mmol) and sodium hydride (60% dispersion in oil prewashed with hexane, 0.13 
g, 3.22 mmol) in dry THE (45 mL) which had been stirred for 10 minutes at 0 °C 
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under an atmosphere of nitrogen. The resulting solution was stirred at room 
temperature for 16 hours and was then quenched with water (35 mL). The solution 
was extracted with ethyl acetate (3 x 75 mL), dried over magnesium sulfate, filtered 
and concentrated in vacuo. Purification by flash column chromatography (Si02,2.5% 
ethyl acetate/petroleum ether 40-60 °C) gave ester 108 (0.55 g, 83%) as a colourless 
oil. [a] D 22 +19.0 (c 1.00, CHCI3, lit 
88 [a] p +18.5 (c 0.66, CHC13); SH(400 MHz) 0.04 
and 0.05 (each 3H, each s, 2x SiCH3), 0.88 (9H, s, SiC(CH3)3), 1.04 (3H, d, J 7.0,4- 
CH3), 1.09 (3H, d, J 6.0,6-H3), 1.29 (3H, t, J7.0, OCH2CH3), 2.32 (1H, m, 4-H), 3.74 
(1 H, dq, J 6.0,5.0,5-H), 4.19 (2H, q, J 7.0, OCH2CH3), 5.79 (1 H, dd, J 16.0,1.0,2- 
H), 6.96 (1H, dd, J 16.0,8.0,3-H); 5ß(100 MHz) -4.9 and -4.4 (2 x SiCH3), 14.3 
(OCH2CH3)9 15.3 (4-CH3), 18.1 (SiC(CH3)3), 21.2 (C-6), 25.8 C(CH3)3)9 44.4 (C-4), 
60.1 (OCH2CH3), 71.4 (C-5), 121.2 (C-2), 151.6 (C-3), 166.7 (C-1). 
(2E, 4R, 55)-5-(tert-Butyldimethylsilanyloxy)-4-methylhex-2-eno110988 
/ OEt 
DIBALH 
/ OH 
OTBDMS 0 OTBDMS 
108 109 
Ethyl ester 108 (0.55 g, 1.90 mmol) was dissolved in dry DCM (20 mL) under an 
atmosphere of nitrogen at -78 °C. Diisobutylaluminium hydride (1.0 M in hexanes, 4.2 
mL, 4.20 mmol) was added dropwise and the solution was stirred at -78 °C for 2 
hours. The reaction was then quenched with saturated aqueous potassium sodium L- 
tartrate tetrahydrate solution (20 mL) and was stirred vigorously at room temperature 
for 3 hours to break up the aluminium complex. The organic layer was removed and 
the aqueous layer was extracted with DCM (3 X 50 mL), dried over magnesium 
sulfate, filtered and concentrated in vacuo. Purification by flash column 
chromatography (Si02,20% ethyl acetate/petroleum ether 40-60 °C) gave alcohol 109 
(0.43 g, 92%) as a colourless oil. [a] ö 22 +12.0 (c 1.00, CHC13, lit. 
88 [a] D+14.7 (c 
0.86, CHC13); SH(400 MHz) 0.03 and 0.04 (each 3H, each s, 2x SiCH3), 0.88 (9H, s, 
SiC(CH3)3)9 0.98 (3H, d, J 7.0,4-CH3), 1.05 (3H, d, J 6.0,6-H3), 2.17 (1H, m, 4-H), 
3.69 (1H, m, 5-H), 4.09 (2H, s, 1-H2), 5.63 (2H, m, 2-H and 3-H); Sß(100 MHz) -4.8 
and -4.3 (2 x SiCH3), 16.0 
(4-CH3), 18.1 (SiC(CH3)3), 20.8 (C-6), 25.9 (SiC(CH3)3)9 
44.0 (C-4), 64.0 (C-1), 71.8 (C-5), 129.0 and 135.5 (C-2 and C-3). 
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(2E, 4R, 5S)-5-(tert-Butyldimethylsilyloxy)-1-iodo-4-methylhex-2-ene 10288 
OH 
OTBDMS 
109 
Iodine (1.21 g, 4.80 mmol) 
12, DIPHOS 
OTBDMS 
102 
was added in portions to 1,2- 
bis(diphenylphosphino)ethane (1.49 g, 3.73 mmol) in dry DCM (4 mL) at 0 °C under 
an atmosphere of nitrogen and the yellow precipitate which formed was stirred for 10 
minutes. Alcohol 109 (0.70 g, 2.86 mmol) in dry DCM (4 mL) was added dropwise 
and the reaction was stirred for 1 hour. Petrol (25 mL) and diethyl ether (20 mL) were 
added and the solution was filtered. The solvent was then removed in vacuo. 
Purification by flash column chromatography (Si02,100% petroleum ether 40-60 °C) 
furnished iodide 102 (0.50 g, 50%) as a pink tinged oil. [a] ö +10.2 (c 1.04, CHC13); 
lit. 88 [a] D +14.8 (c 1.11, CHC13); 
SH(400 MHz) 0.03 and 0.04 (each 3H, each s, each 
SiCH3), 0.89 (9H, s, SiC(CH3)3), 0.96 (3H, d, J 7.0,4-CH3), 1.05 (3H, d, J 6.0,6-H3), 
2.15 (1H, m, 4-H), 3.69 (1H, qd, J 6.0,4.5,5-H), 3.89 (2H, in. 1-H2), 5.68-5.72 (2H, 
m, 2-H and 3-H); Sc(100 MHz) -4.8 and -4.3 (2 x SiCH3), 7.0 (C-1), 15.8 (4-CH3), 
18.1 (SiC(CH3)3), 21.0 (C-6), 25.9 (SiC(CH3)3), 43.8 (C-4), 71.8 (C-5), 127.8 and 
137.2 (C-2 and C-3). 
Methyl N-Ethoxycarbonyl-2-amino-3-methylbutanoate 112180,181 
O ' 
NH2 
)--ý 
OEt (i) AcCI, MeOH HN 
(ii) NaHCO3, CICOZEt OMe 
COOH Y 
111 
112 
Acetyl chloride (21.0 mL, 370.00 mmol) was added dropwise to methanol (100 mL) 
at 0 °C. D, L-Valine 111 (10.00 g, 85.00 mmol) was added and the mixture was heated 
to reflux for 4 hours. The mixture was allowed to cool to room temperature and the 
solvent was removed in vacuo to give a colourless oil. Sodium hydrogen carbonate 
solution (300 mL) was added followed by ethyl chloroformate (10.5 mL, 105.00 
mmol) dropwise and then the reaction mixture was stirred overnight. The solution was 
then extracted with DCM (4 x 100 mL), dried over sodium sulfate, filtered and 
concentrated in vacuo to furnish the ester 112 (15.72 g, 91%) as a colourless oil. This 
was used without further purification. 6H(400 MHz) 0.89 and 0.96 (each 3H, each d, 
J 7.0, CH(CH3)2), 1.25 (3H, t, J 7.0, OCH2CH3), 2.15 (1H, m, 3-H), 3.74 (3H, s, 
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OCH3), 4.12 (2H, q, J 7.0, OCH2CH3), 4.28 0 H, dd, J 9.0,4.5,2-H), 5.19 (1 H, br d, J 
9.0, NH); 8ß(100 MHz) 14.5 (OCH2CH3), 17.6 (CHCH3), 19.0 (CHCH3), 31.3 (C-3), 
52.1 (OCHS), 58.9 (C-2), 61.2 (CH2O)9 156.5 (CON), 172.7 (C-1). 
Methyl (S)-N-Ethoxycarbonyl-2-amino-3-methylbutanoate (S)-112180,181 
The above reaction was repeated using L-valine (5.00 g, 42.50 mmol) to give the 
desired ester (S)-112 (7.89 g, 91%). [a] ö 22 +12.07 (c 2.32, CH2CI2)9 lit- 
181 [a] ö 20 +5.6 (c 
1.00, CH202); Spectral data as above. 
Methyl (R)-N-Ethoxycarbonyl-2-amino-3-methylbutanoate (R)-112180,181 
The above reaction was repeated using D-valine (5.00 g, 42.50 mmol) to give the 
desired ester (R)-112 (7.65 g, 89%). [a] ö 12 -8.87 (c 1.35, CH2C12)9 lit- 
181 [a] D 20 +5.6 (c 
1.00, CH202) for enantiomer; Spectral data as above. 
N-Ethoxycarbonyl-2-amino-3-methyl-l-butano1113182,183 
o0 
HNlk OEt HNß, OEt 
\ oMe 
NaBH4, CaC12 
yl---- 
ITOH O 
112 113 
Calcium chloride (18.93 g, 170.58 mmol) and sodium borohydride (13.93 g, 368.44 
mmol) were added gradually to a solution of ester 112 (15.7 g, 68.23 mmol) in 
ethanol (160 mL) and THE (45 mL) at 0 °C. The suspension was stirred overnight at 
room temperature and was then quenched with aqueous citric acid solution (1.0 M, 50 
mL). Water (700 mL) was added and the suspension was extracted with ethyl acetate 
(3 x 400 mL), dried over magnesium sulfate, filtered and concentrated in vacuo to 
give alcohol 113 (12.28 g, 91%) as a colourless oil. Note: spectral analysis showed 
that some cyclisation had occurred. &H(400 MHz) 0.94 and 0.96 (each 3H, each d, i 
7.0, CH(CH3)2), 1.25 (3H, t, J 7.0, OCH2CH3), 1.85 (IH, m, 3-H), 2.56 (IH, br s, 
OH), 3.48 (1 H, m, 2-H), 3.57-3.76 (2H, m, 1-H2), 4.12 (2H, q, J 7.0, OCH2CH3), 4.88 
(IH, br d, J 8.0, NH); 8(100 MHz) 14.6 (CH3CH2O), 18.5 (CHCH3), 19.5 (CHCH3), 
29.2 (C-3), 58.4 (C-2), 61.0 (CH3CH2O), 64.1 (C-1), 157.5 (CO). 
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(S)-N-Ethoxycarbonyl-2-amino-3-methyl-l-butanol (S)-113182,183 
The above reaction was repeated using the ester (S)-112 (7.89 g, 34.29 mmol) to give 
the desired alcohol (S)-113 (6.39 g, 94%). Note: Spectral analysis showed that some 
cyclisation had occurred and so [a] D value has not been included. Spectral data as 
above. 
(R)-N-Ethoxycarbonyl-2-amino-3-methyl-l-butanol (R)-113182,183 
The above reaction was repeated using the ester (R)-112 (7.65 g, 33.25 mmol) to give 
the desired alcohol (R)-113 (6.39 g, 97%). Note: Spectral analysis showed that some 
cyclisation had occurred and so [a] D value has not been included. Spectral data as 
above. 
4-Isopropyl-2-oxazolidinone (Evans' Auxiliary) 63184 
O0 
HN'OEt K2C03, A HN)LO 
OH -º 
I7 
113 63 
Potassium carbonate (0.28 g, 2.10 mmol) was added to a stirred solution of alcohol 
113 (12.26 g, 70.0 mmol) in toluene (130 mL). The mixture was heated to reflux 
overnight using Dean-Stark apparatus. After cooling, the solution was filtered through 
celite® and washed with ethyl acetate (50 mL). The solution was then dried over 
magnesium sulfate, filtered and concentrated in vacuo to yield oxazolidinone 63 (9.04 
g, 100 %) as an opaque oil which solidified to a white solid upon cooling. This was 
used without further purification. m. p. 70-71 °C (from CHCl3), lit. 
184 69-70 °C; 
SH(400 MHz) 0.91 and 0.97 (each 3H, each d, J 6.5, CH(CH3)2), 1.73 (1 H, app. oct., i 
7.0, CH(CH3)2), 3.62 (IH, m, 4-H), 4.11 (IH, dd, J 9.0,6.5,5-HH), 4.45 (IH, app. t, J 
9.0,5-HH), 6.67 (IH, br s, NH); 5ß(100 MHz) 17.6 (CH3), 18.0 (CH3), 32.7 
(CH(CH3)2)9 58.4 (C-4), 68.6 (C-5), 160.4 (C-2). 
(4S)-4-Isopropyl-2-oxazolidinone (Evans' Auxiliary) (S)-63184 
The above reaction was repeated using the alcohol (S)-113 (3.07 g, 23.70 mmol) to 
give the desired oxazolidinone (S)-63 (2.26 g, 100%). [a] ö -14.5 (c 5.04, EtOH), 
lit. ' 84 [a] D 18 -16.6 (c 5.81, EtOH); 
Spectral data as above. 
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(4R)-4-Isopropyl-2-oxazolidinone (Evans' Auxiliary) (R)-63184 
The above reaction was repeated using the alcohol (R)-113 (6.35 g, 49.02 mmol) to 
give the desired oxazolidinone (R)-63 (4.68 g, 100%). [a] D +18.9 (c 5.51, EtOH), 
, it. 184 [OG] p 18 -16.6 (c 5.81, EtOH) for enantiomer; Spectral data as above. 
(S)- 4"Isopropyl-N-propyl-2-oxazolidinone (S)-103185 
) 00 
IH, nBuLi EtCOCI v` o HN 
u 
, N O 
-- v 
(S)-63 (S)-103 
A solution of oxazolidinone (S)-63 (1.91 g, 14.84 mmol) in dry THE (60 mL) was 
cooled to -78 °C under an atmosphere of nitrogen and treated with n-butyllithium (2.5 
M in hexanes, 6.6 mL, 16.30 mmol). After 30 minutes, propionyl chloride (1.80 mL, 
20.80 mmol) was added dropwise. The mixture was allowed to warm to room 
temperature overnight and was then quenched with water (20 mL). The mixture was 
extracted with ethyl acetate (3 x 50 mL), dried over magnesium sulfate, filtered and 
concentrated in vacuo to afford a yellow/orange oil. Purification by flash column 
chromatography (Si02,20% ethyl acetate/petroleum ether 40-60 °C) furnished the 
acylated oxazolidinone (S)-103 (2.55 g, 93%) as a pale yellow oil. [a] ö +95.4 (c 
8.80, CH2C12)9 lit. 185 [(X] D+96.8 (c 8.7, CH2C12); SH(400 MHz) 0.88 and 0.92 (each 
3H, each d, J 7.0, CH(CH3)2), 1.17 (3H, t, J 7.5,3'-H3), 2.38 (1H, dsept., J 7.0,4.0, 
CH(CH3)2), 2.91 and 2.99 (each 1H, each dq, J 17.5,7.5,2'-H2)9 4.22 (1H, dd, J 9.0, 
3.0,5-HH), 4.28 (IH, dd, J 9.0,8.0,5-HH), 4.44 (IH, ddd, J 8.0,4.0,3.0,4-H); 
5ß(100 MHz) 8.4 (C-3'), 14.6 (CHCH3), 17.9 (CHCH3), 28.3 (CH(CH3)2), 29.1 (C-2'), 
58.4 (C-4), 63.4 (C-5), 154.1 (C-2), 174.0 (C-1'). 
(R)- 4-Isopropyl-N-propyl-2-oxazolidinone (R)-103185 
The above reaction was repeated using (R)-63 (4.00 g, 31.08 mmol) to furnish (R)- 
103 (4.93 g, 86%) as a pale yellow oil. [a] D 23 -81.1 (c 9.10, CH2C12), lit. 
185 [a] D +96.8 
(c 8.70, CH2C12) for enantiomer; Spectral data as above. 
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(4S)-4-Isopropyl-N-((2'R)-2'-methylpent-4'-enoyl)-2-oxazolidinone (4S)-1169°'91 
o00. o 
NJ v Nvo + 
NaHMDS 0 
115 
(4S)-116 
(S)-103 
A solution of oxazolidinone (S)-103 (0.40 g, 2.16 mmol) in dry THE (2 mL) was 
added dropwise to a stirred solution of sodium bis(trimethylsilyl)amide (1.0 M in 
THF, 2.40 mL, 2.40 mmol) in dry THE (18 mL) at -78 °C under an atmosphere of 
nitrogen. After 1 hour, allyl iodide 115 (2.16 mL, 23.76 mmol) was added dropwise. 
The reaction was stirred at -78 °C for 3.5 hours and was then quenched with saturated 
aqueous ammonium chloride solution (30 mL) and allowed to warm to room 
temperature. The solution was extracted with DCM (3 x 50 mL). The combined 
organic extracts were dried over magnesium sulfate, filtered and concentrated in 
vacuo to yield a yellow oil. Purification by flash column chromatography (Si02i 10% 
ethyl acetate/petroleum ether 40-60 °C) gave allylic oxazolidinone (4S)-116 (0.34 g, 
70%) as a colourless oil. [a] D 
24 +58.4 (c 3.41, CH2C12); lit 90 [a] p +62.9 (c 3.48, 
CH2C12); SH(400 MHz) 0.87 and 0.91 (each 3H, each d, J 7.0, CH(CH3)2), 1.15 (3H, 
d, J 7.0,2'-CH3), 2.20 (1 H, app. dtt, J 14.0,7.0,1.0,3'-HH), 2.32 (1 H, dsept., J 7.0, 
4.0, CH(CH3)2), 2.51 (1 H, app. dtt, J 14.0,7.0,1.0,3'-HH), 3.89 (1 H, app. sext., J 7.0, 
2'-H), 4.20 (1 H, dd, J 9.0,3.0,5-HH), 4.27 (1 H, dd, J 9.0,8.5,5-HH), 4.46 (1 H, ddd, 
J 8.5,3.5,3.0,4-H), 5.01-5.11 (2H, m, 5'-H2), 5.79 (1 H, ddt, J 17.0,10.0,7.0,4'-H); 
8ß(100 MHz) 14.6 (CHCH3), 16.2 (2'-CH3)9 18.0 (CHCH3), 28.4 (CH(CH3)2), 37.1 
(C-2'), 38.2 (C-3'), 58.4 (C-4), 63.1 (C-5), 117.1 (C-5'), 135.2 (C-4'), 153.72 (C-2), 
176.4 (C-1'). 
(4R)-4-Isopropyl-N-((2'S)-2'-methylpent-4'-enoyl)- 2-oxazolidinone (4R)-11690'91 
The above reaction was repeated using (R)-103 (2.00 g, 10.80 mmol) to furnish (4R)- 
116 (1.75 g, 72%) as a pale yellow oil. [a] ö 23 - 56.7 (c 3.56, CH2C12); "t, 
90 [a] D +62.9 
(c 3.48, CH2C12) for enantiomer. Spectral data as above. 
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(1S, 2R)-N-[(2'S, 3'S)-3-(Triethylsilanyloxy)-2-methylbutanoyl]-bornane-10,2- 
sultam 120 
TO 
OH 0 OTES 
TESCI, Imidazole 
SAN - so' 
psiý0 = O/""O 105 120 
Alcohol 105 (4.47 g, 14.17 mmol) was dissolved in dry DMF (17 mL) under an 
atmosphere of nitrogen. Imidazole (1.26 g, 18.42 mmol) was added and the reaction 
was cooled to 0 °C. Chlorotriethylsilane (2.85 mL, 17.00 mmol) was added and the 
mixture was stirred for 19 hours at room temperature. The solution was then diluted 
with diethyl ether (50 mL) causing a white precipitate and washed with water (3 x 20 
mL). The organic layer was then dried over magnesium sulfate, filtered and 
concentrated in vacuo. Purification by flash column chromatography (Si02,5-10% 
ethyl acetate/petroleum ether 40-60 °C) gave silyl ether 120 (5.28 g, 87%) as a white 
solid. Found: C, 58.60; H, 9.07; N, 3.36; C21H39NO4SSi requires C, 58.70; H, 9.15; N, 
3.26; [a] ö 22 -13.8 (c 5.35, CHC13); M-13- 148-150 °C (from ethyl acetate and petroleum 
ether 40-60 °C); vm(neat)/cm 1 2955,2877,1685 (C=O), 1458,1333,1213,1132, 
1108,1012,971,943,770,723; SH(400 MHz) 0.58 (6H, q, J 8.0, Si(CH2CH3)3), 0.93 
(9H, t, J 8.0, Si(CH2CH3)3), 0.97 (3H, s, 8-H3 or 9-H3), 1.11 (3H, d, J 7.0,2'-CH3), 
1.14 (3H, d, J 6.5,4'-H3)9 1.18 (3H, s, 8-H3 or 9-H3), 1.26-1.44 (2H, m, 5-HH and 6- 
HH), 1.83-1.96 (3H, m, 4-H, 5-HH and 6-HH), 2.03-2.08 (2H, m, 3-H2), 3.14 (1H, 
app. quint., J 7.0,2'-H), 3.42 (IH, d, J 13.5,10-HH), 3.50 (IH, d, J 13.5,10-HH), 
3.88 (IH, t, J 6.5,2-H), 4.16 (IH, dq, J 7.0,6.5,3'-H); 8ß(100 MHz) 4.9 
(Si(CH2CH3)3), 6.8 (Si(CH2CH3)3), 12.1 (2'-CH3)9 19.9 and 20.2 (C-8 and C-9), 21.0 
(C-4'), 26.5 and 32.8 (C-5 and C-6), 38.6 (C-3), 44.7 (C-4), 47.7 and 48.1 (C-1 and C- 
7), 48.2 (C-2'), 53.1 (C-10), 65.3 (C-2), 70.3 (C-3'), 174.6 (C-1'); m/z (CI) 430 (MH+, 
19%), 400 (100), 330 (65), 159 (12), 135 (20) and 115 (22); Found (Cl): 430.2439 
(MH+), (C21H40NO4SSi requires 430.2447). 
(3R, 4S)-3-Methyl-4-triethylsilanyloxypent-l-ene 11762 
O OTES 
(i) DIBAC. H 
N (ii) NaH, PPh3MeBr 
Y\/ 
öSö= OTES 
120 117 
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Diisobutylaluminium hydride (1.0 M in hexanes, 5.0 mL, 5.00 mmol) was added 
dropwise over 30 minutes to silyl ether 120 (2.00 g, 4.84 mmol) in dry DCM (24 mL) 
under an atmosphere of nitrogen at -78 °C. The reaction was stirred for 5 hours and 
then quenched with saturated aqueous potassium sodium L-tartrate tetrahydrate 
solution (40 mL). The solution was stirred vigorously overnight and was then 
extracted with DCM (3 x 100 mL), dried over magnesium sulfate and concentrated in 
vacuo. The resulting solid was triturated with petroleum ether 40-60 °C and filtered to 
remove the precipitated auxiliary. The filtrate was concentrated in vacuo to yield a 
pale yellow oil. Meanwhile, a solution of methyltriphenylphosphonium bromide (8.74 
g, 24.20 mmol) and sodium hydride (60% dispersion in oil prewashed with dry 
hexane, 4.36 g, 109.20 mmol, ) in dry THE (100 mL) under an atmosphere of nitrogen 
was gently heated with stirring until a green/grey colour was observed. The solution 
was stirred overnight at room temperature and the solids were then allowed to settle. 
The bright yellow solution was transferred via cannula into a solution of the aldehyde 
in dry THE (3 mL) and left to stir at room temperature under an atmosphere of 
nitrogen for 3 hours. The solvent was then removed in vacuo and the resulting yellow 
residue was purified by flash column chromatography (Si02,0-1% ethyl 
acetate/petroleum ether 40-60 °C) to give alkene 117 (0.55 g, 55%) as a colourless oil. 
[a] D 11 +10.5 (c 2.48, CHC13); lit. 
62 [a] D +2.8 (c 2.50, CHC13); 84400 MHz) 0.59 (6H, 
q, J 8.0, Si(CH2CH3)3), 0.96 (9H, t, J 8.0, Si(CH2CH3)3), 0.99 (3H, d, J 7.0,3-CH3), 
1.07 (3H, d, J 6.5,5-H3), 2.18 (IH, m, 3-H), 3.73 (IH, qd, J 6.5,4.5,4-H), 4.98 (IH, 
m, 1-HH), 5.01 (IH, m, 1-HH), 5.79 (IH, ddd, J 17.5,9.5,7.5,2-H); Sc(100 MHz) 
5.1 (Si(CH2CH3)3), 7.0 (Si(CH2CH3)3), 15.1 (3-CH3), 20.4 (C-5), 45.4 (C-3), 71.6 (C- 
4), 114.2 (C-2), 141.3 (C-1). 
(4S)-N. ((2R, 4E, 6R, 7S)-2,6-Dimethyl-7-triethylsilanyloxyoct-4-enoyl)-4-isopropyl- 
2-oxazolidinone 121 
0 
OTES 
117 (4S)-118 
OO\ 
Grubbs' 2nd 
ýy 
O 
INJ 
Generation 
Catalyst 
OTES 121 
07r 
O) 
OTES 
4: 1 123 
To a solution of Grubbs' 2nd generation catalyst (24.3 mg, 0.028 mmol) in dry 
toluene (2 mL) was added a premixed solution of alkene 117 (0.24 g, 1.12 mmol) and 
alkene (4S)-116 (0.12 g, 0.56 mmol) in dry toluene (3 mL). The reaction was stirred 
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at 55-65 °C overnight. Upon cooling, the solvent was removed in vacuo and the 
mixture was then purified by flash column chromatography (Si02,2.5-5% ethyl 
acetate/petroleum ether 40-60 °C) to give an inseparable 4: 1 mixture of alkenes 121 
and 123 (0.12 g, 50%) as a colourless oil. [(x]25 D (of 4: 1 mixture) +14.2 (c 3.32, 
CHC13); v. (neat)/cm 1 2961,2876,1779 (C=O), 1700 (C=O), 1384,1372,1235, 
1201,1093,1006,956; SH(400 MHz) (major isomer) 0.58 (6H, q, J 8.0, 
Si(CH2CH3)3), 0.87 and 0.91 (each 3H, each d, J 7.0, CH(CH3)2), 0.94 (3H, d, J 6.0, 
6'-CH3), 0.95 (9H, t, J 8.0, Si(CH2CHj)3), 1.03 (3H, d, J 6.0,8'-H3), 1.13 (3H, d, J 
7.0,2'-CH3), 2.08-2.19 (2H, m, J 7.0,3'-HH and 6'-H), 2.33 (1H, dsept., J 7.0,3.5, 
CH(CH3)2), 2.47 (1 H, dt, J 13.5,7.0,3'-HH), 3.70 (1 H, qd, J 6.0,4.5,7'-H), 3.80 (1 H, 
app. sext., J 7.0,2'-H), 4.20 (IH, dd, J 9.0,3.0,5-HH), 4.27 (IH, dd, J 9.0,8.5,5- 
HH), 4.46 (IH, ddd, J 8.5,3.5,3.0,4-H), 5.35 (IH, dt, J 15.5,7.0,4'-H), 5.45 (1H, dd, 
J 15.5,7.5,5'-H); &2(100 MHz) (major isomer) 5.0 (Si(CH2CH3)3), 6.9 
(Si(CH2CH3)3), 14.7 (CH(CH3)2), 15.3 and 16.0 (2'-CH3 and 6'-CH3), 18.0 
(CH(CH3)2), 20.2 (C-8'), 28.4 (CH(CH3)2), 37.1 (C-3'), 37.7 (C-2'), 44.2 (C-6'), 58.4 
(C-4), 63.1 (C-5), 71.7 (C-7'), 126.4 (C-4'), 135.7 (C-5'), 153.7 (C-2), 176.6 (C-1'); 
nVz (CI) 412 (MH', 3%), 382 (60), 280 (100), 159 (28) and 151 (23); Found (CI): 
412.2885 (MH+), (C22H42NO4Si requires 412.2883). 
(4R)-N. ((2S, 4E, 6R, 7S)-2,6-Dimethyl-7-triethylsilanyloxyoct-4-enoyl)-4-isopropyl- 
2-oxazolidinone 122 
°o 0 of °ý 
Grubbs' 2nd 
Y 
ON Generation 
°NON 
Catalyst OTES 
OTES OTES 122 4; 1 124 
117 (4R)-116 
To a solution of Grubbs' 2nd generation catalyst (60.8 mg, 0.07 mmol) in dry toluene 
(5 mL) was added a premixed solution of and alkene 117 (0.60 g, 2.80 mmol) and 
alkene (4R)-116 (0.31 g, 1.40 mmol) in dry toluene (7 mL). The reaction was stirred 
at 60-70 °C overnight. Upon cooling, the solvent was removed in vacuo and the 
mixture was then purified by flash column chromatography (Si02,2.5-5% ethyl 
acetate/petroleum ether 40-60 °C) to give an inseparable 4: 1 mixture of alkenes 122 
and 124 (0.22 g, 38%) as a colourless oil. [a] ö (of 4: 1 mixture) -22.7 (c 2.56, 
CHC13); vma, (neat)/cm 1 2960,2876,1779 (C=O), 1700 (C=O), 1458,1384,1372, 
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1235,1200,1093,1006,964,740,724; 6H(400 MHz) (major isomer) 0.58 (6H, q, J 
8.0, Si(CH2CH3)3), 0.87 and 0.91 (each 3H, each d, J 7.0, CH(CH3)2), 0.94 (3H, d, J 
6.5,6'-CH3), 0.95 (9H, t, J 8.0, Si(CH2CH3)3), 1.03 (3H, d, J 6.0,8'-H3), 1.13 (3H, d, 
J 7.0,2'-CH3), 2.08-2.20 (2H, m, 3'-HH and 6'-H), 2.33 (IH, dsept., J 7.0,3.5, 
CH(CH3)2), 2.47 (1 H, app. dt, J 14.0,6.0,3'-HH), 3.70 (1 H, qd, J 6.0,4.5,7'-H), 3.80 
(1 H, app. sext., J 7.0,2'-H), 4.20 (1 H, dd, J 9.0,3.0,5-HH), 4.27 (1 H, dd, J 9.0,8.5, 
5-HH), 4.46 (1 H, ddd, J 8.5,3.5,3.0,4-H), 5.35 (1 H, m, 4'-H), 5.45 (1 H, dd, J 15.5, 
7.0,5'-H); Sc(100 MHz) (major isomer) 4.9 (Si(CH2CH3)3), 6.8 (Si(CH2CH3)3), 14.6 
(CH(CH3)2), 15.0 and 15.8 (2'-CH3 and 6'-CH3), 17.9 (CH(CH3)2), 20.0 (C-8'), 28.4 
(CH(CH3)2), 37.0 (C-3'), 37.6 (C-2'), 44.1 (C-6'), 58.3 (C-4), 63.0 (C-5), 71.6 (C-7'), 
126.3 (C-4'), 135.6 (C-5'), 153.6 (C-2), 176.4 (C-1'); m/z (CI) 412 (MH+, 2%), 382 
(70), 280 (100), 159 (48) and 151 (32); Found (Cl): 412.2866 (MH+), (C22H42NO4Si 
requires 412.2883). 
(2R, 4E, 6R, 7S)-2,6-Dimethyl-7-hydroxyoct-4-enoic acid (mupiric acid) 3 
(i) via deprotection and auxiliary cleavage of silyl ether 121 
0 0 0f 
O 
yJ 
o_ Li off o off OTES (i) oH, HZOz OH 
l+-i 
(ü) AcOH, THF. H2O 
OTES 121 123 
OH 3 125 
Lithium hydroxide monohydrate (0.02 g, 0.50 mmol) and hydrogen peroxide solution 
(30% solution in water, 0.1 mL, 0.75 mmol) were added successively to a solution of 
alkenes 121 and 123 (0.11 g, 0.28 mmol) in THE (3 mL) and water (1.5 mL) at 0 °C. 
This was then stirred at room temperature overnight and quenched with sodium sulfite 
solution (7.6% in water, 1.3 mL, 0.75 mmol). After 10 minutes the solvents were 
removed in vacuo. A mixture of water (3 mL), acetic acid (5 mL) and THE (11 mL) 
was then added to the residue and the mixture was stirred overnight. Solvents were 
removed in vacuo and the crude product was purified by flash column 
chromatography (Si02,20% ethyl acetate/1% acetic acid/petroleum ether 40-60 °C) to 
afford an inseparable 4: 1 mixture of acids 3 and 125 (0.20 g, 40%) as a colourless oil. 
[a] D (of 4: 
1 mixture) +13.4 (c 1.05, CHC13); vmax(neat)/cm 1 3363 (OH), 2971, 
2933,1705 (C=O), 1457,1378,1226,1189,1086,971; BH(400 MHz) (major isomer) 
0.98 (3H, d, J 7.0,6-CH3), 1.16 (3H, d, J 6.5,8-H3), 1.18 (3H, d, J 7.0,2-CH3), 2.09 
(IH, m, 6-H), 2.25 (IH, app. dtd, J 14.0,7.0,1.0,3-HH), 2.35 (IH, app. dt, J 14.0, 
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7.0,1.0,3-HH), 2.56 (IH, app. sext., J 7.0,2-H), 3.53 (1H, app. quint., J 6.5,7-H), 
5.39 (IH, dd, J 15.5,8.5,5-H), 5.53 (1H, dt, J 15.5,7.0,4-H), 6.50 (IH, br s, OH); 
SH(400 MHz, C6D6) (major isomer) 0.90 (3H, d, J 7.0,6-CH3), 1.04 (3H, d, J 7.0,2- 
CH3), 1.12 (3H, d, J 6.0,8-H3), 1.96 (1H, m, 6-H), 2.11 (1H, app. dtd, J 13.5,7.0,3- 
HH), 2.22 (1 H, app. dtd, J 13.5,7.0,3-HH), 2.41 (1 H, m, 2-H), 3.46 (1 H, app. quint., 
J 6.0,7-H), 5.34 (1 H, dd, J 15.5,8.0,5-H), 5.41 (1 H, dt, J 15.5,7.0,4-H), 5.94 (1 H, 
br s, 2x OH); 8ß(100 MHz) (major isomer) 16.2 and 16.5 (2-CH3 and 6-CH3), 20.0 
(C-8), 36.5 (C-3), 39.8 (C-2), 44.9 (C-6), 71.1 (C-7), 128.7 (C-4), 134.9 (C-5), 181.2 
(C-1); m/z (CI) 187 (MH+, 5%), 169 (63), 151 (78), 123 (67), 95 (100), 85 (28), 83 
(36) and 69 (43); Found (Cl): 187.1332 (MH+), (CloH1903 requires 187.1334). 
(ii) Via auxiliary cleavage of alcohol 142 
000 
O OH O OH ONO 
T- 
= OH OH (i) UOH, H 202 
/ . may / '". i + 
142 143 
OH 3 125 
OH 
Lithium hydroxide monohydrate (0.14 g, 0.36 mmol) and hydrogen peroxide solution 
(30% in water, 0.07 mL, 0.56 mmol) were added successively to a solution of 
alcohols 142 and 143 (0.072 g, 0.24 mmol) in THE (3 mL) and water (1.5 mL). The 
solution was stirred at room temperature overnight and was then quenched with 
sodium sulfite solution (3 mL). Solvents were removed in vacuo and the crude 
product was purified by flash column chromatography (SiO2,20% ethyl acetate/1% 
acetic acid/petroleum ether 40-60 °C) to afford an inseparable 6: 1 mixture of acids 3 
and 125 (0.012 g, 27%) as a colourless oil. [(x]25 (of 6: 1 mixture) +11.5 (c 0.61, 
CHC13); Spectral data as above. 
(2S, 4E, 6R, 7S)-2,6-Dimethyl-7-hydroxyoct-4-enoic acid 4 
O'ýIro O"ro 
ON 
)TON ES (ii) AcOH. 'INF, H2O 
OTES 122 124 
OH 4 126 
Lithium hydroxide monohydrate (0.02 g, 0.50 mmol) and hydrogen peroxide solution 
(30% solution in water, 0.1 mL, 0.75 mmol) were added successively to a solution of 
alkenes 122 and 124 (0.13 g, 0.32 mmol) in THE (3 mL) and water (1.5 mL) at 0 °C. 
This was then stirred at room temperature overnight and quenched with sodium sulfite 
solution (7.6% in water, 1.25 mL, 0.75 mmol). After 10 minutes the solvents were 
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removed in vacuo. A mixture of water (3 mL), acetic acid (5 mL) and THE (11 mL) 
was then added to the residue and the mixture was stirred overnight. Solvents were 
removed in vacuo and the crude product was purified by flash column 
chromatography (Si02,20% ethyl acetate/1% acetic acid/petroleum ether 40-60 °C) to 
afford an inseparable 4: 1 mixture of acids 4 and 126 (0.45 g, 76%) as a colourless oil. 
[a] D (of 4: 1 mixture) +35.0 (c 1.95, CHC13); vm. (neat)/cm 
I 3333 (OH), 2971, 
2933,1705 (C=O), 1456,1377,1228,1191,1086,971; 8,1(400 MHz) (major isomer) 
0.98 (3H, d, J 7.0,6-CH3), 1.16 (3H, d, J 6.0,8-H3), 1.18 (3H, d, J 7.0,2-CH3), 2.07 
(IH, m, 6-H), 2.21 (IH, app. dtd, J 14.0,7.0,1.0,3-HH), 2.34 (IH, app. dt, J 14.0, 
7.0,3-HH), 2.52 (1 H, m, 2-H), 3.52 (1 H, app. quint., J 6.0,7-H), 5.35 (1 H, dd, J 15.0, 
8.5,5-H), 5.51 (1 H, dt, J 15.0,7.0,4-H), 6.07 (1 H, br s, OH); 6H(400 MHz, C6D6) 
(major isomer) 0.98 (3H, d, J 7.0,6-CH3), 1.05 (3H, d, J 7.0,2-CH3), 1.14 (3H, d, J 
6.0,8-H3), 1.92 (IH, m, 6-H), 2.04 (1H, app. dtd, J 13.5,5.5,1.0,3-HH), 2.26 (IH, 
app. dt, J 13.5,8.5,3-HH), 2.40 (1 H, m, 2-H), 3.47 (1 H, app. quint., J 6.0,7-H), 5.31 
(IH, dd, J 15.5,8.0,5-H), 5.39 (IH, dt, J 15.5,7.0,4-H), 6.32 (IH, br s, 2x OH); 
8ß(100 MHz) (major isomer) 16.6 (2 coincident peaks, 2-CH3 and 6-CH3), 19.9 (C-8), 
37.0 (C-3), 39.7 (C-2), 45.1 (C-6), 71.2 (C-7), 129.3 (C-4), 134.9 (C-5), 180.8 (C-1); 
m/z (CI) 187 (MH+, 31%), 169 (100), 151 (93), 123 (82), 95 (98), 85 (10), 83 (16), 74 
(23) and 69 (49); Found (CI): 187.1334 (MH+), (C1oH1903 requires 187.1334). 
(1S, 2R)-N-[(2'S, 3'S)-3-Benzyloxy-2-methylbutanoyl]-bornane-10,2-sultam 134 
7OOH 
pp- 
105 
TfOH 
NH 
CI3CAO^Ph 
O OBn 
ýN ý/% pp 
134 
Trifluoromethanesulfonic acid (0.4 mL, 3.96 mmol) was added to a stirred solution of 
alcohol 105 (8.30 g, 26.33 mmol) and benzyl 2,2,2-trichloroacetimidate (6.4 mL, 
33.90 mmol) in a mixture of cyclohexane (40 mL) and dry DCM (40 mL) at room 
temperature under an atmosphere of nitrogen. The solution was stirred for 3 hours and 
then filtered through celite to remove the crystalline trichloroacetimidate. The solid 
was washed with DCM and the combined organic extracts were adjusted to pH 7 with 
saturated aqueous sodium hydrogen carbonate solution. The extracts were then 
washed with saturated sodium hydrogen carbonate solution (40 mL) and water (40 
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mL), dried over magnesium sulfate, filtered and concentrated in vacuo to yield a 
white solid. Purification by flash column chromatography (Si02,0-30% ethyl 
acetate/petroleum ether 40-60 °C) gave benzyl ether 134 (10.55 g, 99%) as a white 
crystalline solid. Found: C, 65.01; H, 7.91; N, 3.31; S, 7.68; C22H31NO4S requires C, 
65.15; H, 7.70; N, 3.45; S, 7.91; [a] D 21 +23.5 (c 1.02, CHC13); m. p. 148-150 °C (from 
ethyl acetate and petroleum ether 40-60 °C); vm(neat)/cm's 3366,3241,3180,2981, 
2956,2883,1679 (C=O), 1616,1386,1333,1109,829 and 747; &H(400 MHz) 0.89 
and 0.91 (each 3H, each s, 8-H3 and 9-H3), 1.14 (3H, d, J 5.5,2'-CH3), 1.20 (3H, d, J 
6.0,4'-H3), 1.23-1.44 (2H, m, 5-HH and 6-HH), 1.78-1.92 (5H, m, 3-H2,4-H, 5-HH 
and 6-HH), 3.29 (1 H, app. quint., J 7.0,2'-H), 3.39 (1 H, d, J 14.0,10-HH), 3.46 (1 H, 
d, J 14.0,10-HH), 3.81-3.85 (IH, m, 3'-H), 4.38 (IH, d, J 11.5, CHHPh), 4.56 (IH, d, 
111.5. CHHPh), 7.28-7.32 (5H, m, 5x Ar-H); Sc(100 MHz) 12.7 and 16.5 (2'-CH3 
and C4'), 19.88 and 20.6 (C-8 and C-9), 26.5 and 32.8 (C-5 and C-6), 38.4 (C-3), 44.7 
(C-4), 46.0 (C-2'), 47.6 and 48.2 (C-1 and C-7), 53.2 (C-10), 65.2 (C-2), 71.1 
(CH2Ph), 78.1 (C-3'), 127.3 (Ar-C), 128.1 (2 x Ar-C), 128.1 (2 x Ar-C), 138.6 (Ar- 
C; pso), 174.8 (C-1'); m/z (CI) 406 (MH+, 
50%), 306 (100), 298 (30), 216 (34), 135 
(33), 119 (26) and 91 (98); Found (CI): 406.2047 (MH+), (C22H32NO4S requires 
406.2052). 
(3R, 4S)-4-Benzyloxy-3-methylpent-l-ene 135 
O OBn (i) DIBAIrH 
N (ii) NaH, PPh3MeBr 
Y\/ 
öSö OBn 
134 135 
Diisobutylaluminium hydride (1.0 M in toluene, 3.71 mL, 3.71 mmol) was added 
dropwise in 3 portions at 15 minute intervals to benzyl ether 134 (1.00 g, 2.46 mmol) 
in dry DCM (10 mL) under an atmosphere of nitrogen at -78 °C. The reaction was 
stirred for 1 hour and then a further addition of diisobutylaluminum hydride (1.0 M in 
toluene, 0.5 mL, 0.5 mmol) was made. The reaction was stirred for 30 minutes and 
was then quenched with saturated aqueous potassium sodium L-tartrate tetrahydrate 
solution (50 mL). The solution was stirred vigorously overnight and was then 
extracted with DCM (3 x 100 mL), washed with brine (20 mL), dried over 
magnesium sulfate and concentrated in vacuo. The resulting oil was triturated with 
-134- 
Chapter 6 Experimental 
petroleum ether 40-60 °C for several minutes and filtered to remove the precipitated 
auxiliary. The filtrate was concentrated in vacuo to yield a pale yellow oil. 
Meanwhile, a solution of methyltriphenylphosphonium bromide (4.13 g, 11.43 mmol) 
and sodium hydride (60% dispersion in oil prewashed with dry hexane, 0.98 g, 24.6 
mmol) in dry THE (25 mL) under an atmosphere of nitrogen was gently heated with 
stirring until a green/yellow tinge was observed. The solution was stirred overnight at 
room temperature and the solids were then allowed to settle. The bright yellow 
solution was then transferred via cannula into a solution of the aldehyde in dry THE 
(3 mL) and left to stir at room temperature under an atmosphere of nitrogen for 3 
hours. The solvent was then removed in vacuo and the resulting yellow residue was 
purified by flash column chromatography (Si02,0-1% ethyl acetate/petroleum ether 
40-60 °C, dry loaded) to give alkene 135 (0.22 g, 46%) as a colourless oil. [a]" 
+16.8 (c 3.04, CHC13); vm. (neat)/cm'1 2973,2869,1454,1373,1094,1067,911, 
733,695; 8H(400 MHz) 1.07 (3H, d, J 7.0,3-CH3), 1.15 (3H, d, J 6.5,5-H3), 2.45 
(IH, m, 3-H), 3.48 (IH, qd, J 6.5,5.0,4-H), 4.51 and 4.60 (each 1H, each d, J 12.0, 
CH2Ph), 5.08 (1 H, ddd, J 10.5,2.0,1.0,1-HH), 5.09 (1 H, ddd, J 17.0,2.0,1.0,1-HH), 
5.86 (1H, ddd, J 17.0,10.5,7.5,2-H), 7.25-7.40 (5H, m, 5x Ar-H); Sc(100 MHz) 
14.8 (3-CH3), 16.2 (C-5), 42.6 (C-3), 70.7 (CH2Ph), 78.3 (C-4), 114.5 (C-1), 127.5 
(Ar-C), 127.7 (2 x Ar-C), 128.4 (2 x Ar-C), 139.2 (Ar-C1 0), 141.2 (C-2); rn/z (ESI) 
213 (MNa+, 100%) and 193 (55); Found (ESI): 213.1240 (MNa+), (C13Hi8ONa 
requires 213.1250). 
(4S)-N-((2R, 4E, 6R, 7S)-7-Benzyloxyoct-2,6-dimethyl-4-enoyl)-4-isopropyl-2- 
oxazolidinone 136 
00° 
0 
ON 
ý 
Grubbs' 2nd 0NO NJ 
Generation Catalyst OBn 
OBn 135 (4S)-116 
OBn 136 137 
To a solution of Grubbs' second generation catalyst (66.2 mg, 0.076 mmol) in dry 
toluene (5.5 mL) was added a premixed solution of alkene 135 (0.30 g, 1.53 mmol) 
and alkene (4S)-116 (0.17 g, 0.76 mmol) in dry toluene (7 mL). The reaction was 
stirred overnight at 50 °C and then solvents were removed in vacuo to give a purple- 
black oil. Purification by flash column chromatography (Si02,2.5-5% ethyl 
acetate/petroleum ether 40-60 °C) afforded an inseparable 6: 1 mixture of alkenes 136 
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and 137 (0.12 g, 41%) as a colourless oil. [a] ö (of 6: 1 mixture) +18.2 (c 2.96, 
CHC13); v,,, (neat)/cm 1 2969,2917,1777 (C=O), 1700 (C=O), 1495,1454,1386, 
1373,1235,1203,1094,1056,991,734,698; SH(400 MHz) (major isomer) 0.86 and 
0.90 (each 3H, each d, J 7.0, CH(CH3)2), 0.99 (3H, d, J 7.0,6'-CH3), 1.10 (3H, d, J 
6.0,8'-H3), 1.12 (3H, d, J 7.0,2'-CH3), 2.13 (1H, app. dt, J 14.0,7.0,3'-HH), 2.26- 
2.42 (2H, m, CH(CH3)2 and 6'-H), 2.48 (1 H, app. dt, J 14.0,7.0,3'-HH), 3.42 (1 H, qd, 
J 6.0,4.5,7'-H), 3.80 (IH, app. sext., J 7.0,2'-H), 4.19 (IH, dd, J 9.0,3.0,5-HH), 
4.26 (1 H, dd, J 9.0,8.5,5-HH), 4.45 (1 H. m, 4-H), 4.46 (1 H, d, J 12.0, CHHPh), 4.55 
(1 H, d, J 12.0, CHHPh), 5.39 (1 H, dt, J 15.5,7.0,4'-H), 5.48 (1 H, dd, J 15.5,7.0,5'- 
H), 7.30-7.36 (5H, m, 5x Ar-H); 8ß(100 MHz) (major isomer) 14.7 (CHCH3), 15.2 
(6'-CH3), 16.0 and 16.1 (2'-CH3 and C-8'), 17.9 (CHCH3), 28.4 (CH(CH3)2), 37.0 (C- 
3'), 37.7 (C-2'), 41.4 (C-6'), 58.4 (C-4), 63.1 (C-5), 70.6 (CH2Ph), 78.4 (C-7'), 126.7 
(C-4'), 127.3 (Ar-C), 127.5 (2 x Ar-C), 128.2 (2 x Ar-C), 135.5 (C-5'), 139.1 (Ar- 
C; pso), 153.7 (C-2), 176.5 (C-1'); mJi (ESI) 
410 (MNa, 100%) and 137 (11); Found 
(ESI): 410.2308 (MNa+), (C23H33O4NNa requires 410.2302). 
(4R)-N-((2S, 4E, 6R, 7S)-2,6-Dimethyl-7-benzyloxyoct-4-enoyl)-4-isopropyl-2- 
oxazolidinone 138 
o\-o o\_o oy 
O 
`Ný 
Grubbs 2nd O 
`N 
Oý 
O 
IN 
Generation Catalyst 
OBn 135 (4R)-116 OBn 138 
139 
To a solution of Grubbs' second generation catalyst (12.2 mg, 0.014 mmol) in dry 
toluene (2 mL) was added a premixed solution of alkene 135 (0.11 g, 0.56 mmol) and 
alkene (4R)-116 (0.06 g, 0.28 mmol) in dry toluene (2.5 mL). The reaction was stirred 
overnight at 50 °C and then solvents were removed in vacuo to give a purple-black 
oil. Purification by flash column chromatography (SiO2,2.5-5% ethyl 
acetate/petroleum ether 40-60 °C) afforded a 6: 1 mixture of alkenes 138 and 139 
(0.04 g, 40%) as a colourless oil. [a] 2 (of 6: 1 mixture) -23.2 (c 1.12, CHC13); 
v(neat)/cm' 2967,2920,2860,1778 (C=O), 1701 (C=O), 1454,1385,1300,1236, 
1203,1094,966,737,698; 8H(400 MHz) (major isomer) 0.86 and 0.91 (each 3H, each 
d, J 7.0, CH(CH3)2), 1.00 (3H, d, J 7.0,6'-CH3), 1.10 (3H, d, J 6.5,8'-H3), 1.13 (3H, 
d, J 7.0,2'-CH3), 2.14 (1 H, app. dt, J 13.5,7.0,3'-HH), 2.26-2.44 (2H, m, CH(CH3)2 
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and 6'-H), 2.49 (1 H, app. dt, J 13.5,7.0,3'-HH), 3.42 (1 H, qd, J 6.5,4.5,7'-H), 3.80 
(1 H, app. sext., J 7.0,2'-H), 4.20 (1 H, dd, J 9.0,3.0,5-HH), 4.27 (1 H, dd, J 9.0,8.5, 
5-HH), 4.47 (1H, m, 4-H), 4.48 (IH, d, J 12.0, CHHPh), 4.56 (IH, d, J 12.0, CHHPh), 
5.39 (1 H, dt, J 15.5,7.0,4'-H), 5.49 (1 H, dd, J 15.5,7.0,5'-H), 7.30-7.36 (5H, m, 5x 
Ar-H); Sß(100 MHz) (major isomer) 14.7 (CHCH3), 14.9 (6'-CH3), 15.9 and 16.0 (2'- 
CH3 and C-8'), 18.0 (CHCH3), 28.4 (CHCH3), 37.0 (C-3'), 37.7 (C-2'), 41.3 (C-6'), 
58.4 (C-4), 63.1 (C-5), 70.6 (CH2Ph), 78.3 (C-7'), 126.6 (C-4'), 127.3 (Ar-C), 127.5 (2 
x Ar-C), 128.2 (2 x Ar-C), 135.5 (C-5'), 139.1 (Ar-C1 0), 153.7 (C-2), 176.5 (C-I'); 
mlz (ESI) 410 (MNa+, 100%); Found (ESI): 410.2312 (MNa+), (C23H33O4NNa 
requires 410.2302). 
(4S)-N-((2R, 4E, 6R, 7S)-2,6-Dimethyl-7-hydroxyoct-4-enoyl)-4-isopropyl-2- 
oxazolidinone 142 
TO 0 
0ýý0_ 
en 
00Tý UUQ Butler pH 70 
0" 
J 
OH 
00 N -) 
OBn 136 137 OH 144 tq 
To benzyl ethers 136 and 137 (0.11 g, 0.28 mmol) in DCM (5.5 mL) and buffer pH 7 
solution (1.0 M solution prepared by dissolving sodium dihydrogen phosphate (0.5999 
g, 5 mmol) and disodium hydrogen phosphate (0.7098 g, 5 mmol) in water (10 mL) 
and adjusting the pH to 7 by addition of the relevant substrate, 1.0 mL) was added 
2,3-dichloro-5,6-dicyanobenzoquinone (0.048 g, 0.21 mmol). The mixture was shaken 
at 250 rpm for 3 days. Ethyl acetate (30 mL) and sodium hydrogen carbonate solution 
(10 mL) were added. The layers were separated and the aqueous phase was extracted 
with ethyl acetate (2 x 30 mL). The combined organic phases were washed with brine 
(10 mL), dried over sodium sulfate, filtered and concentrated in vacuo to give a dark 
red residue. Purification by flash column chromatography (Si02,20% ethyl 
acetate/petroleum 40-60 °C) afforded an inseparable 6: 1 mixture of alcohols 142 and 
143 (0.06 g, 71 %) as a colourless oil. [a] D (of 6: 1 mixture) +61.2 (c 1.77, CHC13); 
vmax(neat)/cm 1 3499 (OH), 2966,2933,2877,1774 (C=O), 1698 (C=O), 1457,1385, 
1300,1234,1200,1092,1054,966,775,691; 6H(400 MHz) (major isomer) 0.87 and 
0.91 (each 3H, each d, J 7.0, CH(CH3)2), 0.95 (3H, d, J 7.0,6'-CH3), 1.13 (3H, d, J 
7.0,2'-CH3), 1.15 (3H, d, J 6.0,8'-H3), 1.97 (1H, br s, OH), 2.05 (1H, m, 6'-H), 2.20 
(IH, dddd, J 14.0,7.0,6.5,1.0,3'-HH), 2.31 (IH, sept. d, J 7.0,4.0, CH(CH3)2), 2.47 
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(IH, dtd, J 14.0,6.5,1.0,3'-HH), 3.44 (IH, app. quint., J 6.5,7'-H), 3.86 (IH, app. 
sext., J 7.0,2'-H), 4.20 (IH, dd, J 9.0,3.0,5-HH), 4.26 (IH, dd, J 9.0,8.5,5-HH), 
4.44 (1 H, ddd, J 8.5,4.0,3.0,4-H), 5.31 (1 H, ddt, J 15.5,8.5,1.0,5'-H), 5.51 (1 H, 
dtd, J 15.5,6.5,0.5,4'-H); Sß(100 MHz) (major isomer) 14.6 (CHCH3), 15.8 and 16.4 
(6'-CH3 and C-8'), 18.0 (CHCH3), 20.0 (2'-CH3), 28.4 (CH(CH3)2), 36.7 (C-3), 37.4 
(C-2'), 45.1 (C-6'), 58.4 (C-4), 63.1 (C-5), 70.8 (C-7'), 128.6 (C-4'), 135.2 (C-5'), 
153.7 (C-2), 176.3 (C-1'); m/z (ESI) 320 (MNa+, 100%), 280 (9) and 107 (11); Found 
(ESI): 320.1829 (MNa+), (C16H27NO4Na requires 320.1832). 
(R)-1-Benzyloxyhex-4-yn-2-ol 16399 
OI 
" OBn CH3CCH, nBuU, BF3. OEt OBn 
162 
OH 
163 
Propyne (--20 mL) was condensed into a 2-necked round bottom flask connected to a 
cold finger at -78 °C. n-Butyllithium (20 mL, 50 mmol) was then added dropwise 
followed by boron trifluoride diethyl etherate (5.1 mL, 36.00 mmol), epoxide 162 (5.0 
mL, 32.80 mmol) and dry THE (20 mL) and the reaction was left at -78 °C for 3 
hours. The reaction was then quenched using saturated aqueous ammonium chloride 
solution (50 mL) and was allowed to warm to room temperature. The solution was 
extracted with ethyl acetate (3 x 100 mL), dried over magnesium sulfate, filtered and 
concentrated in vacuo to yield a yellow oil. Purification by flash column 
chromatography (Si02,10-20% ethyl acetate/petroleum ether 40-60 °C) furnished 
alkyne 163 (4.51 g, 67%) as a colourless oil. Although a known compound, (R)-1- 
benzyloxy-hex-4-yn-2-ol has not been previously characterised. [a] ö +8.16 (c 0.98, 
CH2C12); vmax(neat)/cm 1 3471 (OH), 3364 (C=C), 2920,2869,1074,734 and 698; 
SH(400 MHz) 1.77 (3H, t, J 2.5,6-H3), 2.39 (2H, dq, J 5.5,3.0,3-H2), 2.50 (1 H, d, j 
4.5, OH), 3.48 (IH, dd, J 9.5,7.0,1-HH), 3.59 (IH, dd, J 9.5,4.0,1-HH), 3.92 (IH, 
m, 2-H), 4.56 (2H, s, PhCH2O), 7.27-7.37 (6H, m, 5x Ar-H); Sc(l00 MHz) 3.5 (C-6), 
23.9 (C-3), 69.1 (C-2), 73.1 and 73.4 (C-1 and PhCH2O), 74.7 (C-5), 78.1 (C-4), 
127.7 (2 x Ar-C), 127.8 (Ar-C), 128.4 (2 x Ar-C), 137.9 (Ar-C1 0); mIz (CI) 204 (M+, 
20%), 187 (30), 169 (27), 157 (20), 145 (30), 143 (55), 127 (68) and 91 (100); Found 
(CI): 203.0990 (M+ - H+), (C13H1502 requires 203.1078). 
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(2R, 4E)-Hex-4-en-1,2-diol 16499 
nu OBn Na, Eq. NH3 OH 
163 164 
Homopropargyl alcohol 163 (1.00 g, 4.90 mmol) was dissolved in dry THE (1.5 mL) 
and cooled to -44 °C. Liquid ammonia (; z40 mL) was condensed into the flask using a 
cold finger at -78 °C. Sodium metal (prewashed in hexane, =1.00 g, 43.4 mmol) was 
added in pieces until the colour of the solution remained indigo for >50 minutes. The 
reaction was then quenched with solid ammonium chloride and the mixture was 
allowed to warm to room temperature. When all the ammonia had evaporated off, 
water (40 mL) was added to the mixture and the solution was extracted with diethyl 
ether (3 x 50 mL). The combined organic extracts were washed with water (20 mL) 
and brine (20 mL), dried over magnesium sulfate, filtered and concentrated in vacuo. 
The resulting yellow oil was purified by flash column chromatography (SiO2,10- 
100% ethyl acetate/petroleum ether 40-60 °C) to give diol 164 (0.34 g, 61 %) as a pale 
yellow oil. Although a known compound, diol 164 has not previously been 
characterised. [a]24 -5.5 (c 1.45, CHC13); vm(neat)/cm-1 3337 (OH), 2919,1668 
(C=C), 1062,1028,966 (C=C); SH(400 MHz) 1.69 (3H, qd, J 6.5,1.0,6-H3), 2.10- 
2.32 (4H, m, 3-H2 and 2x OH), 3.48 (1H, m, 2-H), 3.63-3.76 (2H, m, 1-H2), 5.44 
(1H, dtq, J 15.0,7.0,1.5,4-H), 5.59 (IH, dqt, J 15.0,6.5,1.0,5-H); 5ß(100 MHz) 
18.1 (CH3), 36.7 (C-3), 66.3 (C-1), 71.5 (C-2), 126.3 and 129.2 (C-4 and C-5); m/z 
(EI) 117 (MH+, 6%), 98 (32), 91 (36), 86 (82), 84 (100), 67 (34), 61 (50) and 56 (67); 
Found (Cl): 99.0805 (M+ - H20), (C6H1 10 requires 99.0810). 
(2R, 4E)-1-Benzyloxy-hex-4-en-2-ol (R)-151186 
HO 
OH NaH, BnBr, TBAI, DMPU 
HO ýOBn 
164 (R)-151 
Sodium hydride (60% dispersion oil prewashed in hexane, 0.12 g, 4.88 mmol) was 
suspended in dry THE (15 mL) and cooled to 0 °C under an atmosphere of nitrogen. 
Diol 164 (0.34 g, 2.93 mmol) in dry THE (5 mL) was added dropwise and the solution 
was stirred for 30 minutes. 1,3-Dimethyl-3,4,5,6-tetrahydro-2-(1H)-pyrimidinone 
(0.63 g, 0.49 mmol), tetrabutylammonium iodide (0.18 g, 0.49 mmol) and benzyl 
bromide (0.84 g, 4.88 mmol) were added and the solution was stirred at room 
temperature for 23 hours. The reaction was then quenched with saturated aqueous 
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ammonium chloride solution (50 mL). The layers were separated and the aqueous 
layer was extracted with DCM (3 x 100 mL). The combined organic extracts were 
then dried over magnesium sulfate, filtered and concentrated in vacuo. Purification by 
flash column chromatography (Si02,10% ethyl acetate/petroleum ether 40-60 °C) 
yielded homoallylic alcohol (R)-151 (0.06 g, 10%) as a colourless oil. [a] ö 22 +10.8 (c 
1.48, Et20), [a] D lit. 
186 +1.52 (c 4.70, Et20); 8H(400 MHz) 1.67 (3H, qd, J 6.0,1.0,6- 
H3), 2.19 (2H, app. tt, J 7.0,1.0,3-H2), 2.33 (1 H, d, J 3.5, OH), 3.36 (1 H, dd, J 9.5, 
3.5,1-HH), 3.50 (1H, dd, J 9.5,7.5,1-HH), 3.83 (1H, m, 2-H), 4.55 (2H, s, PhCH2O), 
5.42 (1H, dtq, J 15.0,7.0,1.0,4-H), 5.53 (1H, dqt, J 15.0,6.5,1.0,5-H), 7.28-7.38 
(5H, m, 5x Ar-H); Sß(100 MHz) 18.0 (CH3), 36.7 (C-3), 70.1 (C-2), 73.4 and 74.0 
(C-1 and C-2), 126.5 (C-4 or C-5), 127.8 (2 coincident peaks, 2x Ar-C and C-4 or C- 
5), 128.4 (3 x Ar-C), 138.1 (Ar-C; ps0); m/z (EI) 206 (M+, 22%), 151 (41), 107 (52), 91 
(100), 86 (60), 84 (77), 65 (56) and 57 (67). 
(2S, 4E)-1-Benzyloxyhex-4-en-2-o1 (S)-151186 
0OH, HO.,. 0 
. ý\ OBn 
BnOý 
TsOH. H20 
H+ _-ý 
169 (S)-151 
166 
p-Toluenesulfonic acid monohydrate (0.31 g, 1.62 mmol) was added to a solution of 
aldehyde 169 (2.50 g, 16.64 mmol) and alcohol 166 (7.00 g, 33.27 mmol) in dry 
DCM (80 mL) at room temperature. The reaction was stirred for 20 hours and was 
then quenched with triethylamine (1.00 mL) and saturated sodium hydrogen 
carbonate solution (50 mL). After 15 minutes of vigorous stirring the layers were 
separated and the aqueous layer was extracted with DCM (3 x 100 ML). The 
combined extracts were dried over magnesium sulfate, filtered and concentrated in 
vacuo to yield an orange oil. Purification by flash column chromatography (Si02. 
10% ethyl acetate/petroleum ether 40-60 °C) yielded alcohol (S)-151 (2.02 g, 59%) as 
-2.00 (c 4.00, Et2O), NO D lit. +1.52 (c 4.70, Et20) for a pale yellow oil. [a] ö 
22 186 
enantiomer; Spectral data as above. 
2-Benzyloxyethanol 168187 
^/OH 
NaH, BnBr, TBAI, DMPU 
^/OH 
HO Bn0 
167 168 
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Sodium hydride (60% dispersion in oil prewashed in hexane, 2.40 g, 60.00 mmol) 
was suspended in dry THE (70 mL) and cooled to 0 °C under an atmosphere of 
nitrogen. After 10 minutes, ethane-1,2-diol 167 (34.36 g, 553.50 mmol), DMPU (0.75 
mL, 6.20 mmol), TBAI (2.00 g, 5.40 mmol) and benzyl bromide (7.0 mL, 59.00 
mmol) were added slowly and the mixture was stirred at room temperature for 21 
hours. The reaction was quenched with saturated aqueous ammonium chloride 
solution (50 mL). The layers were separated and the aqueous layer was extracted with 
DCM (3 x 50 mL). The combined organic extracts were dried over magnesium 
sulfate, filtered and concentrated in vacuo to yield an orange oil. Purification by flash 
column chromatography (Si02,50% ethyl acetate/petroleum ether 40-60 °C) 
furnished alcohol 168 (7.48 g, 83%) as a yellow oil. SH(400 MHz) 2.38 (1H, br s, 
OH), 3.57 (2H, t, J 4.5,2-H2), 3.73 (2H, m, 1-H2), 4.55 (2H, s, CH2Ph), 7.26-7.38 
(5H, m, 5x Ar-H); 5ß(100 MHz) 61.8 (C-1), 71.4 (C-2), 73.2 (CH2Ph), 127.8 (2 x Ar- 
C), 128.4 (3 x Ar-C), 137.9 (Ar-C; pso). 
2-Benzyloxyethanal 169188 
0 
BnO"ýOH (COCI)2, DMSO, NEt3 BnO'-AH 
168 169 
Dimethylsulfoxide (12.2 mL, 171.26 mmol) was added slowly to a solution of oxalyl 
chloride (7.46 mL, 85.66 mmol) in dry DCM (150 mL) at -78 °C under an atmosphere 
of nitrogen. The mixture was stirred for 20 minutes and then a solution of 2- 
benzyloxyethanol 168 (10.00 g, 65.87 mmol) in dry DCM (30 mL) was added 
dropwise via cannula. The reaction mixture was stirred for 1 hour and then 
triethylamine (freshly distilled over calcium hydride, 10.4 mL, 74.70 mmol) was 
added and the reaction was allowed to warm to room temperature. After a further 20 
minutes, saturated aqueous ammonium chloride solution (200 mL) was added and the 
layers were separated. The aqueous phase was extracted with DCM (3 x 100 mL) and 
the combined organic extracts were washed with hydrochloric acid (1.0 M, 50 mL), 
dried over magnesium sulfate, filtered and concentrated in vacuo at 0 °C to yield a 
yellow oil. Purification by flash column chromatography (Si02i 10% ethyl 
acetate/petroleum ether 40-60 °C) gave aldehyde 169 (4.31 g, 44%) as a colourless 
oil. SH(400 MHz) 4.10 (2H, s, 2-H2), 4.62 (2H, CH2Ph), 7.27-7.43 (5H, m, 5x Ar-H), 
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9.72 (1H, s, CHO); 8ß(100 MHz) 73.7 (COCH2), 75.3 (C-2), 128.0 (Ar-C), 128.2 (2 x 
Ar-C), 128.6 (2 x Ar-C), 136.8 (Ar-C1 0), 200.5 (C-1). 
(2S, 5R)-Menthone 280189 
(a) via Dess-Martin Oxidation 
OH O 
DMP 
165 280 
A solution of (1R, 2S, 5R)-menthol 165 (1.08 g, 6.93 mmol) in dry DCM (20 mL) was 
added dropwise to Dess-Martin periodinane (15% w/w in DCM, 20.0 mL, 9.60 
mmol, ) in dry DCM (15 mL) at room temperature under an atmosphere of nitrogen. 
The reaction mixture was stirred for 4 hours and was then added to sodium hydroxide 
solution (1.0 M, 50 mL). The aqueous layer was extracted with diethyl ether (3 x 50 
mL) and then the combined extracts were washed with water (50 mL), dried over 
magnesium sulfate, filtered and concentrated in vacuo to yield (2S, 5R)-menthone 280 
(1.02 g, 97%) as a colourless oil. This was used without further purification. [a] D- 
25.4 (neat), lit. ' 89 [a] D -25.3 (neat); 6H(400 MHz) 0.86 and 0.92 (each 3H, each d, J 
7.0,1'-(CH3)2), 1.01 (3H, d, J 6.5,5-CH3), 1.15-1.45 (2H, m, 3-HH and 4-HH), 1.75- 
2.20 (6H, m, 1'-H, 2-H, 3-HH, 4-HH, 5-H, 6-HH), 2.36 (1H, ddd, J 12.5,3.5,2.5,6- 
HH); Sc(100 MHz) 18.7 and 21.2 (2 x 1'-CH3), 22.3 (5-CH3), 25.9 (C-Vor C-5), 27.9 
and 33.9 (C-3 and C-4), 35.9 (C-For C-5), 50.9 (C-6), 55.9 (C-2), 212.4 (C-1). 
(b) via sodium hypochlorite oxidation 
O OH 
NaCIO, CH3000H 
165 280 
Aqueous sodium hypochlorite (138 mL, 179.6 mmol, = 1.3 M) was added slowly to a 
solution of OR, 2S, 5R)-menthol 165 (20.00 g, 127.80 mmol) in acetic acid (96 mL) at 
0 °C. The reaction mixture was stirred at room temperature for 2 hours and was then 
quenched by addition of sodium hydrogen sulfite solution until the yellow solution 
had become white in colour. Brine (60 mL) and diethyl ether (60 mL) were added and 
the layers were separated. The aqueous layer was extracted with diethyl ether (3 x 200 
mL) and the combined organic layers were then washed with saturated aqueous 
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sodium hydrogen carbonate solution (50 mL), dried over magnesium sulfate, filtered 
and concentrated in vacuo to gave (2S, 5R)-menthone 280 (38.84 g, 98%) as a 
colourless oil. This was used without further purification. Spectral data as above. 
(1S, 2S, 5R, 1'R)-1-(1-Methylallyl)menthol 166102 
CI fý ' OH 
Mgr -ýCI *I 11 
280 166 
A solution of crotyl chloride (5.94 mL, 56.80 mmol) in dry THE (40 mL) was added 
slowly to freshly ground magnesium turnings (1.38 g, 56.80 mmol) at room 
temperature under an atmosphere of nitrogen. When addition was complete the 
reaction was maintained at reflux for 25 minutes. The solution was then cooled to 0 
°C and (2S, 5R)-menthone 280 (5.16 g, 33.4 mmol) in dry THE (12 mL) was added 
dropwise and the mixture was stirred for 2 hours at 0 °C. The reaction was quenched 
with saturated aqueous ammonium chloride solution (200 mL). Water (50 mL) was 
added and the biphasic solution was filtered prior to extraction with ethyl acetate (3 x 
100 mL). The combined extracts were dried over magnesium sulfate, filtered and 
concentrated in vacuo to yield pale yellow oil. Purification by flash column 
chromatography (Si02,1% ethyl acetate/petroleum ether 40-60 °C) gave alcohol 166 
(3.57 g, 51%) as a colourless oil. [a] D +26.9 (c 1.02, CHC13), lit-102 [a] D +27.4 (c 
1.00, CHC13); SH(400 MHz) 0.79 (3H, d, J 6.5,5-CH3), 0.68-1.09 (2H, m), 0.84 (3H, 
d, J 2.5,1 "-CH3), 0.85 (3H, d, J 2.5,1 "-CH3), 0.89 (3H, d, J 7.5,1'-CH3), 1.18 (1 H, 
m), 1.19-1.31 (2H, m), 1.40-1.47 (2H, m), 1.60-1.72 (2H, m), 2.09 (1H, app. quint. d, i 
7.0,1.5,1 "-H), 2.52 (IH, app. quint., J 7.5,1'-H), 4.94-5.09 (2H, m, 3'-H2), 5.81 (IH, 
ddd, J 18.0,10.5,8.5,2'-H); Sß(100 MHz) 14.7 and 18.0 (1'-CH3 and 5-CH3), 20.6 
(C-3), 22.6 and 23.4 (2 x1 "-CH3)9 25.0 (C-1 "), 27.6 (C-5), 35.3 (C-4), 41.5 (C-6), 
45.2 (C-1'), 46.0 (C-2), 76.2 (C-1), 116.6 (C-3'), 140.8 (C-2'). 
Ethyl (2E, 4R, 5S)-5-Benzyloxy-4-methylhex-2-enoate 171 
(i) DIBAL-H 
(ii) nBuLi, (EtO)2P(O)CH2CO2Et / OR 
OBn 0 
O; 1 0 134 171 
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Benzyl ether 134 (2.00 g, 4.92 mmol) was dissolved in dry DCM (40 mL) under an 
atmosphere of nitrogen and cooled to -78 °C. Diisobutylaluminium hydride (1.0 M in 
hexanes, 4.9 mL, 4.92 mmol) was added dropwise in 3 portions at 15 minute 
intervals. After 1.5 hours a further addition of diisobutylaluminium hydride (2.5 mL, 
2.46 mmol) was required. After 2.5 hours the reaction was quenched with saturated 
aqueous potassium sodium L-tartrate tetrahydrate solution (20 mL). The reaction was 
warmed to room temperature and stirred vigorously overnight to break up the 
aluminium complex. The mixture was then extracted with DCM (3 x 50 mL) and the 
combined organic layers were washed with water (5 mL), dried over magnesium 
sulfate, filtered and concentrated in vacuo at 0 °C. The resulting oil was triturated 
with petroleum ether 40-60 °C and filtered to remove the precipitated auxiliary. The 
filtrate was concentrated in vacuo to yield a colourless oil. This was then dissolved in 
dry THE (6 mL) and added dropwise to a solution of triethyl phosphonoacetate (2.2 
mL, 10.82 mmol) and n-butyllithium (2.5 M in hexanes, 4.2 mL, 10.82 mmol) in dry 
THE (60 mL) which had been stirred for 10 minutes at 0 °C under an atmosphere of 
nitrogen. The resulting solution was stirred at room temperature for 20 hours and was 
then quenched with water (50 mL). The solution was extracted with ethyl acetate (3 x 
150 mL), dried over magnesium sulfate, filtered and concentrated in vacuo. 
Purification by flash column chromatography (Si02,5% ethyl acetate/petroleum ether 
40-60 °C) gave ester 171 (1.70 g, 66%) as a colourless oil. [cx] D 20 +22.7 (c 2.29, 
CHC13); vmax(neat)/cm 1 2976,2932,2359,2333,1715 (C=O), 1652 (C=C), 1454, 
1368,1183,1094,1038,984,734,697; 8H(400 MHz) 1.08 (3H, d, J 7.0,4-CH3), 1.15 
(3H, d, J 6.5,6-H3), 1.29 (3H, t, J 7.0, OCH2CH3), 2.55 (1H, m, 4-H), 3.50 (1H, dq, J 
6.5,5.5,5-H), 4.19 (2H, q, J 7.0, OCH2CH3), 4.46 (1H, d, J 11.5, CHHPh), 4.58 (1H, 
d, J 11.5, CHHPh), 5.83 (1H, dd, J 16.0,1.0,2-H), 6.98 (1H, dd, J 16.0,7.5,3-H), 
7.20-7.38 (5H, in, 5x Ar-H); Sß(100 MHz) 14.3 (OCH2CH3), 14.6 (4-CH3), 16.5 (C- 
6), 41.8 (C-4), 60.2 (OCH2CH3), 70.7 (CH2Ph), 77.5 (C-5), 121.3 (C-2), 127.5 (Ar-C), 
127.6 (2 x Ar-C), 128.3 (2 x Ar-C), 138.6 (Ar-C1 0), 151.1 (C-3), 166.7 (C-1); m/z 
(CI) 263 (MH+, 19%), 235 (24), 221 (20), 181 (96), 155 (38), 127 (21), 91 (100) and 
84 (25); Found (Cl): 263.1639 (MH+), (C16H2303 requires 263.1647). 
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(2E, 4R, 5S)-5-Benzyloxy-4-methylhex-2-eno1172 
/ OEt DIBAIrH OH 
OBn 
171 
0 OBn 
172 
Ethyl ester 171 (1.07 g, 4.08 mmol) was dissolved in dry DCM (55 mL) under an 
atmosphere of nitrogen at -78 °C. Diisobutylaluminium hydride (1.0 M in hexanes, 9.0 
mL, 9.0 mmol) was added dropwise and the solution was stirred at -78 °C for 2 hours. 
The reaction was then quenched with saturated aqueous potassium sodium L-tartrate 
tetrahydrate solution (40 mL) and was stirred vigorously at room temperature for 3 
hours to break up the aluminium complex. The organic layer was removed and the 
aqueous layer was extracted with ethyl acetate (3 x 50 mL), dried over magnesium 
sulfate, filtered and concentrated in vacuo to yield alcohol 172 (0.90 g, 100%) as a 
pale yellow oil. This was used without further purification. [a] ö +22.4 (c 1.43, 
CHC13); vma, (neat)/cm 1 3360 (OH), 2971,2871,1453,1374,1076,972,734,697; 
8H(400 MHz) 1.02 (3H, d, J 7.0,4-CH3), 1.11 (3H, d, J 6.0,6-H3), 2.19 (1H, br s, 
OH), 2.39 (1H, m, 4-H), 3.42 (1H, app. quint., J 6.0,5-H), 4.03 (2H, d, J 4.5,1-H2), 
4.44 (IH, d, J 11.5, CHHPh), 4.56 (IH, d, J 11.5, CHHPh), 5.56-5.68 (2H, m, 2-H 
and 3-H), 7.20-7.37 (5H, in, 5x Ar-H); Sc(100 MHz) 15.3 (4-CH3), 16.2 (C-6), 41.2 
(C-4), 63.5 (C-1), 70.6 (CH2Ph), 78.2 (C-5), 127.3 (Ar-C), 127.5 (2 x Ar-C), 128.2 (2 
x Ar-C), 129.2 and 134.7 (C-2 and C-3), 138.9 (Ar-Cip,, ); mhz (ESI) 243 (MNa+, 
100%) and 203 (9); Found (ESI): 243.1361 (MNa+), (C14H2OO2Na requires 243.1356). 
(2S, 3R, 4S, 6S)-2-((1'E, 3'R, 4'S)-4'-(Benzyloxy)-3'-methylpent-1'-enyl)-3-methyl- 
1,8-dioxa-bicyclo[1.2.3]octane 174 and (2S, 3R, 4S, 6S)-6-Benzyloxymethyl)-2-[(1E, 
3R, 4S)-4. (benzyloxy)-3-methylpent-l-enyl]-4-hydroxy-3-methyltetrahydropyran 
175 
(i) DMP 
(") IFA, - 
HO., 5*Er 
/OH 
OBn 
crY ýý. Y OfrY: 
O 
OBn 
ÖBn ý'u 
,, I 
Y OBn (S}151 - OBn 
172 174 4 (ii) K2C03, McOH OH 
175 
A solution of alcohol 172 (0.69 g, 3.13 mmol) in dry DCM (10 mL) was added 
dropwise to Dess-Martin periodinane (15% w/w in DCM, 9.0 mL, 4.34 mmol) in dry 
DCM (7.5 mL) at room temperature under an atmosphere of nitrogen. The reaction 
mixture was stirred for 1 hour and was then added to sodium hydroxide (1.0 M, 25 
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mL). Water (20 mL) was added to dissolve the resulting precipitate and the solution 
was then extracted with diethyl ether (3 x 50 mL). The extracts were washed with 
water (25 mL), dried over magnesium sulfate, filtered and concentrated in vacuo to 
yield yellow oil. The aldehyde produced (0.66 g, 3.02 mmol) was added to a solution 
of alcohol (S)-151 (0.94 g, 6.26 mmol) in dry DCM (20 mL) under an atmosphere of 
nitrogen. Trifluoroacetic acid (16.8 mL, 219.10 mmol) was added slowly and the 
mixture was stirred for 4 hours. The reaction was quenched with saturated aqueous 
sodium hydrogen carbonate solution (50 mL) and the pH was adjusted to above 7 by 
addition of triethylamine. The layers were separated and the aqueous phase was 
extracted with DCM (3 x 50 mL). The combined organic extracts were dried over 
magnesium sulfate, filtered and concentrated in vacuo to yield a yellow oil. Potassium 
carbonate (4.33 g, 31.30 mmol) and methanol (50 mL) were added and the mixture 
was stirred for 1 hour. Volatiles were removed in vacuo and then water (100 mL) and 
DCM (100 mL) were added. The layers were separated and the aqueous phase was 
extracted with DCM (3 x 100 mL). The combined extracts were dried over 
magnesium sulfate, filtered and concentrated in vacuo to give an orange/brown oil. 
Purification by flash column chromatography (Si02,2.5-5% ethyl acetate/petroleum 
ether 40-60 °C) furnished the bicyclic ether 174 (0.30 g, 31 %) as a colourless oil and 
tetrahydropyran 175 (0.074 g, 6%) as a yellow oil. Bicyclic ether 174: [a] ö 21 +43.5 (c 
4.05, CHC13); v,,, (neat)/cm 1 2966,2933,2874,1454,1373,1204,1092,1062,1002, 
972,870,734,697; SH(400 MHz) 0.84 (3H, d, J 7.0,3-CH3), 1.05 (3H, d, J 7.0,3'- 
CH3), 1.12 (3H, d, J 6.0,5'-H3), 1.38 (1H, dq, J 9.5,7.0,3-H), 1.82 (lH, ddd, J 11.5, 
6.5,3.0,5-HH), 1.90 (1 H, d, J 11.5,5-HH), 2.40, (IH, m, 3'-H), 3.43 (IH, m, 4'-H), 
3.80 (2H, m, 7-HH and 2-H), 4.08 (IH, d, J 10.0,7-HH), 4.18 (IH, d, J 6.5,4-H), 
4.46 (1 H, d, J 11.5, OCH2Ph), 4.51 (IH, m, 6-H), 4.57 (IH, d, J 11.5, OCH2Ph), 5.39 
(1 H, dd, J 15.5,8.0,1'-H), 5.71 (1 H, dd, J 15.5,8.0,2'-H), 7.13-7.51 (5H, m, 5x Ar- 
H); Sc(100 MHz) 15.0 (3-CH3), 15.5 and 16.4 (3'-CH3 and C-5'), 38.2 (C-5), 41.5 and 
41.7 (C-3 and C-3'), 70.6 and 71.1 (C-1" and OCH2Ph), 75.1 (C-6), 78.3 and 78.6 and 
79.0 (C-2, C-4 and C-4'), 127.3 (Ar-C), 127.5 (2 x Ar-C), 128.2 (2 x Ar-C), 129.4 (C- 
1'), 137.3 (C-2'), 139.0 (Ar-C; PS0); filz (ESI) 339 (MNa+, 100%), 334 (35), 317 (3), 
271 (33), 266 (3), 215 (3) and 113 (5); Found (ES»: 339.1934 (MNa+), (C20H28O3Na 
requires 339.1931). Tetrahydropyran 175: [a] ö 
22 +12.17 (c 4.93, CHC13); 
vmax(neat)/cm 13417 (OH), 2965,2928,2869,1496,1453,1095,1060,908,734,697; 
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SH(400 MHz) 0.90 (3H, d, J 6.5,3-CH3), 1.04 (3H, d, J 7.0,3'-CH3), 1.12 (3H, d, J 
6.5,5'-H3)9 1.25 (IH, m, 3-H), 1.38 (IH, app. q, J 12.5,5-HH), 1.97 (IH, ddd, J 12.5, 
5.0,2.0,5-HH), 2.48 (1 H, m, 3'-H), 3.25-3.75 (6H, m, 2-H, 4-H, 4'-H, 6-H and 7-H2), 
4.42-4.60 (4H, m, 2x OCH2Ph), 5.43 (1 H, ddd, J 15.5,8.0,1.0,1'-H), 5.70 (1 H, dd, J 
15.5,7.0,2'-H), 7.23-7.36 (10H, m, 10 x Ar-H); 8ß(100 MHz) 13.3 (3'-CH3), 14.5 (3- 
CH3), 16.0 (C-5'), 37.7 (C-5), 40.8 (C-3'), 43.7 (C-3), 70.5 (OCH2Ph), 73.0 and 73.3 
(OCH2Ph and C-7), 73.3 and 74.5 and 78.0 and 83.1 (C-2, C-4, C-4' and C-6), 127.3 
(Ar-C), 127.5 (2 x Ar-C), 127.6 (Ar-C), 127.7 (2 x Ar-C), 128.2 (2 x Ar-C), 128.3 (2 
x Ar-C), 128.8 (C-1'), 136.8 (C-2'), 138.2 (Ar-C; ps0), 139.0 (Ar-C1 0); m/z (ESI) 447 
(MNa+, 100%), 431 (53), 395 (14), 379 (46), 363 (19) and 149 (10); Found (ESI): 
447.2495 (MNa+), (C27H36O4Na requires 447.2506). 
(2S, 3R, 4S, 6S)-2-vinyl)-3-methyl-1,8-dioxa-bicyclo[1.2.3]octane 177, (2S, 3R, 4S, 6S) 
-6-((Benzyloxy)methyl)-4-hydroxy-3-methyl-2-vinyl-tetrahydropyran 178 and 
(2S, 3R, 4R, 6S)-6-((Benzyloxy)methyl)-4-hydroxy-3-methyl-2-vinyl 
tetrahydropyran 179 
0 "--08n ýOBn 
+ 
0-1ýtl- ý-' (ii) KZC03, MeOH + 
ýl\/J 
+ 
176 
(S)-ßs1 aH OH 177 178 179 
Alcohol (S)-151 (0.50 g, 2.43 mmol) and propenal 176 (0.66 mL, 9.70 mmol) were 
dissolved in dry DCM (25 mL) under an atmosphere of nitrogen. Trifluoroacetic acid 
(7.4 mL, 97.00 mmol) was added slowly and the mixture was stirred for 4 hours. The 
reaction was quenched with saturated aqueous sodium hydrogen carbonate solution 
(60 mL) and the pH was adjusted to above 7 by addition of triethylamine. The layers 
were separated and the aqueous phase was extracted with DCM (3 x 50 mL). The 
combined organic extracts were dried over magnesium sulfate, filtered and 
concentrated in vacuo to yield yellow oil. Potassium carbonate (2.24 g, 16.17 mmol) 
and methanol (25 mL) were added and the mixture was stirred for 1 hour. Volatiles 
were removed in vacuo and then water (50 mL) and DCM (50 mL) were added. The 
layers were separated and the aqueous phase was extracted with DCM (3 x 50 mL). 
The combined extracts were dried over magnesium sulfate, filtered and concentrated 
in vacuo to give a yellow oil. Purification by flash column chromatography (Si02,1- 
10% ethyl acetate/petroleum ether 40-60 °C) gave bicyclic ether 177 (0.050 g, 14%) 
as a colourless oil, tetrahydropyran 178 (0.029 g, 5%) as a yellow oil and a second 
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tetrahydropyran 179 (0.009 g, 2%) also as a yellow oil. Bicyclic ether 177: [a] ö 
+49.0 (c 2.49, CHC13); vmax(neat)/cml 2965,2935,2877,1740,1455,1376,1222, 
1205,1133,1062,870,699; SH(400 MHz) 0.89 (311, d, J 7.0,3-CH3), 1.42 (1H, dq, J 
9.5,7.0,3-H), 1.83 (IH, ddd, J 11.5,6.0,3.0,5-HE), 1.92 (1H, dt, J 11.5,1.5,5-HH), 
3.81-3.86 (2H, m, 2-H and 7-HH), 4.10 (IH, dd, J 10.0,1.0,7-HH), 4.21 (IH, d, J 
6.0,4-H), 4.54 (1 H, app. dt, J, 3.0,1.5,6-H), 5.19 (1 H, ddd, J 10.5,1.5,1.0,2'-HH), 
5.28 (1 H, ddd, J 17.0,1.5,1.0,2'-HH), 5.78 (1 H, ddd, J 17.0,10.5,7.5,1'-H); Sß(100 
MHz) 14.8 (3-CH3), 38.1 (C-5), 41.2 (C-3), 71.1 (C-7), 75.1 (C-6), 78.6 and 79.0 (C-2 
and C-4), 117.5 (C-2'), 137.3 (C-1'); m/z (EI) 154 (Mt, 4%), 139 (3), 123 (4), 110 
(10), 85 (62), 83 (100), 69 (37) and 55 (24); Mass ion could not be detected at high 
resolution and so an accurate mass has not been included. Tetrahydropyran 178: 
[a] D +2.4 (c 1.69, CHC13); Vmax(neat)/cm' 3403 (OH), 2859,1721,1454,1365, 
1101,1046,735,697; 8H(400 MHz) 0.95 (3H, d, J 7.0, CH3), 1.29 (1H, m, 3-H), 1.41 
(IH, app. q, J 12.5,5-HH), 1.68 (IH, br s, OH), 2.01 (IH, ddd, J 12.5,5.0,2.0,5- 
HH), 3.39 (IH, m, 2-H), 3.45 (IH, m, 4-H), 3.47 (IH, dd, J 10.0,5.0,7-HH), 3.57 
(1 H, dd, J 10.0,5.5,7-HH), 3.66 (1 H, m, 6-H), 4.57 (2H, d, J 2.0, CH2Ph), 5.22 (1 H, 
dd, J 10.5,2.0,2'-HH), 5.27 (1 H, dt, J 17.0,1.0,2'-HH), 5.81 (1 H, ddd, J 17.0,10.5, 
7.5,1'-H), 7.27-7.37 (5H, m, 5x Ar-H); 6c(100 MHz) 13.1 (3-CH3), 37.8 (C-5), 43.5 
(C-3), 73.0 (C-7 or CH2Ph), 73.4 (two coincident signals, C-2 and either C-7 or 
CH2Ph), 74.7 (C-6), 83.1 (C-4), 117.9 (C-2'), 127.6 (Ar-C), 127.7 (2 x Ar-C), 128.4 
(2 x Ar-C), 136.8 (C-1'), 138.3 (Ar-C; p50); nilz (CI) 263 (MH+, 18%), 245 (21), 189 
(18), 171 (21), 159 (15), 99 (17), 91 (100) and 87 (18); Found (Cl): 263.1641 (MH+), 
(C16H2303 requires 263.1647). Tetrahydropyran 179: [a] ö -6.5 (c 0.62, CHC13); 
v, (neat)/cm1 3408 (OH), 2927,1722,1454,1099,1040,989,925,736,697; SH(400 
MHz) 0.96 (3H, d, J 6.5,3-CH3), 1.41 (1 H, m, 3-H), 1.70 (1 H, ddd, J 13.0,10.0,6.0, 
5-HH); 2.01 (1 H, ddd, J 13.0,4.5,3.0,5-HH), 3.55 (1 H, dd, J 10.0,5.5,7-HH), 3.62 
(1 H, m, 4-H), 3.66 (1 H, dd, J 10.0,6.5,7-HH), 3.75 (1 H, app. t, J 8.0,2-H), 4.26 (1 H, 
m, 6-H), 4.58 (2H, s, CH2Ph), 5.19-5.28 (2H, m, 2'-H2), 5.83 (1H, ddd, J 17.0,10.5, 
7.0,1'-H), 7.27-7.38 (5H, m, 5x Ar-H); Sß(100 MHz) 13.9 (3-CH3), 34.6 (C-5), 42.9 
(C-3), 70.0 (C-4 or C-6), 70.6 (C-7), 70.9 (C-4 or C-6), 73.2 (CH2Ph), 77.8 (C-2), 
117.5 (C-2'), 127.6 (2 x Ar-C), 127.7 (Ar-C), 128.4 (2 x Ar-C), 137.5 (C-1'), 138.2 
(Ar-C; Ps0); m/z (CI) 263 (MH+, 19%), 261 (20), 245 (30), 209 (22), 203 (53), 197 (27), 
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91 (100), 87 (29), 85 (65) and 83 (94); Found (ESI): 263.1639 (MH+), (C16H23O3 
requires 263.1647). 
(2S, 3R, 4S, 6S)-2-Crotyl)-3-methyl-1,8-dioxa-bicyclo[1.2.3]octane 181 and 
(2S, 3R, 4S, 6S)-6-((Benzyloxy)methyl)-2-crotyl-4-hydroxy-3-methyl- 
tetrahydropyran 18299 
HO.,.. (i) TFA OO OBn ýOBn 
+ 
Oýý (ii) K2CO3, MeOH + 
180 
(b}1S1 181 äH 
1 
Alcohol (S)-151 (0.50 g, 2.43 mmol) and but-2-enal 180 (0.80 mL, 9.70 mmol) were 
dissolved in dry DCM (25 mL) under an atmosphere of nitrogen. Trifluoroacetic acid 
(7.4 mL, 97.00 mmol) was added slowly and the mixture was stirred for 2.5 hours. 
The reaction was quenched with saturated aqueous sodium hydrogen carbonate 
solution (50 mL) and the pH was adjusted to above 7 with triethylamine. The layers 
were separated and the aqueous phase was extracted with DCM (3 x 50 mL). The 
combined organic extracts were dried over magnesium sulfate, filtered and 
concentrated in vacuo to yield yellow oil. Potassium carbonate (2.24 g, 16.17 mmol) 
and methanol (25 mL) were added and the mixture was stirred for 1 hour. Volatiles 
were removed in vacuo and then water (50 mL) and DCM (50 mL) were added. The 
layers were separated and the aqueous phase was extracted with DCM (3 x 50 mL). 
The combined extracts were dried over magnesium sulfate, filtered and concentrated 
in vacuo to give a yellow oil. Purification by flash column chromatography (SiO2, 
2.5-30% ethyl acetate/petroleum ether 40-60 °C) gave bicyclic ether 181 (0.050 g, 
59%) as a colourless oil and tetrahydropyran 182 (0.029 g, 7%) as a yellow oil. 
Although a known compound, tetrahydropyran 182 has not been previously 
characterised 
99 Bicyclic ether 181: [a] D 
24 +43.8 (c 1.30, CHC13); vmax(neat)/cm I 
2964,2936,2876,1677,1454,1376,1290,1221,1206,1135,1061,1001,964,869, 
763; 5H(400 MHz) 0.84 (3H, d, J 6.5,3-CH3), 1.39 (1H, dq, J 9.5,6.5,3-H), 1.70 (3H, 
dd, J 6.5,1.5,3'-H3), 1.80 (1H, ddd, J 11.5,6.5,3.0,5-HH), 1.89 (1H, dt, J 11.5,1.0, 
5-HH), 3.76 (IH, m, 2-H), 3.80 (1H, dd, J 10.0,3.0,7-HH), 4.07 (IH, dd, J 10.0,1.0, 
7-HH), 4.18 (1 H, d, J 6.5,4-H), 4.50 (1 H, m, 6-H), 5.40 (1 H, ddq, J 15.0,8.0,1.5,1'- 
H), 5.73 (IH, dqd, J 15.0,6.5,1.0,2'-H); 8ß(100 MHz) 14.9 (3-CH3), 17.7 (C-3'), 
38.1 (C-5), 41.4 (C-3), 71.1 (C-7), 75.0 (C-6), 78.3 (C-2), 78.9 (C-4), 129.8 (C-2'), 
130.4 (C-1'); nilz (ESI) 168 (M+, 23%), 153 (22), 149 (18), 91 (32), 85 (62), 83 (100), 
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69 (11) and 55 (10); Found (EI): 168.1146 (M+), (C1oH1602 requires 168.1150). 
Tetrahydropyran 182: [a] D +2.6 (c 2.30, CHC13); vmax(neat)/cm' 3401 (OH), 2916, 
2857,1453,1365,1037,965,933,733,697; SH(400 MHz) 0.93 (3H, d, J 6.5,3-CI13), 
1.29 (1H, app. tq, J 6.5,3.0,3-H), 1.40 (1H, app. q, J 12.0,5-HH), 1.72 (3H, dd, J 
6.5,1.5,3'-H3), 1.77 (1 H, br s, OH), 2.00 (1 H, ddd, J 12.0,4.5,2.0,5-HH), 3.34-3.43 
(2H, m, 2-H and 4-H), 3.47 (1 H, dd, J 10.0,4.5,7-HH), 3.57 (1 H, dd, J 10.0,5.5,7- 
HH), 3.64 (IH, m, 6-H), 4.55 (1H, d, J 12.0, CHHPh), 4.59 (IH, d, J 12.0, CHHPh), 
5.44 (1 H, ddq, J 15.0,8.0,1.5,1'-H), 5.72 (1 H, dqd, J 15.5,6.5,1.0,2'-H), 7.27-7.36 
(5H, m, 5x Ar-H); 8ß(100 MHz) 13.2 (3-CH3), 17.8 (C-3'), 37.7 (C-5), 43.6 (C-3), 
72.9 and 73.3 (C-7 and CH2Ph), 73.4 (C-2), 74.4 (C-6), 82.9 (C-4), 127.5 (C-2'), 
127.7 (2 x Ar-C), 128.3 (2 x Ar-C), 129.9 (Ar-C), 130.1 (C-1'), 138.2 (Ar-C; PS0); rn/z 
(ESI) 299 (MNa+, 100%); Found (ESI): 299.1608 (MNa+), (C17H24O3Na requires 
299.1618). 
(2S, 3R, 4S, 6S)-4-Acetoxy-6-((benzyloxy)methyl)-3-methyl-2-vinyl 
tetrahydropyran 183 
HOB,.. ^ BnOýýýý' OBn 
+ 
O, ýý BF3. OEt2, AcOH, TMSAc 
176 
(S)-151 OAc 
183 
A stirred solution of homoallylic alcohol (S)-151 (0.30 g, 1.45 mmol), propenal 176 
(0.12 mL, 1.74 mmol), acetic acid (0.42 mL, 7.25 mmol) and trimethylsilyl acetate 
(0.87 mL, 5.80 mmol) in dry hexane (12 mL) was treated dropwise with boron 
trifluoride diethyletherate (0.37 mL, 2.90 mmol) under an atmosphere of nitrogen. A 
brown precipitate formed. The solution was stirred vigorously for 23 hours and was 
then quenched with saturated aqueous sodium hydrogen carbonate solution (25 mL). 
The mixture was extracted with DCM (3 x 50 mL), washed with water (10 mL), dried 
over magnesium sulfate, filtered and concentrated in vacuo to yield a pale yellow oil. 
purification by flash column chromatography (Si02,10% ethyl acetate/petroleum 
ether 40-60 °C) gave tetrahydropyran 183 (0.60 g, 14%) as a pale yellow oil. [a] ö 23 
+19.11 (c 3.14, CHC13); vnax(neat)/cm'' 2968,2932,2860,1730 (C=O), 1454,1363, 
1236,1104,1027,736 and 698; SH(400 MHz) 0.84 (3H, d, J 6.5,3-CH3), 1.46 (111, 
app. q. J 12.0,5-HH), 1.55 (1H, in. 3-H), 2.06 (4H, m, 5-HH and COCH3), 3.40-3.63 
(3H, m, 2-H and 7-H2), 3.69 (1H, in, 6-H), 4.51-4.60 (2H, m, OCH2Ph), 4.67 (1H, 
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app. td, J 11.0,4.5,4-H), 5.24 (1 H, dm, J 10.5,2'-HH), 5.29 (1 H, dm, J 17.0,2'-HH), 
5.80 (IH, ddd, J 17.0,10.5,7.5,1'-H), 7.27-7.37 (5H, m, 5x Ar-H); Sß(100 MHz) 
13.1 (3-CH3), 21.2 (CH3CO), 34.1 (C-5), 40.3 (C-3), 72.7 and 73.4 (C-7 and CH2Ph), 
74.4 (C-4), 75.2 (C-6), 83.1 (C-2), 118.3 (C-2'), 127.6 (Ar-C), 127.7 (2 x Ar-C), 
128.4 (2 x Ar-C), 136.4 (Ar-C1 0), 138.2 (C-1'), 170.7 (CO); m/z (CI) 305 (MH+, 
16%), 295 (68), 245 (46), 189 (68), 181 (56), 171 (88), 159 (60) and 91 (100); Found 
(CI): 305.1747 (MH+), (C18HuO4Na requires 305.1753). 
2-(tert-Butyldiphenylsilyloxy)ethano1185190 
HO^. 
OH nBuU, TBDPSCI 
TBDPSO^'OH 
167 185 
n-Butyllithium (2.5 M in hexanes, 18.50 mL, 46.25 mmol) was added dropwise to a 
solution of ethane-1,2-dio1167 (2.56 mL, 46.00 mmol) in dry THE (95 mL) at -78 °C 
under an atmosphere of nitrogen. After 15 minutes, tert-butylchlorodiphenylsilane 
(11.96 mL, 46.00 mmol) was added and the mixture was stirred at -78 °C for 15 
minutes and then allowed to warm to room temperature. The solution was refluxed for 
24 hours and then the solvent was removed in vacuo to give a pale yellow oil 
interspersed with white solid. Purification by flash column chromatography (Si02,5- 
50% ethyl acetate/petroleum ether 40-60 °C) furnished alcohol 185 (12.01 g, 87%) as 
a pale yellow oil. 8H(400 MHz) 1.07 (9H, s, SiC(CH3)3), 2.16 (1 H, t, J 6.0, OH), 3.68 
and 3.76 (each 2H, each in, 1-H2 and 2-H2), 7.36-7.46 (6H, m, 6x Ar-H), 7.65-7.69 
(4H, m, 4x Ar-H); 8ß(100 MHz) 19.2 (SiC(CH3)3), 26.9 (SiC(CH3)3), 63.7 and 65.0 
(C-1 and C-2), 127.8 (4 x Ar-C), 129.8 (2 x Ar-C), 133.3 (2 x Ar-C1 0), 135.5 (4 x 
Ar-C). 
2-(tert-Butyldiphenylsilyloxy)ethana1186190 
0 
TBDPSO^, 
OH (COCI)2, DMSO, NEt3 TBDPSO"-'O'oý'H 
185 186 
Dimethylsulfoxide (3.7 mL, 51.90 mmol) was added slowly to a solution of oxalyl 
chloride (2.3 mL, 25.96 mmol) in dry DCM (40 mL) at -78 °C under an atmosphere 
of nitrogen. The mixture was stirred for 10 minutes and then a solution of alcohol 185 
(6.00 g, 19.96 mmol) in dry DCM (16 mL) was added dropwise. The reaction mixture 
was stirred for 20 minutes and then triethylamine (freshly distilled over calcium 
hydride, 16.6 mL, 119.76 mmol) was added. After a further 20 minutes the reaction 
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was allowed to warm to room temperature and stirred for 1 hour. Saturated aqueous 
ammonium chloride solution (80 mL) was added and the layers were separated. The 
aqueous phase was extracted with DCM (3 x 100 mL) and the combined organic 
extracts were washed with hydrochloric acid (0.5 M, 100 mL) and brine (50 mL), 
dried over magnesium sulfate, filtered and concentrated in vacuo to yield a yellow oil. 
Purification by flash column chromatography (Si02,10% ethyl acetate/petroleum 
ether 40-60 °C) furnished aldehyde 186 (3.00 g, 50%) as a colourless oil. 311(400 
MHz) 1.10 (9H, s, SiC(CH3)3), 4.21 (2H, s, 2-H2), 7.37-7.47 (6H, m, 6x Ar-H), 7.63- 
7.70 (4H, in, 4x Ar-H), 9.72 (1H, s, 1-H); 8ß(100 MHz) 19.3 (SiC(CH3)3), 26.7 
(SiC(CH3)3), 70.0 (C-2), 128.0 (4 x Ar-C), 130.1 (2 x Ar-C), 132.5 (2 x Ar-C1 0), 
135.5 (4 x Ar-C), 201.7 (C-1). 
(2S, 4E)-1-(tert-Butyldiphenylsilyloxy)hex-4-en-2-01187 
OH HO., 0 
pTSAOTBDPS 
TBDPSO, -k, + -ý \ 
186 187 
166 
p-Toluenesulfonic acid monohydrate (0.18 g, 0.95 mmol) was added to a solution of 
aldehyde 186 (2.92 g, 9.73 mmol) and alcohol 166 (4.00 g, 19.01 mmol) in dry DCM 
(100 mL) at room temperature. The reaction was stirred for 3 days and was then 
quenched with triethylamine (1.00 mL) and saturated aqueous ammonium chloride 
solution (100 mL). After 15 minutes of vigorous stirring the layers were separated and 
the aqueous layer was extracted with DCM (4 x 75 mL). The combined extracts were 
dried over magnesium sulfate, filtered and concentrated in vacuo to yield an orange 
oil. Purification by flash column chromatography (Si02,1% ethyl acetate/petroleum 
ether 40-60 °C) yielded homoallylic alcohol 187 (2.61g, 76%) as a pale yellow oil. 
[a] 23 -2.86 (c 1.40, CHC13)9 vmax(neat)/cm 
4 3421 (OH), 2931,2892,2857,1428 
(C=C), 1111,699; SH(400 MHz) 1.07 (9H, s, SiC(CH3)3), 1.63 (3H, dq, J 6.5,1.5,6- 
H3), 2.14-2.19 (2H, m, 3-HH and OH), 2.41 (1H, m, 3-HH), 3.54 (1H, dd, J 10.0,7.0, 
1-HH), 3.65 (1H, dd, J 10.0,4.0,1-HH), 3.72 (1H, m, 2-H), 5.38 (1H, dtq, J 15.0,7.0, 
1.5,5-H), 5.49 (2H, dqt, J 15.0,6.5,1.0,4-H), 7.33-7.46 (6H, m, 6x Ar-H), 7.60-7.73 
(4H, m, 4x Ar-H); 8ß(100 MHz) 18.0 (C-6), 19.3 (SiC(CH3)3), 26.9 (SiC(CH3)3), 
36.4 (C-3), 67.3 (C-1), 71.7 (C-2), 126.7 (C-4 or C-5), 127.8 (4 x Ar-C), 129.8 (2 x 
Ar-C), 133.3 (2 x Ar-C1 0), 134.8 (C-4 or C-5), 135.6 (4 x Ar-C); 'n/z (ESI) 377 
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(MNa+, 100%), 277 (9), 244 (15), 192 (11) and 125 (9); Found (ESI): 377.1915 
(MNa+), (C22H3002SiNa requires 377.1907). 
(2S, 3R, 4S, 6S)-6-((tert-Butyldiphenylsilyloxy)methyl)-4-hydroxy-3-methyl-2- 
vinyl-tetrahydropyran 188 
HO., 
OTBDPS 
187 
(i) TFA 
(ii) K2C03, McOH 
176 
55 OTBDPS 
Iv, 
OH 
188 
Alcohol 187 (0.30 g, 0.85 mmol) and propenal 176 (0.58 mL, 8.50 mmol) in dry 
DCM (8.5 mL) at 0 °C under an atmosphere of nitrogen. Trifluoroacetic acid (0.65 
mL, 8.50 mmol) was added slowly and the reaction was stirred at room temperature 
for 5.5 hours. The reaction was quenched with saturated aqueous sodium hydrogen 
carbonate solution (20 mL) and the pH was adjusted to above 7 by addition of 
triethylamine. The layers were separated and the aqueous phase was extracted with 
DCM (3 x 50 mL). The combined organic extracts were dried over magnesium 
sulfate, filtered and concentrated in vacuo to yield yellow oil. Potassium carbonate 
(0.59 g, 4.25 mmol) and methanol (6 mL) were added and the mixture was stirred for 
2 hours. Volatiles were removed in vacuo and then water (50 mL) and DCM (50 mL) 
were added. The layers were separated and the aqueous phase was extracted with 
DCM (3 x 50 mL). The combined extracts were dried over magnesium sulfate, 
filtered and concentrated in vacuo to give a yellow oil. Purification by flash column 
chromatography (Si02,5-10% ethyl acetate/petroleum ether 40-60 °C) gave 
tetrahydropyran 188 (0.180 g, 52%). [a] ö -4.11 (c 4.87, CHC13); vm (neat)/cm' 
3393 (OH), 2930,2857,1428,1111,1048,823,739,700; SH(400 MHz) 0.95 (3H, d, J 
6.5,3-CH3), 1.05 (9H, s, SiC(CH3)3), 1.27 (IH, m, 3-H), 1.37 (IH, app. q, J 12.0,5- 
HH), 1.72 (IH, br s. OH), 2.15 (IH, ddd, J 12.0,4.5,1.5,5-HH), 3.30-3.45 (2H, m, 2- 
H and 4-H), 3.50-3.63 (2H, m, 6-H and 7-HH), 3.79 (IH, m, 7-HH), 5.19 (IH, dd, J 
10.0,1.5,2'-HH), 5.26 (IH, ddd, J 17.5,1.5,1.0,2'-HH), 5.77 (1H, ddd, J 17.5,10.0, 
7.5,1'-H), 7.33-7.43 (6H, m, 6x Ar-H), 7.65-7.70 (4H, m, 4x Ar-H); 6c(100 MHz) 
13.1 (3-CH3), 19.3 (SiC(CH3)3), 26.9 (SiC(CH3)3), 37.8 (C-5), 43.7 (C-3), 66.7 (C-7), 
73.5 (C-2 or C-4), 75.8 (C-6), 82.9 (C-2 or C-4), 117.6 (C-2'), 127.6 (4 x Ar-C), 129.6 
(2 x Ar-C), 133.6 (2 x Ar-C1 0), 135.6 (4 x Ar-C), 136.9 (C-1'); m/z (ESI) 433 
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(MNa+, 100%), 397 (24), 353 (10), 192 (76) and 167 (12); Found (ESI): 433.2179 
(MNa+), (C25H3403SiNa requires 433.2169). 
(2E, 4E)-4-Methylhexa-2,4-dienoic acid 193191,192 
/ OEt NaOH OH 
OBn 00 
171 193 
Ester 171 (0.17 g, 0.65 mmol) in ethanol (1 mL) and aqueous sodium hydroxide 
solution (2.0 M, 10 mL) was heated to reflux for 16 hours. The reaction was allowed 
to cool to room temperature and was then diluted with water (50 mL). The pH of the 
solution was adjusted to 2 with hydrochloric acid (2.0 M). The solution was extracted 
with ethyl acetate (3 x 50 mL) and the organic extracts were dried over sodium 
sulfate, filtered and concentrated in vacuo to give acid 193 (0.12 g, 82%) as colourless 
needles. m. p. 94 °C, lit-191 94-95 °C; vmax(neat)/cm 
1 2987,1688 (C=O), 1409,1361, 
1258,1216,1064,983,894,868,678; SH(400 MHz) 1.79 (3H, s, 4-CH3), 1.84 (3H, d, 
J7.0,6-H3)9 5.80 (IH, d, J 15.5,2-H), 6.05 (IH, q, J 7.0, H-5), 7.42 (1H, d, J 15.5,3- 
H); Sc(100 MHz) 11.8 (4-CH3), 14.7 (C-6), 133.8 (C-2), 114.3 (C-4), 137.9 (C-5), 
151.9 (C-3), 173.0 (C-1); mlz (CI) 127 (MH+, 7%), 125 (47), 115 (100), 99 (28) and 
97 (50); Found 127.0753 (Cl): (MH+), (C7H1102 requires 127.0759). 
(2E, 4R, 5S)-5-Benzyloxy-4-methylhex-2-enoic acid 189 
(i) via Dess-Martin Periodinane and Pinnick oxidation of alcohol 172 
'- (i) DMP 
/ OH (ii) NaCIO, Me2CCHMe, Buffer / OH 
OBn 
172 
OBn 
189 
0 
Alcohol 172 (0.50 g, 2.27 mmol) in dry DCM (13 mL) was added to a solution of 
Dess-Martin periodinane (15% w/t in DCM, 7.1 mL, 3.41 mmol) in DCM (13 mL) 
under an atmosphere of nitrogen. After stirring for 1 hour the reaction was deemed 
complete by T. L. C. and was diluted with ether (20 mL) prior to quenching with 
sodium hydroxide (1.0 M, 20 mL). The aqueous phase was extracted with ether (3 x 
50 mL) and then the combined extracts were washed with water (2 x 30 mL), dried 
over magnesium sulfate and concentrated in vacuo. The resulting yellow oil was 
dissolved in tert-butanol (30 mL) and 2-methyl-but-2-ene (13 mL). A solution of 
sodium chlorite (2.44 g, 26.96 mmol) and sodium dihydrogen phosphate (2.04 g, 1.70 
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mmol) in water (15 mL) was added. The reaction was stirred for 2 hours and was then 
extracted with ethyl acetate (3 x 100 mL), dried over magnesium sulfate and 
concentrated in vacuo to give a colourless oil. Purification by flash column 
chromatography (Si02,5% ethyl acetate/1% acetic acid/petroleum ether 40-60 °C) 
gave acid 189 (1.05 g, 88%) as a colourless oil. [a] D 
22 +16.9 (c 4.02, CHC13); 
vma, (neat)/cm 12973,2873,1692 (C=O), 1649 (C=C), 1495,1454,1418,1284,1093, 
1065,984,984,924,733,696; SH(400 MHz) 1.09 (3H, d, J 7.0,4-CH3), 1.15 (3H, d, 
J 6.0,6-H3), 2.56 (IH, m, 4-H), 3.50 (IH, dq, J 6.0,5.5,5-H), 4.45 (IH, d, J 12.0, 
CHHPh), 4.59 (1H, d, J 12.0, CHHPh), 5.85 (IH, dd, J 15.5,1.5,2-H), 7.11 (IH, dd, 
J 15.5,7.5,3-H), 7.24-7.35 (5H, m, 5x Ar-H), 11.58 (1H, br s, COOH); Sc(100 
MHz) 14.6 (4-CH3), 16.6 (C-6), 42.0 (C-4), 70.8 (CH2Ph), 77.4 (C-5), 120.7 (C-2), 
127.5 (Ar-C), 127.6 (2 x Ar-C), 128.4 (2 x Ar-C), 138.5 (Ar-C; PS°), 154.2 (C-3), 172.2 
(C-1); m/z (ESI) 257 (MNa+, 100%), 252 (14) and 115 (18); Found (ESI): 257.1147 
(MNa+), (C14H18O3Na requires 257.1148). 
(ii) via hydrolysis of methyl ester 194108 
e 
OMe TMSO Na OH 
OBn 0 OBn 0 
194 189 
Sodium trimethylsilanoate (1.0 M in DCM, 0.4 mL, 0.40 mmol) was added to a 
solution of methyl ester 194 (0.05 g, 0.20 mmol) in dry DCM (4 mL) under an 
atmosphere of nitrogen. The reaction was stirred overnight and then volatiles were 
removed in vacuo to give the sodium salt as a pale yellow solid. Purification by flash 
column chromatography (Si02,20% ethyl acetate/1% acetic acid/petroleum ether 40- 
60 °C) gave acid 189 (0.037 g, 85%) as a colourless oil. Spectral data as above. 
(iii) via hydrolysis of ethyl ester 171 
OR LiOH, H202 OH 
OBn 0 OBn 0 
171 189 
Lithium hydroxide (0.027 g, 1.14 mmol) and hydrogen peroxide (30% in water, 0.2 
mL, 1.71 mmol) in THE (6 mL) and water (1.8 mL) was cooled to 0 °C. Ester 171 
(0.15 g, 0.57 mmol) in THE (1 mL) was added dropwise and the reaction was allowed 
to warm to room temperature. After 1 week, the reaction was cooled to 0 °C and 
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quenched with sodium sulfite solution (20 mL). Solvents were removed in vacuo and 
then water (17 mL) was added. The pH of the solution was adjusted to 2 with 
hydrochloric acid (6.0 M) and the solution was then extracted with DCM (3 x 50 mL). 
The combined organic layers were dried over magnesium sulfate, filtered and 
concentrated in vacuo to give a colourless oil. Purification by flash column 
chromatography (Si02,5% ethyl acetate/petroleum ether 40-60 °C) furnished acid 
189 (0.02 g, 15%) as a colourless oil. Spectral data as above. 
Methyl (2Z, 4R, 5S)-5-Benzyloxy-4-methylhex-2-enoate 282 and methyl 
(2E, 4R, 5S)-5-Benzyloxy-4-methylhex-2-enoate 194 
OBn = 
47 p OBn (i) DIBALH (ii) n BuULi ,( jl Iýý' Me0)2P(O)CH2C02Me OMe OMe 
SiN OBn 0 
i ýý 282 194 00 134 
Benzyl ether 134 (0.50 g, 1.23 mmol) was dissolved in dry DCM (10 mL) under an 
atmosphere of nitrogen and cooled to -78 °C. Diisobutylaluminium hydride (1.0 M in 
hexanes, 1.2 mL, 1.2 mmol) was added dropwise in 3 portions at 15 minute intervals. 
After 1.5 hours a further addition of diisobutylaluminium hydride (1.0 M in hexanes, 
0.62 mL, 0.62 mmol) was required. After 2.5 hours the reaction was quenched with 
saturated aqueous potassium sodium L-tartrate tetrahydrate solution (20 mL). The 
reaction was warmed to room temperature and stirred vigorously overnight to break 
up the aluminium complex. The mixture was then extracted with DCM (3 x 50 mL) 
and the combined organic layers were washed with water (5 mL), dried over 
magnesium sulfate, filtered and concentrated in vacuo on a cool rotary evaporator. 
The resulting oil was triturated with petroleum ether 40-60 °C and filtered to remove 
the precipitated auxiliary. The filtrate was concentrated in vacuo to yield a colourless 
oil. This was then dissolved in dry THE (3 mL) and added dropwise to a solution of 
trimethyl phosphonoacetate (0.44 mL, 2.71 mmol) and n-butyllithium (2.5 M in 
hexanes, 1.1 mL, 2.71 mmol) in dry THE (15 mL) which had been stirred for 1 hour 
at 0 °C under an atmosphere of nitrogen. The resulting solution was stirred at room 
temperature for 20 hours and was then quenched with water (25 mL). The solution 
was extracted with ethyl acetate (3 x 50 mL), dried over magnesium sulfate, filtered 
and concentrated in vacuo to give a pale yellow oil. Purification by flash column 
chromatography (Si02,2.5-5% ethyl acetate/petroleum ether 40-60 °C) furnished (Z)- 
Ný 
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methyl ester 282 (0.049 g, 16%) then (E)-methyl ester 194 (0.073 g, 24%) both as a 
colourless oils. (Z)-methyl ester 282: [a] 2 -33.7 (c 2.52, CHC13); v. (neat)/cm 
2969,2929,2873,1720 (C=O), 1644 (C=C), 1454,1437,1195,1176,825,733,696; 
SH(400 MHz) 1.08 (3H, d, J 7.0,4-CH3), 1.15 (3H, d, J 6.0,6-H3), 3.50 (IH, dq, J 6.0, 
4.5,5-H), 3.70 (3H, s, OCHS), 3.75 (1H, m, 4-H), 4.49 (1H, d, J 11.5, CHHPh), 4.61 
(1 H, d, J 11.5, CHHPh), 5.81 (1 H, dd, J 11.5,1.0,2-H), 6.23 (1 H, dd, J 11.5,10.0,3- 
H), 7.24-7.36 (5H, m, 5x Ar-H); Sß(100 MHz) 16.2 (4-CH3), 17.0 (C-6), 37.9 (C-4), 
51.0 (OCHS), 70.5 (CH2Ph), 78.0 (C-5), 119.2 (C-2), 127.3 (Ar-C), 127.6 (2 x Ar-C), 
128.2 (2 x Ar-C), 139.0 (Ar-C; Ps0), 152.8 (C-3), 166.7 (C-1); m/z (ESI) 271 (MNa+, 
100%), 177 (14) and 125 (11); Found (ESI): 271.1313 (MNa+), (C15H2OO3Na requires 
271.1305). (E)-methyl ester 194: [a] D +20.1 (c 2.59, CHC13); v,,, (neat)/cm 1 2973, 
2874,1720 (C=O), 1656 (C=C), 1454,1435,1250,1093,734,697; 6H(400 MHz) 
1.08 (3H, d, J 7.0,4-CH3), 1.14 (3H, d, J 6.0,6-H3), 2.54 (1 H, m, 4-H), 3.50 (1 H, dq, 
J 6.0,5.5,5-H), 3.73 (3H, s, OCHS), 4.45 (1 H, d, J 11.5, CHHPh), 4.58 (1 H, d, J 11.5, 
CHHPh), 5.84 (IH, dd, J 15.5,1.5,2-H), 6.99 (IH, dd, J 15.5,7.5,3-H), 7.24-7.34 
(5H, m, 5x Ar-H); Sc(100 MHz) 14.6 (4-CH3), 16.5 (C-6), 41.8 (C-4), 51.4 (OCHS), 
70.7 (CH2Ph), 77.4 (C-5), 120.9 (C-2), 127.4 (Ar-C), 127.5 (2 x Ar-C), 128.3 (2 x Ar- 
C), 138.6 (Ar-C1 0), 151.4 (C-3), 167.0 (C-1); mlz (ESI) 271 (MNa+, 100%), 245 (14), 
217 (9), 177 (22) and 125 (16); Found (ESI): 271.1313 (MNa+), (C15H2003Na requires 
271.1305). 
(1'S, 3'E)-1'-tert-Butyldiphenylsilanoxymethylhex-3'-en-1'-yl (2E, 4R, 5S)-5- 
(benzyloxy)-4-methylhex-2-enoate 190 
HO,,, 
OTBDPS 
"/O1. OTBDPS 
'/ OH DCGDMAP 
+I --. OBn O 
OBn 
189 
0 187 190 
To a solution of acid 189 (0.95 g, 4.05 mmol) and alcohol 187 (1.05 g, 3.04 mmol) in 
DCM (44 mL) was added DCC (0.84 g, 4.05 mmol) in dry DCM (3 mL) and 4- 
DMAP (0.04 g, 0.33 mmol). The solution was stirred overnight and then hexane (50 
mL) was added and the solution was filtered to remove the urea by-product. Solvents 
were removed in vacuo to give a yellow oil, which was purified by flash column 
chromatography (Si029 0-5% ethyl acetate/hexane) to afford ester 190 (1.11 g, 66%) 
as a colourless oil. [a] D 
22 +2.0 (c 2.03, CHC13); vmax(neat)/cm 1 2963,2931,2857, 
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1717 (C=O), 1652 (C=C), 1589 (C=C), 1428,1261,1112,968,823,739,700; ö11(400 
MHz) 1.03 (9H, s, SiC(CH3)3), 1.09 (3H, d, J 7.0,4-CH3), 1.13 (3H, d, J 6.5,6-H3), 
1.61 (3H, dd, J 6.5,1.5,5'-H3), 2.33 (IH, m, 2'-HH), 2.42 (IH, m, 2'-HH), 2.57 (IH, 
m, 4-H), 3.51 (1 H, dq, J 6.5,5.0,5-H), 3.72 (2H, dd, J 5.0,1.0,1'-CH2), 4.47 (IH, d, 
J 12.0, OCHHPh), 4.58 (1 H, d, J 12.0, OCHHPh), 5.03 (IH, app. tt, J 6.5,5.0,1'-H), 
5.34 (1 H, dtq, J 15.0,7.0,1.5,3'-H), 5.50 (IH, dqt, J 15.0,6.5,1.0,4'-H), 5.83 (1 H, 
dd, J 16.0,1.5,2-H), 6.98 (1H, dd, J 16.0,7.5,3-H), 7.23-7.44 (11H, m, 11 x Ar-H), 
7.63-7.68 (4H, m, 4x Ar-H); 8ß(100 MHz) 14.5 (4-CH3), 16.4 (C-6), 18.0 (C-6'), 
19.2 (SiC(CH3)3), 26.7 (SiC(CH3)3), 33.8 (C-2'), 41.7 (C-4), 64.3 (1'-CH2), 70.7 
(PhCH2O), 73.8 (C-1'), 77.4 (C-5), 121.5 (C-2), 125.7 (C-3' or C-4'), 127.5 (Ar-C), 
127.6 (2 x Ar-C), 127.6 (2 x Ar-C), 127.6 (2 x Ar-C), 128.3 (2 x Ar-C), 128.4 (C-3' 
or C-4'), 129.6 (2 x Ar-C), 133.4 (Ar-C; p, o), 133.5 (Ar-C; p, o), 135.6 (2 x Ar-C), 135.6 
(2 x Ar-C), 138.7 (Ar-C1ps0), 151.1 (C-3), 166.0 (C-1); m/z (ESI) 593 (MNa+, 100%), 
588 (26), 571 (7), 493 (14) and 198 (10); Found (ESI): 593.3080 (MNa+), 
(C36Ha6O4SiNa requires 593.3058). 
(2S, 4E)-2-Acetoxy-l-tert-butyldiphenylsilanoxyhex-4-ene 196 and (2E, 4R, 5S)-1- 
Acetoxy-5-(benzyloxy)-4-methylhex-2-ene 195 
O 
OTBDPS (i) DIBALrH 
AcO 
(ii) pyridine, DMAP, Ac2O 
OTBDPS 
/ OAC OBn O 
190 196 OBn 195 
Ester 190 (0.05 g, 0.09 mmol) was dissolved in dry DCM (6 mL) and cooled to -78 
°C. Diisobutylaluminium hydride (1.0 M in hexanes, 0.18 mL, 0.18 mmol) was added 
dropwise and the solution was stirred for 45 minutes. Pyridine (0.02 mL, 0.27 mmol), 
DMAP (0.03 g, 0.27 mmol) in of dry DCM (1 mL) and acetic anhydride (0.05 mL, 
0.54 mmol) were added sequentially dropwise. The mixture was stirred for 14.5 hours 
at -78 °C and was then allowed to warm gradually to 0 °C. Saturated aqueous 
ammonium chloride solution (5 mL) and saturated aqueous potassium sodium L- 
tartrate tetrahydrate solution (5 mL) were added and the resulting mixture was 
allowed to warm to room temperature and stirred for 2 hours. The layers were then 
separated and the aqueous phase was extracted with DCM (3 x 50 MIL). The 
combined organic extracts were washed with saturated aqueous sodium sulfate 
solution (10 mL) and saturated aqueous sodium hydrogen carbonate solution (10 mL), 
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dried over magnesium sulfate, filtered and concentrated in vacuo to give a yellow oil. 
This was purified by flash column chromatography (Si02,2.5-5% ethyl 
acetate/hexane) to afford silyl ether 196 (0.0287 g, 83%) and acetate 195 (0.0147 g, 
64%) both as colourless oils. Silyl ether 196: [a] ö 
23 -6.9 (c 1.44, C1103); 
vmax(neat)/cm"1 3072,2932,2858,1739 (C=O), 1428,1373,1237,1112,968,823, 
740,701; SH(400 MHz) 1.08 (9H, s, SiC(CH3)3), 1.66 (3H, dq, J 6.5,1.5,6-H3), 2.05 
(3H, s, C(O)CH3), 2.30 (IH, app. dtt, J 14.0,7.0,1.0,3-HH), 2.40 (IH, app. dtt, J 
14.0,7.0,1.0,3-HH), 3.72 (2H, dd, J 5.0,1.0,1-H2), 5.00 (1 H, app. tt, J 6.5,5.0,2- 
H), 5.35 (1 H, dtq, J 15.0,7.0,1.5,4-H), 5.53 (IH, dqt, J 15.0,6.5,1.0,5-H), 7.39- 
7.49 (6H, m, 6x Ar-H), 7.67-7.72 (4H, in, 4x Ar-H); Sß(100 MHz) 18.0 (C-6), 19.2 
(SiC(CH3)3), 21.2 (C(O)CH3), 26.7 (SiC(CH3)3), 33.8 (C-3), 64.3 (C-1), 74.1 (C-2), 
125.7 (C-4 or C-5), 127.6 (2 x Ar-C), 127.7 (2 x Ar-C), 128.4 (C-4 or C-5), 129.6 
(Ar-C), 129.7 (Ar-C), 133.4 (Ar-C; ps0), 133.5 (Ar-C; pso), 135.5 (2 x Ar-C), 135.6 (2 x 
Ar-C), 170.5 (CO); nz/z (ESI) 419 (MNa, 100%), 325 (8), 285 (41) and 139 (11); 
Found (ESI): 419.2025 (MNa+), (C24H32O3SiNa requires 419.2013). Acetate 195: 
[a] D 
23 +16.2 (c 0.74, CHC13); v,. (neat)/cm 1 3032,2969,2932,2872,1737 (C=O), 
1454,1375,1226,1094,1026,972,736,698; 8H(400 MHz) 1.03 (3H, d, J 7.0,4- 
CH3), 1.12 (3H, d, J 6.0,6-H3), 2.05 (3H, s, C(O)CH3), 2.41 (1H, m, 4-H), 3.42 (1H, 
app. quint., J 6.0,5-H), 4.45 (1H, d, J 12.0, CHHPh), 4.53 (2H, d, J 6.5,1-H2), 4.57 
(IH, d, J 12.0, CHHPh), 5.58 (1H, dtd, J 15.5,6.5,1.0,2-H), 5.76 (IH, ddt, J 15.5, 
7.5,1.0,3-H), 7.25-7.40 (5H, m, 5x Ar-H); 5ß(100 MHz) 15.1 (4-CH3), 16.3 (C-6), 
21.0 (C(O)CH3), 41.5 (C-4), 65.5 (C-1), 70.7 (CH2Ph), 78.1 (C-5), 123.9 (C-2), 127.4 
(Ar-Q, 127.5 (2 x Ar-C), 128.3 (2 x Ar-C), 138.3 (C-3), 138.9 (Ar-C1 0), 170.9 
(CO); m/z (ESI) 285 (MNa+, 100%); 'Found (ESI): 285.1460 (MNa+), (C16H22O3Na 
requires 285.1461). 
Ethyl (E)-3-phenylpropenoate 203193 
000 
Et0 ; /o II NaH ý Ph +P 
AOEt 
-º Ph 
\ OM 
202 2 EtO 37 203 
Sodium hydride (60% dispersion oil prewashed in hexane, 0.12 g, 3.00 mmol) was 
stirred in dry THE (10 mL) under an atmosphere of nitrogen. Triethyl 
phosphonoacetate 37 (0.58 g, 2.60 mmol) in dry THE (3 mL) was added dropwise and 
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stirred for 25 minutes. Then benzaldehyde 202 (0.25 g, 2.36 mmol) in THE (3 mL) 
was added dropwise over a period of approximately 30 minutes (in order to prevent a 
gum like precipitate which had previously been observed). The resulting solution was 
stirred for 20 hours at room temperature. The reaction mixture was then quenched 
with water (100 mL) and was extracted with ethyl acetate (3 x 100 mL). The 
combined organic extracts were dried over magnesium sulfate, filtered and 
concentrated in vacuo. Purification by flash column chromatography (SiO2,20% ethyl 
acetate/petroleum ether 40-60 °C) afforded unsaturated ester 203 (0.27 g, 67%) as a 
yellow oil. SH(400 MHz) 1.33 (3H, t, J 7.0, CH3), 4.34 (2H, q, J 7.0, OCH2), 6.45 
(1H, d, J 16.0,2-H), 7.34-7.45 (3H, m, 3x Ar-H), 7.50-7.57 (2H, m, 2x Ar-H), 7.80 
(1H, d, J 16.0,3-H); SC(100 MHz) 14.4 (CH3), 60.5 (OCH2), 118.4 (C-2), 128.1 (2 x 
Ar-C), 128.9 (2 x Ar-C), 130.3 (Ar-C), 134.5 (Ar-C; pso), 144.6 (C-3), 167.0 (C-1). 
(E)-3-Phenylpropanoic Acid (Cinnamic Acid) 200194 
(a) via hydrolysis of ethyl ester 203 
O0 
Ph' 
ýNaOH u 
OEt Phi \/LOH 
203 200 
Ethyl (E)-3-phenylpropenoate 203 (0.27 g, 0.99 mmol) dissolved in ethanol (1 mL) 
was added dropwise to sodium hydroxide (2.0 M, 10 mL) and heated to reflux for 24 
hours. The mixture was quenched with water (40 mL) and acidified to pH 2 with 
hydrochloric acid (2.0 M, 30 mL). The solution was then extracted with ethyl acetate 
(3 x 100 mL), dried over sodium sulfate, filtered and concentrated in vacuo to yield 
cinnamic acid 200 (0.17 g, 100%) as a white solid. m. p. 132-134 °C, lit. 120 132-135 
°C; SH(400 MHz) 6.46 (1H, d, J 16.0,2-H), 7.34-7.45 (3H, m, 3x Ar-H), 7.50-7.57 
(2H, m, 2x Ar-H), 7.80 (IH, d, J 16.0,3-H); 8ß(100 MHz) 117.3 (C-2), 128.4 (2 x 
Ar-C), 129.0 (2 x Ar-C), 130.8 (Ar-C), 134.1 (Ar-C; pso), 147.1 (C-3), 171.8 (C-1); m/z 
(EI) 149 (MH+, 99%), 131 (74), 107 (100), 91 (15) and 84 (9). 
(b) via Knoevenagel Reaction 
0 
HOOCCOOH + Ph1ý1 H 
206 202 
O Pyridine, Piperidine 
Na2SO4 Ph OH 
200 
Malonic acid 206 (0.25 g, 2.40 mmol), benzaldehyde 202 (0.25 g, 2.36 mmol), 
pyridine (0.25 mL), piperidine (15 µL) and sodium sulfate (0.05 g, 1.25 mmol) were 
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refluxed for 4 hours. The solution was acidified with concentrated hydrochloric acid 
and the white precipitate which formed was dissolved by adding diethyl ether (20 
mL). The organic phase was extracted with sodium hydroxide (2.0 M, 3x 20 mL) and 
the combined aqueous extracts were acidified with concentrated hydrochloric acid and 
then filtered to furnish cinnamic acid 200 (0.27 g, 87%) as shiny white crystals. These 
were used without further purification. Spectral data as before. 
[3-13C]-(E)-Cinnamic Acid 6120 
The above Knoevenagel reaction was repeated using [1-13C]-benzaldehyde 205 (0.50 
g, 4.72 mmol), to give acid 6 (0.70 g, 100%). 6H(400 MHz) 6.47 (1H, dd, J 16.0,1.0, 
2-H), 7.39-7.44 (3H, m, 3x Ar-H), 7.54-7.59 (2H, m, 2x Ar-H), 7.81 (IH, dd, J 
156.5,16.0,3-H); 8(100 MHz) signal assigned to C-3 (147.1 ppm) showed an 
enhancement of >95% (based on 1H NMR and MS data); m/z (CI) 150 (MH+, 65%), 
132 (32), 106 (8), 93 (11), 79 (6), 75 (100), 65 (20) and 59 (19). 
[2,3-1302]-(2E)-Cinnamic Acid 209 
The above Knoevenagel reaction was repeated using [1-13C]-benzaldehyde 205 (0.25 
g, 2.36 mmol) and [2-13C]-malonic acid 207 (0.25 g, 2.40 mmol) to give acid 209 
(0.20 g, 57%). 8H(400 MHz) 6.47 (1H, ddd, J 163.0,16.0,1.0,2-H), 7.39-7.44 (3H, 
m, 3x Ar-H), 7.54-7.59 (2H, m, 2x Ar-H), 7.81 (1H, ddd, J 156.5,16.0,3.0,3-H); 
Sc(100 MHz) signals assigned to C-2 (117.3 ppm) and C-3 (147.1 ppm) appear as 
doublets (J 70.5) with an enhancement of >90% (based on 'H NMR and MS data); 
m/z (EI) 150 (M+, 91%), 149 (100), 133 (46), 105 (68), 92 (43), 84 (30), 78 (50) and 
63 (25). 
Cinnamic Acid N-Acetylcysteamine Thiol Ester 204195 
OH 
Ph' ý/ SOH + HSN 
200 42 0 
0H 
DCC. DMAP 
Ph 
\ 
S^/NIr 
204 0 
Freshly prepared N-acetylcysteamine 42 (0.09 g, 0.78 mmol) in dry DCM (5 mL) was 
stirred at 0 °C under an atmosphere of nitrogen. DCC (0.12 g, 0.60 mmol) in dry 
DCM (1 mL) was added followed by DMAP (0.003 g, 0.02 mmol) in dry DCM (1 
mL). This was stirred for 10 minutes before addition of cinnamic acid 200 (0.07 g, 
0.53 mmol). The solution was left at 0 °C for 2 hours and was allowed to warm to 
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room temperature overnight. The reaction was subsequently quenched with saturated 
aqueous ammonium chloride solution (100 mL) and was extracted with DCM (3 x 
100 mL). The combined organic extracts were dried over magnesium sulfate, and 
copper sulfate impregnated silica (prepared by stirring flash silica in a saturated 
solution of copper sulfate for 10 minutes and then drying in vacuo to a free flowing 
powder) 170 was added to remove any unreacted N-acetylcysteamine 42. The solution 
was then filtered and concentrated in vacuo to yield a white solid. Ethyl acetate (3 
mL) was added to dissolve the product and the insoluble urea by-product was then 
filtered off. The filtrate was then concentrated in vacuo give thiol ester 204 (0.09 g, 
68%) as an off white solid. m. p. 91-94 °C (from ethyl acetate/petroleum ether 40-60 
°C), lit. '95 97-98 °C; SH(400 MHz) 1.99 (3H, s, CH3), 3.17 (2H, t, J 6.5, CH2S), 3.51 
(2H, app. q, J 6.5, CH2N), 6.26 (IH, br s, NH), 6.73 (IH, d, J 16.0,2-H), 7.36-7.43 
(3H, in, 3x Ar-H), 7.51-7.56 (2H, in, 2x Ar-H), 7.62 (1H, d, J 16.0,3-H); Sß(100 
MHz) 23.3 (COCH3), 28.6 (CH2S), 39.8 (CH2N), 124.7 (C-2), 128.5 (2 x Ar-C), 
129.1 (2 x Ar-C), 130.9 (Ar-C), 133.9 (Ar-Cips°), 141.3 (C-3), 170.5 (CON), 190.2 
(C-1); m/z (EI) 249 (MH+, 28%), 221 (63), 190 (75), 162 (14), 131 (100), 103 (40), 77 
(33) and 56 (10). 
[3.13C]-Cinnamic Acid N-Acetylcysteamine Thiol Ester 6120 
The above was repeated using [3-13C]-cinnamic acid 208 (0.20 g, 1.34 mmol) to 
furnish the thiol ester 6 (0.23 g, 60%) as an off white solid. SH(400 MHz) 1.99 (3H, s, 
CH3), 3.18 (2H, t, J 6.5, CH2S), 3.52 (2H, app. q, J 6.5, CH2N), 5.99 (1 H, br s, NH), 
6.74 (1H, d, J 16.0,2-H), 7.27-7.42 (3H, m, 3x Ar-H), 7.54-7.57 (2H, m, 2x Ar-H), 
7.64 (IH, dd, J 156.0,16.0,3-H); 8ß(100 MHz) signal assigned to C-3 (141.3 ppm) 
showed an enhancement of >95% (based on 1H NMR and MS data); m/z (EI) 250 
(M+, 15%), 222 (35), 191 (46), 132 (100), 104 (43), 78 (24) and 77 (25). 
[2,3-13C2]-Cinnamic Acid N-Acetylcysteamine Thiol Ester 7 
The above was repeated using [2,3-13C2]-cinnamic acid 209 (0.20 g, 1.33 mmol) to 
yield the crude product as a yellow solid. The product was purified by flash column 
chromatography (Si02,50%-100% ethyl acetate/petroleum ether 40-60 °C) furnishing 
the thiol ester 7 (0.25 g, 67%) and a slight impurity believed to be N, S- 
diacetylcysteamine 240 as fine white needles. However, a small analytical sample was 
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later purified by flash column chromatography (Si02,2.5% methanol/ethyl acetate, 
followed by Si02,50%-100% ethyl acetate/petroleum ether 40-60 °C). 51j(400 MHz) 
1.99 (3H, s, CH3), 3.17 (2H, t, J 6.5, CH2S), 3.51 (2H, app. q, J 6.5, CH2N), 6.10 (111, 
br s, NH), 6.73 (1H, ddd, J 161.0,16.0,1.5,2-H), 7.35-7.43 (3H, m, 3x Ar-H), 7.53- 
7.58 (2H, m, 2x Ar-H), 7.65 (IH, ddd, J 155.5,16.0,2.5,3-H); Sß(100 MHz) signals 
assigned to C-2 (124.7 ppm) and C-3 (141.3 ppm) appear as doublets (J 70.5) with an 
enhancement of >90% (based on 'H NMR and MS data); m/z (EI) 251 (M+, 21%), 
223 (64), 192 (84), 164 (19), 143 (27), 133 (100), 105 (58) and 78 (26). 
(E)-p-Fluorocinnamic Acid 234196 
O0 
H Pyridine, Piperidine \ 
HOOC COON + Na2SO4 I 
OH 
206 FF 
233 234 
Malonic acid 206 (0.26 g, 2.50 mmol), p-fluorobenzaldehyde 233 (0.35 g, 2.82 
mmol), pyridine (0.25 mL), piperidine (15 µL) and sodium sulfate (0.05 g, 1.25 
mmol) were refluxed for 4 hours. The solution was acidified with concentrated 
hydrochloric acid and the white precipitate which formed was dissolved in diethyl 
ether (20 mL). The organic phase was extracted with sodium hydroxide (2.0 M, 3x 
20 mL) and the combined aqueous extracts were acidified with concentrated 
hydrochloric acid and then filtered to furnish (2E) p-fluorocinnamic acid 234 (0.42 g, 
100%) as an off white powdery solid. This was used without further purification. m. p. 
209-211 °C (from MeOH), lit. 196 205-207 °C; SN(400 MHz) 6.38 (1H, d, J 16.0,2-H), 
7.10 (2H, t, J 8.5,2 x CHCF), 7.52-7.57 (2H, m, 2x Ar-H), 7.75 (1 H, d, J 16.0,3-H); 
5ß(100 MHz) 116.3 (d, J 22.5,2 x Ar-C), 117.0 (d, J 2.5, C-2), 130.1 (d, J 3.0, Ar- 
Cip,. ), 130.4 (d, J 8.5,2 x Ar-C), 145.8 (C-3), 164.2 (d, J 253.0, C-F), 171.3 (C-1); 
m/z (CI) 167 (MH+, 100%), 166 (66), 149 (80), 121 (10), 109 (6) and 79 (11). 
[2-13C]-(E) p-Fluorocinnamic Acid 235 
The above reaction was repeated using [2-13C]-malonic acid 207 (0.25 g, 2.40 mmol) 
to give acid 235 (0.33 g, 83%). SH(400 MHz) 6.38 (1H, dd, J 162.5,16.0,2-H), 7.06 
(2H, t, J 8.5,2 x CHCF), 7.52-7.58 (2H, m, 2x Ar-H), 7.75 (1 H, dd, J 16.0,3.0,3- 
H); Sc(100 MHz) signal assigned to C-2 (117.0 ppm, d, J 2.5) showed an 
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enhancement of >90% (based on 'H NMR and MS data); Wz (EI) 167 (M+, 100%), 
166 (48), 150 (44), 122 (39), 109 (26), 102 (38), 86 (46) and 84 (72). 
(E)-p-Fluorocinnamic Acid N-Acetylcysteamine Thiol Ester 223 
OH0H 
DCC, DMAP 
OH + HSI \ 
0/0 F 234 42 F "'a 
Freshly prepared N-acetylcysteamine 42 (0.09 g, 0.78 mmol) in dry DCM (5 mL) was 
stirred at 0 °C under an atmosphere of nitrogen. DCC (0.12 g, 0.60 mmol) in dry 
DCM (1 mL) was added followed by DMAP (0.003 g, 0.02 mmol) in dry DCM (1 
mL). This was stirred for 10 minutes before addition of p-fluorocinnamic acid 234 
(0.07 g, 0.53 mmol). The solution was left at 0 °C for 2 hours and was allowed to 
warm to room temperature overnight. The reaction was subsequently quenched with 
saturated aqueous ammonium chloride solution (100 mL) and extracted with DCM (3 
x 100 mL). The combined organic extracts were dried over magnesium sulfate, and 
copper sulfate impregnated silica (prepared by stirring flash silica in a saturated 
solution of copper sulfate for 10 minutes and then drying in vacuo to a free flowing 
powder) 170 was added to remove any unreacted N-acetylcysteamine 42. The solution 
was then filtered and concentrated in vacuo to yield a white solid. Ethyl acetate was 
added (3 mL) to dissolve the product and the insoluble urea by-product was then 
filtered off. The filtrate was removed in vacuo and the resulting solid was purified by 
flash column chromatograpy (Si02,2.5% methanol/ethyl acetate, followed by Si02, 
50%-100% ethyl acetate/petroleum ether 40-60 °C) to furnish the thiol ester 223 (0.09 
g, 68%) as an off white solid. Found: C, 58.43; H, 5.02; F, 6.91; N, 4.95; S, 11.93; 
C13H14FN02S requires C, 58.41; H, 5.28; F, 7.11; N, 5.24; S, 12.00; m. p. 152-154 °C 
(from MeOH); vm. (neat)/cm 1 3287 (CONH), 3073 (CONH), 2923,1665,1651, 
1614,1591,1544,1506,1226,1160,1042,978,815,737; SH(400 MHz) 1.98 (3H, s, 
CH3), 3.17 (2H, t, J 6.5, CH2S), 3.51 (2H, app. q, J 6.5, CH2N), 5.89 (1H, br s, NH), 
6.64 (1H, d, J 15.5,2-H), 7.10 (2H, t, J 8.5,2 x CHCF), 7.52-7.57 (2H, m, 2x Ar-H), 
7.59 (1H, d, J 15.5,3-H); 8ß(100 MHz) 23.3 (CH3), 28.6 (CH2S), 39.8 (CH2N), 116.4 
(d, J 22.5,2 x Ar-C), 124.4 (d, J 2.5, C-2), 130.2 (d, J 3.0, Ar-C1 0), 130.6 (d, J 9.0,2 
x Ar-C), 140.0 (C-3), 164.2 (C-F, d, J 253.0), 170.4 (CON), 190.1 (C-1); m/z (EI) 267 
(M+, 30%), 239 (53), 208 (76), 150 (46), 149 (100), 121 (60), 101 (50) and 86 (42). 
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[2-13C]-(E) p-Fluorocinnamic Acid N-Acetylcysteamine Thiol Ester 8 
OH + 
F/ 235 
F 
+OH I 
H$ 3^ýN 
Oy NJ 
1 237 
H0H 
I 
HS^, 
N 
D(C DMAP 
\ S^-- 
N 
ýre 
42 F0 
Q0 
eJ V/ "n 
N0 
vn- 
236 
The above was repeated using [2-13C] p-fluorocinnamic acid 235 (0.30 g, 1.34 mmol) 
to furnish the thiol ester 8 (0.12 g, 23%) as an off white solid and the by-products 236 
(0.07g) and 237 (0.12g) as a white solid and an orange oil respectively. Thiol ester 8: 
8H(400 MHz) 1.98 (3H, s, CH3), 3.17 (2H, t, J 6.5, CH2S), 3.51 (2H, app. q, J 6.5, 
CH2N), 6.01 (1 H, br s, NH), 6.66 (1 H, dd, J 161.0,15.5,2-H), 7.10 (2H, app. t, J 8.5, 
2x CHCF), 7.52-7.57 (2H, m, 2x Ar-H), 7.59 (1H, dd, J 15.5,2.5,3-H); 8ß(100 
MHz) signal assigned to C-2 (124.4 ppm, d, J 2.5) showed an enhancement of >90% 
(based on 'H NMR and MS data); m/z (EI) 268 (M+, 27%), 240 (50), 209 (75), 150 
(100), 122 (70), 102 (58), 86 (33) and 76 (27). N-Acyl urea 236: m. p. 169-170 °C 
(from ethyl acetate/petroleum ether 40-60 °C), vm. (neat)/cm' 3259 (CONH), 3045 
(CONH), 2932,2854,1703 (C=O), 1633 (C=O), 1508,1374,1227,1162,994,985, 
831,810; SH(400 MHz) 0.80-2.05 (20H, m, 10 x CH2), 3.76 and 4.09 (each 1H, each 
m, each NCH), 6.66 (1 H, dd, J 158.5,15.5,2-H), 6.92 (1 H, br s NH), 7.07 (2H, app. t, 
J 8.5,2 x CHCF), 7.44-7.50 (2H, m, 2x Ar-H), 7.64 (IH, dd, 1 15.5,3.5,3-H); 
Sc(100 MHz) signal assigned to C-2 (119.2 ppm) showed an enhancement of >90% 
(based on 'H NMR and MS data); m/z (ESI) 396 (MNa+, 100), 374 (28), 265 (29), 256 
(14), 185 (7) and 132 (11); Found (ESI) 396.2140 (MNa+), (C2113CH29O2N2FNa 
requires 396.2139). Addition compound 237: vm(neat)/cm 
1 3285 (CONH), 3079 
(CONH), 2931,1646 (C=O), 1548 (C=O), 1508 (C=O), 1432,1374,1290,1222, 
1039,975,725; 6H(400 MHz) 1.94 and 1.97 (each 3H, each s, each CH3), 2.47 (2H, t, 
J 7.0, CH2S), 2.83 (2H, t, J 6.5, CH2S), 3.00 (2H, m, 2-H2), 3.30-3.40 (2H, m, CH2N), 
3.55 (2H, app. q, J 6.5, CH2N), 4.35 (1H, dt, J 7.5,5.0,3-H), 6.26 and 6.33 (each 1H, 
each br s, each NH), 7.02 (2H, app. t, J 8.5,2 x CHCF), 7.32 (2H, m, 2x Ar-H); 
&(100 MHz) signal assigned to C-2 (50.2 ppm) showed an enhancement of >90% 
(based on 'H NMR and MS data); m/z (EI) 388 (M+, 56), 270 (46), 150 (100), 123 
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(41), 118 (52), 102 (34), 86 (52) and 60 (38); Found (EI): 388.1254 (Mt), 
(C1613CH24FN203S2 requires 388.1246). 
Ethyl (Z)-2,4-Dimethylhex-2-enoate 257158 and Ethyl (E)-2,4. Dimethylhex-2- 
enoate 260158 
000P 
^+ EtOEt O 
ýOEt 
/I _H 
IT 
254 256 
nBuU 
1XEt 
257 
O 
+ OEt 
260 
Triethyl 2-phosphonopropionate 256 (2.04 mL, 9.53 mmol) in dry THE (50 mL) 
under an atmosphere of nitrogen was cooled to 0 °C. n-Butyllithium (2.5 M in 
hexanes, 3.81 mL, 9.53 mmol) was added slowly and the mixture was stirred for 1 
hour. 2-Methylbutanal 254 (1.00 mL, 9.33 mmol) was then added dropwise and the 
resulting solution was stirred at room temperature for 17 hours. The reaction was 
quenched with water (40 mL), extracted with ethyl acetate (3 x 100 mL), dried over 
magnesium sulfate, filtered and concentrated in vacuo to yield a colourless oil. 
Purification by flash column chromatography (Si02,2% ethyl acetate/petroleum ether 
40-60 °C) furnished (Z)-ethyl ester 257 (1.04 g, 65%) and (E)-ethyl ester 260 (0.43 g, 
27%), both as colourless oils. (Z)-Ethyl ester 257: SH(400 MHz) 0.86 (3H, t, J 7.5,6- 
H3), 0.98 (3H, d, J 6.5,4-CH3), 1.22-1.40 (2H, m, 5-H2), 1.30 (3H, t, J 7.0, 
OCH2CH3)9 1.90 (3H, d, J 1.5,2-CH3), 3.01 (1H, m, 4-H), 4.20 (2H, q, J 7.0, 
OCH2CH3), 5.65 (1H, dq, J 10.0,1.5,3-H); 8ß(100 MHz) 11.8 (C-6), 14.3 
(OCH2CH3), 20.2 and 20.8 (2-CH3 and 4-CH3), 30.1 (C-5), 35.0 (C-4), 60.0 
(OCH2CH3), 126.1 (C-2), 148.3 (C-3), 168.4 (C-1). (E)-Ethyl ester 260: 6H(400 MHz) 
0.85 (3H, t, J 7.5,6-H3), 0.99 (3H, d, J 6.5,4-CH3), 1.25-1.45 (2H, m, 5-H2), 1.29 
(3H, t, J 7.0, OCH2CH3), 1.83 (3H, d, J 1.5,2-CH3), 2.39 (1H, m, 4-H), 4.19 (2H, q, J 
7.0, OCH2CH3), 6.53 (1H, dq, J 10.0,1.5,3-H); Sß(100 MHz) 11.9 (C-6), 12.5 
(OCH2CH3)9 14.3 (2-CH3), 19.7 (4-CH3)9 29.7 (C-5), 34.9 (C-4), 60.4 (OCH2CH3), 
126.6 (C-2), 147.8 (C-3), 168.5 (C-1). 
(E)-2,4. Dimethylhex-2-enoic Acid 263197 
O 
NaOH 
260 
OH 
263 
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Unsaturated ester 260 (0.22 g, 1.29 mmol) in ethanol (1 mL) was added dropwise into 
sodium hydroxide (2.0 M, 15 mL). The solution was heated to reflux for 17 hours. The 
reaction was quenched with water (30 mL) and was acidified to pH 2 with 
hydrochloric acid (2.0 M). The solution was stirred for 10 minutes and was then 
saturated with sodium chloride. The mixture was extracted with ethyl acetate (3 x 50 
mL) and the combined organic extracts were dried over magnesium sulfate, filtered 
and concentrated in vacuo to yield acid 263 as a colourless oil (0.20 g, 100%). This 
was used without further purification. 8H(400 MHz) 0.86 (3H, t, J 7.5,6-H3), 1.01 
(3H, d, J 6.5,4-CH3), 1.25-1.50 (2H, m, 5-H2), 1.85 (3H, d, J 1.5,2-CH3), 2.44 (1H, 
m, 4-H), 6.70 (1H, dq, J 10.5,1.5,3-H), 12.16 (1H, br s, COON); Sc(100 MHz) 11.9 
(C-6), 12.2 (2-CH3), 19.5 (4-CH3), 29.6 (C-5), 35.2 (C-4), 125.9 (C-2), 150.8 (C-3), 
174.3 (C-1). 
(E)-2,4-Dimethylhex-2-enoic Acid 263 and (Z)-2,4-Dimethylhex-2-enoic Acid 
272197,198 
O0 
+\ OEt -º + OH 
""'Tý NaOH 
O OEt 
X 
0H 
257 260 263 272 
The above procedure was repeated using a mixture of unsaturated esters 257 and 260 
(1.17 g, 6.87 mmol) to furnish a mixture of unsaturated acids 263 and 272 (0.98 g, 
100%) as a colourless oil. This was used without further purification. 8H(400 MHz) 
0.85 and 0.86 (each 3H, each t, J 7.5,2 x 6-H3), 0.97 and 1.01 (each 3H, each d, J 6.5, 
2x 4-CH3), 1.15-1.50 (4H, m, 2x 5-H2), 1.85 and 1.92 (each 3H, each d, J 1.5,2 x 2- 
CH3), 2.44 and 3.16 (each 1H, each m, 2x 4-H), 5.83 and 6.70 (each 1H, each dq, i 
10.5,1.5,2 x 3-H), 11.75 (2H, br s, 2x COOH); Sß(100 MHz) 11.8 and 11.9 (2 x C- 
6), 12.2 (2-CH3), 19.5 (4-CH3), 20.2 and 20.7 (2-CH3 and 4-CH3), 29.6 and 29.7 (2 x 
C-5), 35.1 and 35.2 (2 x C-4), 125.0 and 125.8 (2 x C-2), 150.9 and 152.2 (2 x C-3), 
174.1 and 174.2 (2 x C-1). 
(E)-2,4. Dimethylhex-2-enoic Acid N-Acetylcysteamine Thiol Ester 91" 
H OH0 
DCC, DMAP 
--ý SýýNIr OH + HS"' 
0O 
263 42 9 
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Acid 263 (0.18 g, 1.27 mmol) in dry DCM (40 mL) was stirred at 0 °C. DCC (0.34 g, 
1.61 mmol) in dry DCM (3 mL) was added, followed by DMAP (0.008 g, 0.06 mmol) 
in dry DCM (3 mL). This was stirred for 15 minutes before addition of N- 
acetycysteamine 42 (0.28 g, 2.37 mmol) in dry DCM (4 mL). The solution was left at 
0 °C for 2 hours and was then allowed to warm to room temperature overnight. The 
reaction was subsequently quenched with saturated aqueous ammonium chloride 
solution (10 mL) after 48 hours and was extracted with DCM (3 x 100 mL). The 
combined organic extracts were dried over magnesium sulfate, and copper sulfate 
impregnated silica (prepared by stirring flash silica in a saturated solution of copper 
sulfate for 10 minutes and then drying in vacuo to a free flowing powder), 70 was 
added to remove any unreacted N-acetylcysteamine 42. The solution was then filtered 
and concentrated in vacuo to yield a white solid. DCM was added (3 mL) to dissolve 
the product and the insoluble urea by-product was then filtered off. The filtrate was 
concentrated in vacuo and purified by flash column chromatography (Si02,50% ethyl 
acetate/petroleum ether 40-60 °C) to furnish the thiol ester 9 (0.15 g, 49%) as a 
colourless low melting solid. 6H(400 MHz) 0.87 (3H, t, J 7.5,6-H3), 1.03 (3H, d, J 
6.5,4-CH3), 1.27-1.52 (2H, in, 5-H2), 1.89 (3H, d, J 1.5,2-CH3), 1.96 (3H, s, 
COCH3), 2.44 (1H, m, 4-H), 3.06 (2H, t, J 6.5, CH2S), 3.41-3.49 (2H, m, CH2N), 6.05 
(IH, br s, NH), 6.54 (IH, dq, J 10.0,1.5,3-H); 8ß(100 MHz) 11.8 (C-6), 12.6 (2- 
CH3), 19.5 (4-CH3), 23.1 (COCH3), 28.5 (C-5), 29.6 (CH2S)9 35.1 (C-4), 39.8 
(CH2N), 134.6 (C-2), 147.4 (C-3), 170.2 (CON), 194.2 (C-1); m/z (ESI) 266 (MNa+, 
100%); Found (ESI): 266.1191 (MNa+); (C12H2jNO2SNa requires 266.1185). 
2,4-Dimethyihexanoic Acid 269200 
0 00 
+ OH Pd/C' H2 OH + OH 
O OH 7 bar c 263 272 () 269 () 
A mixture of unsaturated acids 263 and 272 (0.98g, 6.89 mmol) was dissolved in 
methanol (10 mL) and palladium on carbon (= 20 mg) was added. The solution was 
stirred under an atmosphere of hydrogen (at a pressure of 7 bar) for 2 days. The 
catalyst was filtered off and washed with methanol. The solvent was then removed in 
vacuo to yield an approximately 1: 1 mixture of the two diastereomeric pairs of acid 
269 (0.97g, 100%) as a colourless oil. SH(400 MHz) 0.83-0.92 (12H, m, 2x 4-CH3 
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and 2x 6-H3), 1.10-1.21 (10H, m, 2x 2-CH3 and 2x 5-H2), 1.24-1.47 (4H, m, 2x 3- 
HH and 2x 4-H), 1.53 (IH, m, 3-HH), 1.74 (1H, ddd, J 13.5,9.0,5.5,3-HH), 2.56 
(2H, m, 2x 2-H), 11.53 (2H, br s, 2x COOH); Sß(100 MHz) 11.1 and 11.2 (2 x C-6), 
16.8 and 17.8 (2 x 2-CH3), 18.8 and 19.0 (2 x 4-CH3), 29.5 (2 x C-5), 32.3 (2 x C-4), 
37.2 and 37.4 (2 x C-2), 40.4 and 40.9 (2 x C-3), 183.9 and 184.1 (2 x C-1). 
2,4-Dimethylhexanoic Acid N-Acetylcysteamine Thiol Ester 10 
O00HOH 
OH 
H 
0 
269 HS^/N' 
(*) 10 (_) 
42 
0 
Acid 269 (0.17 g, 1.18 mmol) in dry DCM (40 mL) was stirred at 0 °C. DCC (0.34 g, 
1.61 mmol) in dry DCM (3 mL) was added, followed by DMAP (0.008 g, 0.06 mmol) 
in dry DCM (3 mL). This was stirred for 15 minutes before addition of N- 
acetycysteamine 42 (0.28 g, 2.37 mmol) in dry DCM (4 mL). The solution was left at 
0 °C for 2 hours and was then allowed to warm to room temperature overnight. The 
reaction was subsequently quenched with saturated aqueous ammonium chloride 
solution (30 mL) after 2 days and was extracted with DCM (3 x 100 mL). The 
combined organic extracts were dried over magnesium sulfate, and copper sulfate 
impregnated silica (prepared by stirring flash silica in a saturated solution of copper 
sulfate for 10 minutes and then drying in vacuo to a free flowing powder) 170 was 
added to remove any unreacted N-acetylcysteamine 42. The solution was then filtered 
and concentrated in vacuo to yield a white solid. DCM was added (3 mL) to dissolve 
the product and the insoluble urea by-product was filtered off. The filtrate was then 
concentrated in vacuo and purified by flash column chromatography (Si02,50% ethyl 
acetate/petroleum ether 40-60 °C) to furnish the two diastereomeric pairs of thiol ester 
10 (0.22 g, 76%) as a colourless oil. v. (neat)/cm' 3288,2963,2930,1688 (C=O), 
1651 (C=O), 1549,1454,1374,1289,963,753; 8H(400 MHz) 0.78-0.87 (12H, m, 2x 
4-CH3 and 2x 6-H3), 1.06-1.15 (10H, m, 2x 2-CH3 and 2x 5-H2), 1.21-1.39 (4H, m, 
2x 3-HH and 2x 4-H), 1.47 (1 H, m, 3-HH), 1.73 (1 H, ddd, J 13.5,9.0,5.0,3-HH), 
1.93 (6H, s, 2x COCH3), 2.72 (2H, m, 2x 2-H), 2.98 (4H, t, J 6.5,2 x CH2S), 3.39 
(4H, q, J 6.5,2 x CH2N), 6.19 (2H, br s, 2x NH); Sß(100 MHz) 11.1 and 11.2 (2 x C- 
6), 17.6 and 18.7 (2 x 2-CH3), 18.9 and 19.1 (2 x 4-CH3), 23.2 (COCH3), 28.1 (2 x C- 
5), 29.4 (2 x CH2S), 32.0 and 32.2 (2 x C-4), 39.8 and 39.9 (2 x CH2N), 40.9 and 41.3 
-169- 
Chapter 6 Experimental 
(2 x C-3), 46.5 (2 x C-2), 170.2 (CON), 204.8 and 204.9 (COS); m/z (ESI) 268 
(MNa+, 100%); Found (ESI): 268.1347, (C12H23NO2SNa requires 268.1342). 
Ethyl 2,4-dimethylhexanoate 266158 
000 
+ OEt Pd/C, H2 OEt + OEt 
O OEt 7 bar 
257 260 (*) 266 (t) 
A mixture of unsaturated esters 257 and 260 (0.50 g, 2.94 mmol) was dissolved in 
methanol (5 mL) and palladium on activated charcoal (= 20 mg) was added. The 
solution was stirred under an atmosphere of hydrogen (at a pressure of 7 bar) for 3 
days. The catalyst was filtered off and washed with methanol. The solvent was then 
removed in vacuo to yield an approximately 1: 1 mixture of the two diastereomeric 
pairs of saturated ester 266 (0.51g, 100%) as a colourless oil. 8H(400 MHz) 0.83-0.90 
(12H, m, 2x 4-CH3 and 2x 6-H3), 1.13 (10H, m, 2x 2-CH3 and 2x 5-H2), 1.25 (6H, 
t, J 7.0,2 x OCH2CH3), 1.28-1.44 (4H, m, 2x 3-HH and 2x 4-H), 1.46-1.55 (1H, m, 
3-HH), 1.72 (1 H, ddd, J 13.5,9.5,5.0,3-HH), 2.45-2.57 (2H, m, 2x 2-H), 4.12 (4H, 
q, J 7.0,2 x OCH2); Sc(100 MHz) 11.0 and 11.1 (2 x C-6), 14.2 (2 x OCH2CH3), 17.0 
and 17.9 (2 x 2-CH3), 18.8 and 19.0 (2 x 4-CH3), 29.3 and 29.5 (2 x C-5), 32.1 and 
32.3 (2 x C-4), 37.3 and 37.4 (2 x C-2), 40.6 and 41.1 (2 x C-3), 59.9 and 60.0 (2 x 
OCH2CH3), 176.9 and 177.2 (2 x C-1). 
-170- 
Chapter 7 
Culture Work Experimental 
Chapter 7 Culture Work Experimental 
Preparation of Glucose Deficient L-Agar Slants 
Agar (3.00 g), ammonium sulfate (0.05 g), disodium hydrogen phosphate (0.26 g), 
glucose (0.11 g), monobasic potassium phosphate (0.24 g) and yeast extract (0.285 g) 
were mixed together and made up to 100 mL with water. The pH of the solution was 
adjusted to pH 7.0 with sodium hydroxide (1.0 M) prior to autoclave sterilisation at 
121 °C for 15 minutes. The L-agar solution was then melted in the microwave and 
approximately 2 mL aliquots were poured into sterile tubes which were then allowed 
to set on their side at a gentle slope. 
Preparation of Nutrient Broth 
Glucose (2.00 g) and nutrient broth no. 2 (3.00 g) and were mixed together and made 
up to the 100 mL with water. The pH of the solution was adjusted to pH 7.0 with 
sodium hydroxide (1.0 M) prior to autoclave sterilisation at 121 °C for 15 minutes. 
Rehydration of Pseudomonas f luorescens NCIMB 10586 
A freshly opened lyophile of P. fluorescens NCIMB 10586 was rehydrated by 
suspension in sterile nutrient broth (0.5 mL). The suspension was deposited in sterile 
nutrient broth (4.5 mL) with stirring to ensure homogeneity. 10 tL aliquots of this 
suspension were then pipetted onto the surface of the glucose deficient L-agar slants 
and spread over the surface with a sterile inoculating loop. These were left to grow at 
25 °C for 48 hours and were then stored in the fridge at 4 °C. Under these conditions 
the culture was viable for approximately 3 months. In accordance with the 
instructions issued with the lyophile, the bacteria was subcultured twice prior to use. 
Preparation of Glycerol Stock Solution 
A freshly opened lyophile of P. fluorescens NCIMB 10586 was rehydrated by 
suspension in sterile nutrient broth (0.5 mL). The suspension was deposited in sterile 
nutrient broth (4.5 mL) with stirring to ensure homogeneity. This solution was used to 
inoculate an L-agar plate (see below) and was allowed to grow for 24 hours at 25 °C. 
A single colony from the plate was used to inoculate a flask of primary stage medium 
(see below) and this was shaken at 250 rpm at 25 °C for 24 hours. Meanwhile a 
solution of glycerol (40 mL) was made up to 100 mL with water and sterilised by 
autoclave at 121 °C for 15 minutes. Equal measures of the glycerol solution and the 
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primary stage medium were then mixed together and transferred to vials for storage at 
-80 °C. 
Preparation and Inoculation of L-Agar Plates 
Agar (1.50 g), glucose (0.10 g), sodium chloride (1.00 g), tryptone (I. 00 g) and yeast 
extract (0.50 g) were mixed together and made up to 100 nil- with water. The pH of 
the solution was adjusted to pH 7.0 with sodium hydroxide (1.0 M) prior to autoclave 
sterilisation at 121 °C for 15 minutes. The L-agar solution was then melted in the 
microwave and poured into sterile petri dishes which were allowed to cool and set for 
20 minutes. A slope was flooded with 5 mL of nutrient broth and the bacteria was 
suspended in this by gently scraping the surface with a sterile inoculating loop. 
(Alternatively a glycerol stock solution from the freezer was used to inoculate the 
plates. ) The loop was then repeatedly dragged across the surface of the L-agar plate in 
a series of short lines, turning the plate in such a way as to dilute the concentration of 
bacteria each time (Figure 33). The plates were left to grow at 25 °C for 24 hours and 
then stored in the fridge at 4 °C. 
r, 
t 
Figure 33: L-agar plate inoculated with Pseudomonas fluorescens NCIMB 10586. 
Preparation and Inoculation of Primary Stage Medium 
Glucose (0.10 g), sodium chloride (1.00 g), tryptone (1.00 g) and yeast extract (0.50 
g) were mixed together and made up to 100 mL with water. The pH of the solution 
was adjusted to pH 7.0 with sodium hydroxide (1.0 M). 25 mL measures of media 
were then poured into 4x 250 mL flasks which were bunged and capped with tin foil 
prior to autoclave sterilisation at 121 °C for 15 minutes. Single colonies of bacteria 
were then selected from the L-agar plate using sterile tooth picks, which were then 
-172- 
Chapter 7 Culture Work E pe rimental 
placed in each flask. The flasks were shaken at 250 rpm for 24 hours at 25 °C. The 
solution became cloudy indicating bacterial growth (Figure 34). 
. ice ' 
250 
200 
150, 
'100 
Figure 34: Primary stage medium before inoculation (left) and after 24 hours growth 
(right). 
Preparation and Inoculation of Secondary Stage Medium 
Ammonium sulfate (10.00 g), calcium carbonate (13.50 g), spray dried corn steep 
liquor (5.00 g), disodium hydrogen phosphate (2.00 g), magnesium sulfate 
heptahydrate (1.00 g), monobasic potassium phosphate (3.00 g), potassium chloride 
(2.00 g) and soya flour (40.00 g) were mixed together and made up to 1500 ml- with 
water. Glucose (80.00 g) was dissolved in water and made up to 500 mL. The pH of 
both solutions was adjusted to pH 7.0 with sodium hydroxide (1.0 M) prior to 
autoclave sterilisation at 121 °C for 15 minutes. 20 x 500 mL baffled flasks were 
bunged and capped with tin foil and were also sterilised by autoclave. The glucose 
solution and primary stage medium (100 ml-) were then added to the rest of the 
medium and stirred vigorously. 105 mL aliquots were then transferred to each of the 
20 flasks with a sterile graduated cylinder. The flasks were shaken at 250 rpm for 50 
hours at 25 °C (Figure 35). 
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Figure 35: The secondary stage medium is shaken at 250 rpm for 50 hours at 25 °C. 
Extraction of P. fluorescens Secondary Metabolites 
The combined secondary media were centrifuged at 10,000 rpm for 15 minutes at 4 
°C. The supernatant was then acidified to pH 4.5 and extracted with ethyl acetate (3 x 
1,200 mL). The combined organic layers were dried over magnesium sulfate, filtered 
and concentrated in vacuo to yield the crude extract as an orange-brown oil. 
HPLC Analysis 
A 50 lL sample of supernatant was analysed by HPLC using the conditions set out 
below (Table 3). Under these conditions, pseudomonic acid A has a retention time of 
approximately 21.5 minutes. 
Column: Luna Ci8 (5µ, 4.6 x 250 mm, Phenomenex) 
Mobile Phase A: Water, containing 0.005% formic acid 
Mobile Phase B: Acetonitrile, containing 0.005% formic acid 
0-1 minutes: 95% A, 5% B 
1-2 minutes: ramp to 63% A, 37% B 
2-4 minutes: 63% A, 37% B 
Mobile Phase System: 4-20 minutes: ramp to I% A, 99% B 
20-23 minutes: I% A, 99% B 
23-25 minutes: ramp to 95% A, 5% B 
25-29 minutes: 95% A, 5% B 
Flow Rate: 1 mL min- 
Detector Wavelength: 233 nm 
Table 3: HPLC conditions. 
-174- 
Chapter 7 Culture Work Experimental 
Quantification of Pseudomonic Acid A 
A1 mg/mL volumetric standard of mupirocin was prepared using a 25 mL volumetric 
flask. 25 mg of mupirocin standard was dissolved in a small quantity of HPLC grade 
methanol and the solution was then made up to the mark with methanol. 12.5 mL of 
this solution was then pipetted into a second 25 mL volumetric flask and made up to 
the mark with methanol to prepare a 0.5 mg/mL solution. This procedure was 
repeated a further 6 times to obtain accurate volumetric solutions in the range required 
for pseudomonic acid quantification. Each of the solutions were then run in duplicate 
by HPLC and an average peak area for each solution was calculated (Table 4). The 
data was then correlated into a linear graph from which samples of unknown 
concentration could be determined (See Figure 9, Chapter 2). 
Standard Concentration (mg/mL) Average Peak Area (mAu*min) 
0.0078 5.0031 
0.0156 11.2256 
0.0313 21.8234 
0.0625 45.5028 
0.1250 87.1284 
0.2500 174.6765 
Table 4: HPLC values obtained for volumetric standards. 
Growth Production Study 
Samples of the fermentation broth were taken every two hours, starting ten hours after 
inoculation of the secondary stage medium. 1 mL aliquots were taken from two flasks 
at each interval, combined, micro-centrifuged and then the supernatant was analysed 
immediately by HPLC. The concentration of each sample was determined by 
comparison with the volumetric solution data and the pH of each solution was also 
measured (Table 5). 
Preparation of Ethereal Diazomethane 284175 
0 N=o E) 
KOH ON=N_ öÖ 
284 
283 
Caution: This reaction is potentially explosive and both reagents and products are 
carcinogens. For safety, ground glass joints must be avoided, acetic acid should be 
kept close by, heavy nitrile gloves should be worn and the fume cupboard should be 
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kept closed as much as possible. Potassium hydroxide (0.33 g, 5.89 mmol) was 
dissolved in water (2 mL) and diluted with ethanol (3 mL). This was then placed in 
the reaction flask (for safety reasons a preassembled distillation apparatus, containing 
no ground joints was used and acetic acid was kept beside the reaction flask at all 
times) and cooled to 0 °C. A solution of N-methyl-N-nitroso-p-toluenesulfonamide 
283 (1.25 g, 5.83 mmol) in diethyl ether (5 mL) was added dropwise. When addition 
was complete the ice bath was placed under the receiver flask and a water bath was 
used to warm the contents of the reaction flask to boiling. When the yellow 
diazomethane-ether mixture had finished distilling across and the reaction mixture 
had become colourless, the distillation was deemed complete. The product was used 
immediately. 
Sample Time pH Supernatant 
Area Pseudomonic Acid 
(mAu*min) 
Conc. Pseudomonic Acid 
(mg/mL) 
10 5.67 7.9016 0.0111 
12 5.55 18.7501 0.0263 
14 5.37 31.9608 0.0447 
16 5.49 46.3093 0.0648 
18 5.27 68.4713 0.0959 
20 5.39 66.8376 0.0936 
22 5.35 81.3070 0.1138 
24 5.22 98.4708 0.1379 
26 5.16 85.5693 0.1198 
28 5.18 102.0936 0.1429 
30 5.11 89.9922 0.1260 
32 5.04 93.1250 0.1304 
34 5.00 85.8140 0.1201 
36 5.12 72.2774 0.1012 
38 5.45 84.0376 0.1177 
40 6.11 75.8213 0.1061 
42 6.53 94.2643 0.1320 
44 6.48 79.1372 0.1108 
46 7.09 95.3378 0.1335 
48 6.96 113.3893 0.1587 
50 7.26 89.3494 0.1251 
52 7.25 115.4894 0.1617 
54 7.55 94.0669 0.1317 
56 7.78 88.8304 0.1244 777777d 
Table 5: Results of growth production study. 
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Methylation of P. fluorescens Extracts and Isolation of Methyl Pseudomonate 
Extracts of Pseudomonasfluorescens NCIMB 10586 were stirred in methanol, cooled 
to 0 °C and treated dropwise with an excess of ethereal diazomethane 284. The 
solution was stirred for 10 minutes and then the excess diazomethane was blown off 
with nitrogen. The resulting residue was then purified by column chromatography 
(Sephadex , 100% methanol; 
Si02,50-100% ethyl acetate/petroleum ether 40-60 °C) 
to afford methyl pseudomonate (0.04 g) as a white solid. For spectral data see Section 
2.4, Figure 12 and Figure 13). 
Feeding Study With [1,2-13C2]-9-hydroxynonanoic N-Acetylcysteamine Acid 
Thiol Ester 1 
Primary and secondary media were prepared and inoculated as described above. A 
solution of thiol ester 1 (60 mg) in ethanol (=1-2 mL) was diluted with water (: 48-49 
mL) and sterilised by autoclave at 121 °C for 15 minutes. 1 mL aliquots of this 
solution were transferred to each of 10 secondary stage media flasks 10 hours after 
inoculation. This was repeated hourly for a further 4 hours. The cells were harvested, 
methylated and purified as described above and 18 mg of methyl pseudomonate 
(slightly contaminated with an unknown impurity) were isolated. The 'H and 13C 
NMR spectra were identical to authentic material. 
Feeding Study With [3,3_2 H2]-3-hydroxypropanoic N-Acetylcysteamine Acid 
Thiol Ester 2 
Primary and secondary media were prepared and inoculated as described above. A 
solution of thiol ester 2 (100 mg) in ethanol (=1-2 mL) was diluted with water (=48- 
49 mL). 1 mL aliquots of this solution were transferred to each of 10 secondary stage 
media flasks 10 hours after inoculation. This was repeated hourly for a further 4 
hours. The cells were harvested, methylated and purified as described above. No 
methyl pseudomonate was isolated from the feed flasks nor from the control flasks. 
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